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Résumé 
1) Introduction 
La tectonique moléculaire est une partie de la chimie supramoléculaire traitant de la formation 
d’architectures périodiques mono-, bi- et tridimensionnelles.1, 2 Ces assemblages, décrits tels des 
réseaux moléculaires sont générés via l’auto-assemblage de briques moléculaires complémentaires 
nommées tectons. Ces derniers possèdent des sites de reconnaissance basés sur des interactions 
non-covalentes et réversibles. La dimensionnalité de l’assemblage généré est fonction du nombre, 
de la position, et de l’orientation des sites de reconnaissance localisés à la périphérie des tectons. 
L’itération du processus de reconnaissance entre les tectons conduit ainsi à la formation 
d’architectures moléculaires de géométries et dimensionnalités variées, la reconnaissance entre les 
briques s’effectuant via des interactions supramoléculaires réversibles. Cette réversibilité est 
primordiale au processus puisqu’elle conduit ainsi à la formation d’architectures ordonnées 
thermodynamiquement stables. Le processus de reconnaissance entre les tectons peut faire 
intervenir un seul type d’interactions supramoléculaires mais il est également possible de générer 
des réseaux moléculaires via des interactions supramoléculaires de plusieurs types. Un grand 
nombre d’architectures périodiques utilisent des interactions directionnelles telles que la liaison de 
coordination ou la liaison hydrogène, l’avantage étant de permettre ainsi une certaine maitrise de 
la topologie de l’assemblage final formé.   
Les réseaux de coordination sont obtenus par assemblage de tectons possédant des sites de 
coordination et des cations métalliques. Ces interactions sont sélectives, directionnelles et 
d’énergie relativement fortes (ca  50-100 kJ/mol) sur l’échelle des interactions supramoléculaires.3  
Des ligands tels que porphyrines ou de dipyrrines ont été largement utilisés pour la formation de 
réseaux de coordination et ce grâce à leur stabilité mais également leur capacité à complexer un 
grand nombre de cations métalliques. Outre leur capacité à complexer des cations métalliques dans 
leur cavité centrale, les porphyrines peuvent également proposer des sites coordinants en position 
méso et/ou β pyrroliques.4 Une dipyrrine est schématiquement comparable à une demi-porphyrine 
et possède donc les propriétés associées.  Des tectons à base de pyridines ou de terpyridines ont 
également été largement utilisés pour la formation de polymères de coordination de topologie et 
géométries variées. 
 
Figure 1: Structure de ligands coordinants: porphyrine, dipyrrine, pyridine, terpyridine (de gauche à 
droite). 
Les liaisons Hydrogène ou liaisons H  (D-H· · ·A) sont de interactions directionnelles se produisant 
entre un site donneur, D-H (D étant un atome électronégatif) ) et un site accepteur, A. La 
polarisation de la liaison D-H associée à la présence de doublets non liants sur le site A conduisent 
à une interaction D-H---A dont l’énergie reste relativement forte (ca 4 to 60 kJ/mol). Cette 
interaction est directionnelle, réversible et aisément modulable par différents stimuli externes tels 
que la température, le pH, la nature du solvant, ou encore la  concentration.5,6   Ainsi,  de multiples 
réseaux moléculaires à base de liaisons hydrogène ont été décrits dans la littérature. Les liaisons 
H ont également été utilisées comme interactions secondaires dans les réseaux de coordination.7 
La liaison hydrogène est une interaction largement utilisée pour stabiliser les édifices dans les 
organismes vivants. Ainsi, ce sont les liaisons hydrogène entre bases nucléiques (NBs) 
complémentaires qui conduit à la double hélice d’ADN et d’ARN (Figure 2). 
 
Figure 2: Les NBs présentes dans l’ADN ou l’ARN .  
 
Les NBs se classent en deux catégories: les pyrimidines : Cytosine (C), Thymine (T) and Uracil 
(U) et les purines :   Adenine (A) and Guanine (G).8  Le processus d’appariement des brins d’ADN  
est basé sur la complémentarité des NBs au travers d’interactions dites de Watson-Crick , du nom 
des chercheurs les ayant mises en évidence (figure 3).9 Cette complémentarité s’effectue grâce à  
la formation de 2 ou 3 liaisons hydrogène entre les purines et les pyrimidines complémentaires. 
Ainsi, les paires A-T et A-U sont générées (Ka ca. 10
2 M-1) via la formation de deux liaisons 
hydrogène entre l’Adénine (A) et ses purines complémentaires : la Thymine T (X=CH3) ou 
l’Uracile U  (X=H) respectivement.10 De même, la Guanine G est complémentaire à la Cytosine 
C via la formation de 3 liaisons hydrogène conduisant ainsi à la formation de la paire G-C avec 
une constante d’association Ka  de l’ordre de 10
5 M-1  et donc bien supérieure aux paires 
précédentes.11   
 
Figure 3: les appariements dits de Watson-Crick :  A-T et G-C 
Les appariements de Watson-Crick sont les plus connus, mais il existe de nombreuses autres 
possibilités d’appariements des NBs. Ainsi près de 30 combinaisons ont été identifiées, ceci 
incluant les auto-appariements puisque les 5 NBs sont auto-complémentaires.12   Ces propriétés 
ont suscité un grand intérêt pour les NBs et notamment dans le design de réseaux moléculaires à 
base de liaisons H.13  Outre leur capacité à interagir au travers de la formation de liaison H, les 
NBs peuvent également interagir avec des cations métalliques via les doublets non liants présents 
sur les azote ou les oxygène. Des systèmes à base de NBs judicieusement fonctionnalisées ont 
ainsi trouvé de nombreuses applications telles que par exemple le transfert d’énergie, le transfert 
d’électrons, la formation de gels, les récepteurs biologiques, ou l’administration de médicaments.14 
 
L’un des buts de la tectonique moléculaire est une meilleure compréhension des mécanismes 
conduisant à la formation de réseaux moléculaires, mais aussi la possibilité de prédire la topologie 
des assemblages formés. Il s’agit également d’optimiser les processus de synthèse afin de générer 
des assemblages ciblés à partir de briques moléculaires pré-programmées.  Le but ultime est de 
pouvoir non seulement maitriser la topologie mais aussi les propriétés des architectures formées.  
Ainsi, la formation de tectons fonctionnalisés par des NBs est un sujet d’intérêt dans le champ de 
la tectonique moléculaire. Le but de ce travail de doctorat vise la synthèse d’une librairie de tectons 
de géométries variées substitués par des NBs et possédant également des sites coordinants (Figure 
4). De telles briques moléculaires devraient permettre de générer des assemblages infinis dans 
lesquels les liaisons de coordination et les liaisons H seraient impliquées dans le processus de 
reconnaissance. Ces interactions sont toutes deux directionnelles, permettant ainsi en principe une 
certaine prédiction quant aux assemblages possibles en fonction de conditions données. De plus, 
on peut s’attendre à la formation de réseaux moléculaires de coordination stabilisés par la présence 
de multiples liaisons H additionnelles. Pour le site coordinant nous avons ciblé le macrocycle 
porphyrinique, la dipyrrine, la terpyridine et la pyridine.  
 
Figure 4: Représentation des tectons ciblés.  
 
2)  Résultats et Discussion 
Le macrocycle porphyrinique est d’un grand intérêt en chimie supramoléculaire et plus 
particulièrement en tectonique moléculaire.15 Il peut accepter de nombreux cations métalliques 
dans sa cavité centrale. De plus, il peut être fonctionnalisé à sa périphérie par des sites additionnels 
(sites coordinants, et/ou donneurs ou accepteurs de liaisons H), et son caractère aromatique permet 
la formation d’interactions additionnelles de type  π-π stacking. La première partie de ce travail de 
thèse traite de la synthèse de porphyrines fonctionnalisées par 2 ou 4 NBs et de leur cristallisation 
en présence ou non de cations métalliques additionnels afin de générer des réseaux moléculaires à 
l’état cristallin. En fonction du nombre et de la nature des NBs positionnées à la périphérie de la 
porphyrine, il est possible d’envisager la formation de différents types de réseaux moléculaires.  
La formation de tectons porphyriniques possédant deux NBs en position trans peut s’envisager 
selon plusieurs stratégies. Nous en avons principalement étudié deux (Figure 5). La première est 
basée sur la formation d’une liaison C-C entre la porphyrine et la NBs via une réaction de couplage 
pallado-catalysée (figure 5, réaction de Suzuki et réaction de Sonogashira). Dans un second temps, 
nous avons mis à profit une réaction d’alkylation impliquant les différentes NBs et une porphyrine 
judicieusement substituée (figure 5, bas). 
 
Figure 5: Schéma rétrosynthétique envisagé pour former des porphyrines trans substituées par de 2 NBs. 
Dans un premier temps, nous avons étudié la connexion de NBs à la porphyrine via un couplage 
de Suzuki (Figure 5). La 10,20-dipentyl-porphyrine a été synthétisée, dibromée en position trans.   
La réaction de cette dernière avec le  4,4,5,5-tétraméthyl-1,3,2-dioxaborolane conduit à la 
formation d’un mélange de porphyrines mono et di- « boronée ».16  Un premier essai de couplage 
a été effectué avec le 5-bromouracile (Br-U) préalablement protégé par un groupement 
benzylhydryle en suivant une procédure décrite .17 La réaction de Suzuki entre ce bromouracile 
protégé et la porphyrine « boronée » conduit invariablement à la formation de la 10,20-dipentyle-
porphyrine et non au produit ciblé.  
Nous avons ensuite étudié le couplage de Sonogashira selon une procédure one-pot entre des NBs 
et une porphyrine substituée en position méso trans par des groupements éthynyles protégés. 
(Figure 6). Le complexe porphyrinique de départ, la  5,15-dipentyl-10,20-
(triméthylsilyléthynyle)porphyrine de zinc  (ZnPo1) est obtenue via une réaction dite 2+2 entre le 
dipyrrylméthane (C5-DPM)  et le (triméthylsilyle)propionaldéhyde en présence de BF3.Et2O dans 
le CHCl3 suivi de la métallation de la cavité porphyrinique par du Zn(II) (Figure 6).
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Figure 6: Synthèse de Po1 and Zn-Po1. 
Le 6-iodouracile est protégé par un groupe benzylhydryle selon une procédure décrite conduisant 
à la formation du N1-hydryl-6-iodouracile (I-U-Ph2) (Figure 7(a)).17 La réaction de la porphyrine 
Zn-Po1 avec le I-U-Ph2 selon un couplage de Sonogashira conduit, après purification, à la 
formation du tecton ciblé, T1, avec un rendement de 88 % (Figure 7(b)). La déprotection de 
l’uracile est effectuée par traitement de T1 par une solution d’acide triflique (10%) dans le TFA17 
Ceci conduit à la formation d’un précipité vert de 5,15-diuracil-10,20-dipentylporphyrin (T2) avec 
un rendement de 80 % (Figure 7(c)). T2 est très faiblement soluble dans la plupart des solvants 
organiques et sa caractérisation s’est avérée délicate. Cette faible solubilité peut être expliquée par 
l’auto-assemblage de T2 en solution du fait de l’auto-complémentarité du tecton formé via la 
formation de liaisons H entre les uraciles de porphyrines adjacentes. Aucun essai de cristallisation 
n’a à ce jour conduit à la formation de monocristaux.  
Figure 7: Synthèse de  T1 and T2. 
 
Afin d’optimiser la solubilité du tecton final, nous avons voulu remplacer le groupement 
benzylhydryle par une chaine alkyle en C6. L’alkylation de l’uracile est effectuée en faisant réagir 
2 équivalents de iodouracile avec 1.3 équivalent de Cs2CO3 et 1 équivalent de1-bromohexane dans 
la DMF anhydre. L’uracile alkylé, I-U-C6, est obtenu avec un rendement de 94%. Il est mis à réagir 
avec Zn-Po1 dans des conditions similaires à celles utilisées pour la synthèse de T1, ce qui conduit 
à la formation de Zn(II)[5,15-di(N1-hexyluracil)-10,20-dipentylpoprhyrine, T3, avec un 
rendement de 80 % (figure 8). T3 a été caractérisé par RMN, UV-Vis, IR, and HRMS. Des cristaux 
de T3 ont également été obtenus mais leur qualité n’était pas suffisante pour permettre une 
caractérisation par diffraction des rayons X (DRX).    
 
Figure 8: Synthèse de T3. 
Nous avons tenté de reproduire la même réaction entre Zn-Po1 et la 8-iodo-adenine ou la 6-iodo-
cytosine préalablement alkylées, mais n’avons pu isoler les tectons ciblés.  
Nous avons donc exploré une deuxième stratégie qui consistait à connecter les NBs à la périphérie 
de la porphyrine via des liaison C-N impliquant les sites NH des NBs.  
La substitution des sites N1 des pyrimidines et N9 des purines avec des chaines alkyles ont  été 
décrites.19, 20, 21 Nous l’avons-nous-même mise précédemment à profit pour synthétiser I-U-C6. 
Cette stratégie appliquée à une porphyrine substituée en position méso par 2 ou 4 p-
bromométhylphényle devrait conduire à des tectons fonctionnalisés par 2 ou 4 NBs 
respectivement. 
Nous avons dans un premier temps ciblé la porphyrine précuseur : la 5,15-di(4-
bromomethylphényl)-10,20-di(phényl)porphyrine. Pour ce faire nous avons fait réagir le 4-
(bromométhyl)benzaldéhyde (Ald-Br) avec le phényl-dipyrrométhane (Ph-DPM) (figure 9), en 
visant ainsi la formation exclusive de la porphyrine trans-A2B2 ciblée. Malheureusement, ces 
conditions conduisent à la formation d’un mélange de porphyrines, pouvant être expliqué par le 
phénomène de scrambling. Nous avons néanmoins tenté de séparer les différents constituants du 
mélange par chromatographie sur colonne. La porphyrine symétrique A4, ou méso-
tétraphénylporphyrine (TPP) a ainsi pu être isolée. Par contre les porphyrines A2B2 (cis and trans) 
A3B, et AB3 ont été beaucoup plus délicates à purifier du fait de leur polarité très proche. Nous 
avons tenté de faire réagir ce mélange avec un excès de thymine dans le but de fonctionnaliser 
l’ensemble des porphyrines et ainsi générer des tectons de différence de polarité plus marquée. Le 
mélange de porphyrines Po2 (figure 9) est mis à réagir avec un excès de thymine en présence de 
K2CO3 dans la DMF. Le mélange obtenu est purifié sur colonne. La porphyrine A3B, 5-(N1-
méthylphénylthymine)-10,15,20-triphenylporphyrin (T4), a ainsi pu être isolée. Malheureusement 
les autres constituants du mélange n’ont pas pu être purifiés.   
 
Figure 9: Synthèse de T4. 
 
Afin de diminuer les possibilités de scrambling, nous avons remplacé Ph-DPM par le mésityl-
DPM. En effet, il a été montré que l’utilisation d’un DPM encombré pouvait limiter le scrambling 
lors de la réaction. Nous avons également modifié le catalyseur et utilisé le TFA plutôt que 
BF3.Et2O.  Ainsi, Ald-Br réagit avec le mésityl-DPM en présence de TFA suivant un protocole 
décrit pour des composes similaires.38(a) La 5,15-di(4-(bromométhylphényl)-10,20 
dimésitylporphyrin (Po3) a ainsi pu être isolée avec un rendement de 15%. (Figure 10).  
 
Figure 10: Synthèse de  Po3. 
Po3 réagit avec la thymine et avec l’adénine en présence de K2CO3 dans la DMF pour former 
respectivement  la 5,15-di(N1-méthylphénylthymine)-10,20-dimésitylporphyrin (T5) et la 5,15-
di(N1-méthylphenyladénine)-10,20-dimésityl porphyrin (T6) avec un rendement de 72 % et 54 % 
(Figure 11).  
L’utilisation d’une base plus forte, NaH, a été necessaire avec la cytosine 9(b) et a permis d’isoler 
le tecton T7 avec un rendement de 37% (Figure 11). 
Pour le tecton T9 nous avons procédé en deux étapes du fait de la faible solubilité de la guanine. 
Ainsi, nous avons fait réagir la 2-amino-6-chloropurine P avec Po3 en présence de K2CO3 dans le 
DMF. T8 est isolé avec un rendement de 88% . L’hydrolyse de T8 par une solution aqueuse de 
HCl conduit à la formation de T9 possédant deux guanines en position méso trans avec un 
rendement de 98%. (Figure 11).  
 
Figure 11: The synthesis of T5-T9. 
 
Nous avons également voulu introduire 4 NBs à la périphérie de la porphyrine. La porphyrine de 
départ, la 5,10,15,20-tétrakis(4-(bromométhyl)phényl)porphyrin (Po4) est synthétisée en faisant 
réagir du pyrrole et du 4-(bromométhyl)benzaldehyde selon une procédure décrite.11  (Po4) réagit 
avec un excès de thymine en présence de K2CO3 et conduit à la formation de la porphyrine 
tétrasubstituée par 4 thymines, T8, avec un rendement de 70%. Nous avons effectué le même type 
de réaction à partir de Po4 et de la cytosine ou de l’adénine. Malheureusement dans ces deux cas, 
seules des espèces fortement insolubles sont formées.  
 
Figure 12: Synthèse de  T10. 
 
Nous avons ainsi mis au point la synthèse de 10 nouveaux tectons porphyriniques contenant des 
NBs. Ces tectons ont tous été caractérisés par RMN, UV-Vis, IR et HRMS. De nombreux essais 
de cristallisation, en présence et absence de cations métalliques additionnels ont été effectués afin 
de caractériser les assemblages obtenus par DRX. A ce jour aucune caractérisation structurale n’a 
abouti, mais de nombreux essais de cristallisation sont toujours en cours. Nous avons également 
tenté de générer des assemblage de tectons complémentaires tels que par exemple T5 avec T6 ou 
T7 avec T9. Ces essais sont également toujours en cours.  
Dans un deuxième temps, nous avons voulu étendre cette stratégie à d’autres sites coordinants et 
notamment les dipyrrines. Dans un premier temps nous avons utilisé une stratégie similaire à celle 
utilisée pour les porphyrines, en faisant réagir les NBs avec un dipyrrine substitué en position 5 
par un 4-bromométhyphényl. La première étape consistait à faire réagir du pyrrole avec du 4-
bromomethylbenzaldéhyde selon les conditions classiques d’obtention des dipyrrines. 
Malheureusement, aucun des essais effectués n’a conduit au dipyrrine ciblé. Nous avons donc 
utilisé une stratégie différente, détaillée figure 13 qui consistait à synthétiser dans une première 
étape un aldéhyde fonctionnalisé par une NB puis à le faire réagir avec le 2,4-diméthylpyrrole. Le 
4-(bromométhyl)benzaldéhyde est mis à réagir avec l’une des 4 NBs dans le DMF en présence de 
K2CO3 pour  T, A and P et en présence de  NaH pour C conduisant respectivement à la formation 
de T-Ald, A-Ald, P-Ald et C-Ald  (Figure 13). Ces 4 aldéhydes réagissent séparément avec le 
2,4-diméthylpyrrole, et après oxydation au DDQ, 4 nouveaux tectons à base de dipyrrines (T11, 
T12, T13, T14) ont été isolés.  L’hydrolyse de T14 conduit au tecton T15 (Figure 13). Ces 5 
tectons ont été caractérisés par RMN, UV-Visible, IR and HRMS.   
 
Figure 13: Synthèse de  T11-T15. 
 
De nombreux essais de cristallisation de T11-T15 avec ou sans cations métalliques additionnels 
ont été effectués afin de permettre une caractérisation des assemblages formés par diffraction des 
RX. Nous avons obtenu des monocristaux de T11 (T-dipyrrin) en présence de Zn(OAc)2.2H2O. 
La résolution structurale par DRX montre que la dipyrrine a été métallée durant le processus de 
cristallisation conduisant à la formation d’un complexe bis-dipyrrine de zinc, T-dipyrrin-Zn(II), 
qui s’auto-assemble pour conduire à un réseau moléculaire à base de liaisons H (figure 14). L’ion 
Zn(II) est tétracoordiné par 2 dipyrrines et l’unité asymétrique contient 4 complexes bis-dipyrrine 
de zinc non équivalents (I, II, III, IV). Ces 4 complexes sont connectés via des liaisons H entre 
les thymines formant ainsi un tétramère (I-II-III-IV). Chaque tétramère est en interaction avec 2 
autres tétramères via des interactions CH---O impliquant le CH d’une thymine (position C125) du 
complexe III et le carbonyle d’une thymine du complexe IV conduisant ainsi à la formation d’un 
ruban monodimensionnel.    
 
 
Figure 14: Une portion du réseau 1D obtenu par auto-assemblage de T-dipyrrin-Zn(II) (T11).   
 
Dans une dernière partie, nous nous sommes intéressés à l’introduction de NBs à la périphérie de 
pyridine et de terpyridine via la stratégie concluante utilisée pour les porphyrines et les dipyrrines.    
Ainsi, la 4-bromométhylpyridine est mise à réagir avec la thymine, l’adénine, la cytosine, ou la  
4-chloro-2-aminopurine selon les conditions exposées précédemment. Ceci conduit à la formation 
de 4 nouveaux tectons, T-Py, A-Py, C-Py et P-Py (T16-T19) avec des rendements de 45%, 53 
%, 30 % and 30 % respectivement (Figure 15). P-Py est hydrolysé par une solution aqueuse de 
HCl (0.1 M) pour conduire à G-Py (T20) avec un rendement de 96% (Figure 15).  
N
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Figure 15: Synthèse de  T16-T20. 
Ces briques moléculaires ont été caractérisées par RMN, UV-Visible, IR and HRMS. De 
nombreux essais de cristallisation ont été effectués en présence et en absence de cations 
métalliques additionnels. Des monocristaux de T-Py, A-Py and C-Py ont été obtenus et analysés 
par diffraction des RX. T-Py (T16) s’auto-assemble via des liaisons H (NH—Npy) impliquant le 
NH de la thymine et l’azote de la pyridine d’un tecton adjacent, le tout conduisant à la formation 
d’un réseau 1D en zigzag.   Ces chaines 1D adoptent un empilement anti-parallèle via des 
interactions π-π additionnelles (Figure 16 (a)). L’auto-assemblage de A-Py conduit à la formation 
de dimères grâce à la formation de deux liaisons H entre adénine de tectons adjacents (Figure 16 
(b)). On note également la présence d’interactions supplémentaires de type π-π stacking entre les 
cycles des adénines mais également entre les cycles des pyridines. Enfin, C-Py s’organise à l’état 
solide via la formation de liaisons H entre cytosines pour ainsi former un réseau 
monodimensionnel. Chaque cytosine est en interaction avec 3 cytosines adjacentes via la formation 
de 4 liaisons H (Figure 16 (c)). De plus, les chaines adjacentes sont en interaction de type π-π 
stacking impliquant les cycles de cytosines.  
 
Figure 16: Portions des structures cristallines de (a) T-Py, (b) A-Py and (c) C-Py. 
Des essais de cristallisation ont été effectués avec de nombreux cations métalliques notamment 
des sels Co(II), Cd(II), Ag(II), Cu(II), Pd(II), Ni(II), Zn(II). Des monocristaux de A-Py ont été 
obtenus en présence de Cd(NO3)2.2H2O et en présence de HgCl2. Dans les deux cas, l’analyse par 
DRX montre que la pyridine est liée au cation métallique et que l’adénine est impliquée dans la 
formation du réseau soit au travers de liaisons de coordination et de liaisons H dans A-Py-Cd(II) 
soit uniquement au travers de liaisons de coordination dans A-Py-Hg(II).   
Le complexe A-Py-Cd(II) s’organise en une architecture infinie impliquant deux types 
d’interactions: des liaisons de coordination et des liaisons H (Figure 17). Le Cd(II) hexacordiné,  
4 tectons A-Py occupant le plan équatorial et deux nitrates occupant les deux positions apicales.  
Le plan équatorial est occupé par deux pyridines en trans, les deux autres positions étant occupées 
par 2 adénines liées au cation métallique par l’azote N3 (figure 17). Chaque tecton joue ainsi le 
rôle de ligand bidentate pontant entre deux Cd(II), ce qui conduit à la formation d’un réseau 
monodimensionnel de type ruban dont la stœchiométrie est de 2 A-Py pour 1 Cd(II). Des 
interactions additionnelles de type liaisons H entre les adénines de rubans adjacents (figure 17) 
conduisent au réseau 2D final (Figure 17).  
 
Figure 17: Une portion de la structure de A-Py en présence de Cd(II).  
  
En présence de Hg(II), A-Py forme une structure en hélice pour laquelle la stœchiométrie 
ligand/Hg1 est de 1/1(figure 18 haut). Un deuxième cation Hg2, non équivalent à Hg1, est présent 
dans la maille.  La stœchiométrie finale est différente à celle obtenue avec le Cd(II) puisqu’elle est 
ici de 1 A-Py pour 2 Hg(II).    Hg1 est tétracoordiné et adopte une géométrie tétraédrique déformée. 
Sa sphère de coordination est formée de deux chlorures et de deux ligands A-Py, l’un coordiné via 
la pyridine et le deuxième via l’azote N5 de l’adénine. Ainsi, dans la structure obtenue, A-Py joue 
à nouveau le rôle de ligand bidentate pontant entre deux Hg1, conduisant ainsi à la formation d’une 
hélice (figure 18 haut). Hg2 est en interaction avec l’azote N3 de chaque adénine ainsi qu’avec 3 
chlorures dont l’un, Cl1, fait office de ligand pontant entre Hg1 et Hg2 (Figure 18 bas). Ainsi, dans 
cette structure, l’adénine présente est uniquement impliquée dans des liaisons de coordination, et 
le ligand A-Py forme 3 liaisons de coordination : 2 avec un Hg1 et une avec Hg2 
 
Figure 18: Une portion de la structure obtenue pour A-Py en présence de Hg(II). 
 
Nous avons également pu isoler des monocristaux de C-Py en présence de Zn(NO3)2.6H2O et de 
Cd(NO3)2.4H2O.  Dans les deux cas, le cation métallique est présent dans la structure avec une 
stœchiométrie M(II) / C-Py égale à 1 / 1. Deux C-Py sont connectés à deux cations métalliques, 
Zn(II) ou Cd(II), de façon convergente, ce qui conduit à la formation de dimères, M2(C-Py)2 (figure 
19, gauche).  Dans le cas du Zn(II), chaque C-Py fait office de ligand bidentate pontant. Ainsi 
chaque Zn(II) est coordiné par une pyridine et une cytosine, deux nitrates venant compléter la 
sphère de coordination du cation métallique.  Les cytosines sont impliquées dans des liaisons H 
additionnelles, impliquant les oxygènes des carbonyles et les groupements NH2 (figure 19) , ainsi 
chaque ligand est impliqué dans deux liaisons de coordination et deux liaisons H  
En présence de Cd(II), C-Py forme un dimère comparable via la coordination pontante de C-Py à 
deux Cd(II). De plus, la cytosine chélate le Cd(II) en occupant deux positions en cis du cation 
métallique hexacoordiné (figure 19 droite). Enfin, la sphère de coordination du Cd(II) est 
complétée par 3 nitrates bidentates, l’un étant chélatant et les deux autres étant pontants entre deux 
dimères.  
 
Figure 19: Une portion de la structure obtenue à partir de C-Py en présence de (a) Zn(II) (les anions ont 
été omis par souci de clarté)  et (b) Cd(II)  
 
Dans un dernier temps, nous avons ciblé la formation de tectons à base de terpyridine. Ainsi T,A, 
C ou P réagissent avec la 4'-(4-(bromométhyl)phényl)terpyridine (terPy) dans la DMF en 
présence de base (Figure 20). T-terPy, A-terPy, C-terPy and P-terPy (T21-T24) sont formés 
avec des rendements de 40 % , 54 %,  79% et 43% respectivement. L’hydrolyse de T24 conduit 
au tecton G-Terpy (T25) (Figure 20) avec un rendement de 98%.  
 
0 Synthèse de T21-T25. 
 
Ces 5 nouveaux tectons (T21-T25) ont été caractérisés par RMN, UV-Visible, IR and HRMS. De 
nombreux essais de cristallisation ont été effectués en présence et en absence de cations 
métalliques additionnels. Des monocristaux ont été obtenus pour T-terPy en présence de 
Cu(OAc)2 ou de Cd(NO3)2.4H2O. Leur analyse par DRX a montré la formation de complexes T-
terPy-Cu(II) et T-terPy-Cd(II) (Figure 21). Dans les deux structures, le ligand terpyridine agit 
comme un ligand tridentate pour le cation Cu(II) ou Cd(II). Le complexe T-terPy-Cu(II) s’auto-
assemble en un dimère via la formation de deux liaisons H impliquant les thymines. Chaque dimère 
interagit avec deux dimères adjacents grâce à des interactions de type π-π stacking entre les 
terpyridines (Figure 21(a)). Dans la structure avec Cd(II), chaque complexe T-terPy-Cd(II) est 
en interaction H avec deux complexes adjacents (Figure 21(b)) impliquant les thymines. On 
observe également des interactions de type π-π entre les terpyridines.  
 
Figure 20: Une portion de la structure de (a) T-terPy-Cu(II) et de  T-terPy-Cd(II) (dans les deux cas, 
les anions en interaction avec le cation métallique ont été omis par souci de clarté) 
  
 
3) Conclusion générale 
  
Une librairie de 25 nouveaux tectons à base de porphyrines, dipyrrines, terpyridines ou pyridines 
substituées par des NBs a été constituée. Trois tectons porphyriniques (T1, T2 et T3) ont été 
obtenus via un couplage de Sonogashira entre une porphyrine substituée en position méso trans 
par des groupements éthynyles (Po1) et I-U-Ph2 ou I-U-C6. Malheureusement la même stratégie 
étendue à l’adénine ou à la cytosine n’a pas conduit aux tectons ciblés. Nous avons alors visé la 
substitution de porphyrines via la formation de liaisons C-N utilisant le site N1 des pyrimidines ou 
N9 des purines.  Nous avons fait réagir T, A, C, P et G avec la  5,15-di(4-(bromométhylphényl)-
10,20 dimésitylporphyrine et généré 5 nouveaux tectons : T5 -T9 (Figure 22). Cette même 
stratégie nous a également permis d’isoler le tecton T10, tétrasubstitué par 4 thymines en position 
méso.  Cette stratégie a également été fructueuse avec les dipyrrines et permis de générer les 
tectons T11-T16 ainsi qu’avec les pyridines et les terpyridines, T17-T25 (Figure 22). 
 
Figure 21: Représentation de la librairie des 25 tectons synthétisés.   
L’ensemble de ces tectons ont été caractérisés par RMN, UV-Visible, IR and HRMS et de 
nombreux essais de cristallisation ont été effectués en présence et en absence de cations 
métalliques additionnels. L’analyse DRX a été effectuée pour T16-T18. Les tectons à base de 
pyridine et d’adénine (T17) et de cytosine (T18) s’assemblent via la formation de liaisons H entre 
les NBs. Le tecton T16 forme également un réseau moléculaire à base de liaisons H mais dans ce 
cas la pyridine et la thymine sont toutes les deux impliquées dans la connectivité.  
En présence de Zn(II), le tecton T11 à base de dipyrrine et de thymine forme un réseau complexe 
de (T11)2Zn impliquant 4 complexes bis-dipyrrines non équivalents en interaction via des liaisons 
H entre les thymines présentes à leur périphérie.  
Des réseaux de coordination sont formés à partir de T17 en présence de Cd(II) ou de Hg(II) ainsi 
qu’à partir de T18 en présence de Zn(II) et Cd(II). Les pyridines sont impliquées dans des liaisons 
de coordination avec les cations métalliques présents. Les NBs font office de ligands coordinants 
(T17-Hg(II)) ou ligands coordinants et en interaction H (T17-Cd(II), and T18-Cd(II) et T18-
Zn(II)). Enfin, le complexe à base de terpyridine M(II)-T21 (M=Cu(II) ou Cd(II)) s’assemble à 
l’état solide par formation de liaisons H entre les thymines conduisant soit la formation de dimères 
(avec Cu(II)), soit à la formation d’un réseau moléculaire à base de liaisons H (avec Cd(II)).    
Ce travail est toujours en cours, notamment au travers des nombreux essais de cristallisation en 
cours, et il sera poursuivi par des essais de cristallisation supplémentaires. En effet, de multiples 
combinaisons sont possibles à partir de cette bibliothèque de 25 tectons permettant d’envisager 
des assemblages homoleptiques mais aussi hétéroleptiques, ajouter à un vaste choix des cations 
additionnels potentiels et à de nombreuses possibilités d’interactions additionnelles par liaison H.  
Il conviendra également de poursuivre l’effort de synthèse visant des tectons plus rigides à base 
de dipyrrines, ou de terpyridines, tels que cela avait été envisagé en début de thèse avec les 
porphyrines. De plus, la synthèse de complexes de type BODIPY ou d’hélicates à partir des 
dipyrrines T11-T16 serait un challenge particulièrement intéressant pouvant conduire à des 
assemblages aux propriétés originales.  
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‘‘The human mind adjusts itself to a certain point of view, and those who have regarded nature 
from one angle, during a portion of their life, can adopt new ideas with difficulty ’’ 
Antoine Lavoisier 
Science is the study of the structure and the behavior of the natural world through a series of 
hypotheses, observation and experiments. The constant source of inspiration provided by nature 
challenges scientists to keep on projecting new theories, developing new methods, and designing 
new materials. In the early years, chemists aimed to study the structural and the physical properties 
of natural elements. Observing nature’s complex architectures, inspired construction methods and 
engineering designs. Nowadays, chemists and engineers aim to mimic nature’s complex structures 
relying on two different approaches to construct new products, the “top-down” and the “bottom-
up” approach. 
 
Figure 1: Top-down and bottom-up approach 
 
The top-down approach, as shown in Figure 1, is based on the decomposition of larger materials 
into smaller ones going from the macroscopic level to the microscopic level using tools to cut, 
shape, and break down materials into the desired shape and size. This approach is limited to 
physical methods. However, the bottom-up approach uses the chemical properties of single 
molecules to build larger molecular architectures thus going from the atomic level to the 
macroscopic level. Chemists use this approach through different methods. The first technique deals 
with classical organic or inorganic molecular synthesis, and it is used for synthesizing medication 
for pharmaceutical and biological applications. The second method, to build large scaled materials, 
is covalent polymerization. Polymerization is famous in polymer industry to manufacture plastics, 
caoutchouc, latex and others. This procedure is based on the formation of covalent bonds through 
chain reactions between monomers resulting in long polymers of different chain length and 
molecular weight. The third method is molecular self-assembly, which relies on the principles of 
supramolecular chemistry. This process assembles building blocks into large architectures via 
weak and reversible interactions. 
In general, the first step to produce large scaled architectures is to synthesize monomers or building 
blocks, using the concept of covalent molecular synthesis. The second step is to polymerize 
monomers into large-scale polymer materials, or to self-assemble building blocks into 
supramolecular architectures. The second strategy is the main objective of this thesis, which deals 
with supramolecular chemistry and molecular tectonics.  
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I. Supramolecular chemistry 
The curiosity of chemists was not simply satisfied by the study of the behavior of atoms and 
molecules. Therefore, investigations started to extend beyond the atomic and molecular level into 
the supramolecular level. 
Principles of supramolecular chemistry were first introduced by Johannes Diderik van der Waals 
in 1873 and by Hermann Emil Fischer, who developed the concept of molecular recognition and 
host-guest chemistry in 1894. In the late 20th century, the Nobel Prize winners Donald J. Cram, 
Jean-Marie Lehn and Charles J. Pedersen elaborated the principles of host-guest chemistry through 
“their development and use of molecules with structure-specific interaction of high selectivity.” 
Professor Jean-Marie Lehn, who introduced the concept of supramolecular chemistry in 1978, 
stated, “Just as there is a field of molecular chemistry based on covalent bond, there is a field of 
supramolecular chemistry, the chemistry of molecular assemblies and of the intermolecular 
bonds”.1 He also defined supramolecular chemistry as “chemistry beyond the molecule”.2  
From these descriptions, several important points could be deduced. First, molecular synthesis 
generates molecules by covalent bonds via chemical reactions. However, supramolecular 
chemistry generates molecular architectures by non-covalent intermolecular bonds via the self-
assembly of building blocks. Second, the properties of supramolecular bonds differ from covalent 
bonds because of their reversible nature. Third, supramolecular chemistry is a combination of both: 
molecular synthesis (synthesis of building blocks) and molecular recognition.3  
The inspiration of supramolecular chemistry is related to biological components and processes. 
DNA, ribosomes, hemoglobin and millions of other biological and natural beings are organized, 
structured and function through interactions similar to those discussed in supramolecular 
chemistry. Even if, biological systems are still far more sophisticated than artificial systems, the 
concept of supramolecular chemistry has increased the level of understanding of chemical 
constructions of biological,4 organic, and inorganic materials with promising applications in gas 
storage,5 catalysis,6 photoactivity 7 and others.  
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II. Molecular Tectonics 
 
Molecular tectonics is a field of supramolecular chemistry dealing with the formation of one, two 
and three-dimensional periodic architectures. The term was proposed by Professor Stephan Mann 
in 1993.8 The general concept is to self-assemble molecular tectons or building blocks via 
intermolecular interactions into periodic architectures referred to as molecular networks 
(Figure 1).9 
 
Tectons offer complementary interaction sites leading to a recognition pattern through non-
covalent and reversible interactions, allowing the component to have the ability to self-repair into 
the most thermodynamically stable architecture. The iteration (repetition) of these interactions lead 
to the translation of the recognition pattern in space generating molecular architectures of different 
geometries and dimensionality. The role of supramolecular chemists is to control the self-assembly 
processes by controlling the design of tectons through classical molecular synthesis, which should 
in principle allow the prediction of the topology and geometry of the final assembly. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of the dimensionality of networks. 
 
 
0-D  1-D  
2-D  
3-D 
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II. 1. Molecular tectons 
Tecton comes from the word “tekton” from classical Greek, which means builder. In 
supramolecular chemistry, the word tecton is used to describe the building blocks or active 
molecular construction units designed by using classical molecular synthesis. These tectons bear 
recognition sites (chemical functionalities) which are able to generate certain recognition patterns 
formed by intermolecular interactions. The geometry and dimensionality of the final molecular 
network depends on the position, the orientation, the type and the number of the recognition sites 
of a tecton. Considering those parameters tectons could be classified into different groups.  
II. 1. a) Endo- and Exo-receptors 
Depending on the position and orientation of their recognition sites, tectons can be classified into 
two groups: the endo- and exo- receptors. 
The endo-receptors (Figure 2) possess interaction sites located in a convergent manner thus 
forming discrete architectures. Endo-receptors act as host molecules, and with a suitable substrate 
(guest molecule) they form host-guest complexes called inclusion complexes. Examples of such 
receptors are: crown ethers,10 cryptands11 and cages12.  
 
 
Figure 2: Schematic representation of endo-receptors. 
 
The exo-receptors (Figure 3) display interaction sites with divergent orientation. If exo-receptors 
have one recognition site and are joined with stopper building blocks, they form discrete 
complexes. On the other hand, if exo-receptors have more than one connecting site and are joined 
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with connector building blocks, they form infinite complexes called molecular networks, which 
will be further discussed.  
 
 
Figure 3: Schematic representation of endo-receptors. 
 
II. 1. b) Complementary and self-complementary tectons 
Considering the nature of interaction sites, two families of tectons may be distinguished. Tectons 
bearing complementary interaction sites are referred to as self-complementary tectons. Such 
tectons have the ability to self-assemble into a network on their own. Complementary tectons have 
un-complementary interaction sites and need a complementary partner to assemble into a 
molecular network (Figure 4).  
 
 
Figure 4: Schematic representation of self-complementary and complementary tectons. 
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Last but not least, the chemical nature and the number of recognition sites of tectons dictate the 
type of intermolecular interactions and the dimensionality of the final molecular network 
respectively, which is further elaborated in the following paragraphs.  
 
II. 2. Intermolecular interactions 
As mentioned previously, building supramolecular architectures requires the periodic organization 
of tectons through non-covalent intermolecular interactions, which direct the assembly processes 
by their strength, directionality and specificity. Those interactions are described as supramolecular 
interactions rather than bonds, because compared to covalent bonds they are weak and reversible. 
The use of weak and reversible interaction is an essential key to build a thermodynamically stable 
architecture, since it permits self-repairing processes to take place during the construction event. 
Several interactions, which vary in strength from 0.5 kJ/mol to 400 kJ/mol, offer these 
characteristics (Figure 5). In some cases, tectons assemble into molecular network via one type of 
intermolecular interactions. However, tectons with different interaction sites can assemble into 
networks via more than one intermolecular interaction.  
 
 
Figure 5: Energy scale of molecular interactions used for building supramolecular assemblies. 
 
II. 2. a) van der Waals interactions 
van der Waals interactions are weak attractive forces (0.4-4 kJ/mol) based on electrostatic 
interactions resulting from induced or permanent dipoles in molecules. There are three types of 
van der Waals interactions: 
1) Debye forces: are dipole-induced dipole interactions that take place between a permanent 
dipolar molecule and a polarizable molecule.   
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2) Keesom forces: are dipole-dipole interactions that take place between two permanent dipolar 
molecules. 
3) London forces: are induced dipole-induced dipole interactions that take place between two 
molecules with spontaneous dipoles.  
All of these interactions are non-directional, nor highly selective and only effective in a short 
range. Therefore, they only lead to macroscopic effect when combined in large numbers.  
 
II. 2. b) π-π interactions 
π-π interactions are attractive non-directional interactions slightly stronger (5-12 kJ/mol) than van 
der Waals interactions. They take place between aromatic molecules arranged in parallel fashion 
(π stacking) or in an edge-to-face orientation. Usually, one of the aromatic ring is more electron 
rich while the other is more electron poor. Those types of interactions are famous in molecular 
tectonics since they stack aromatic molecules in an optimal way to minimize repulsive interactions 
and to maximize attraction leading to a more stable network.  
 
II. 2. c) Hydrogen bonds 
Hydrogen bonds (D-H· · ·A) are attractive and directional interactions that take place between 
hydrogen donors (D-H) and a hydrogen acceptor (A). Hydrogen donors (D-H) are based on 
electronegative atoms bearing a labile hydrogen for example: alcohols (-OH), primary amines        
(-NH) and amides ((CO)-NH) functions. Hydrogen acceptors are electronegative functions such 
as ethers (-O-), carbonyls (-C=O) and tertiary amines (=N-). The interaction between a proton 
donor and a proton acceptor is referred to as hydrogen bond since a proton is shared creating a 
local bond between D and A. The average distance between D-A varies from 2.5 Å to 3.2 Å and 
the angle D-H· · ·A falls in a range of 120° to 180°. The energies of H-bonds can vary from 4 to 60 
kJ/mol and more making them relatively strong supramolecular interactions. H-bonds are observed 
frequently in natural architectures for example, the assembly of DNA through Watson-Crick 
hydrogen bonds between nucleobases. The latter is used in designing molecular networks through 
the assembly of H-bonding complementary tectons bearing nucleobases, which is the main concept 
of this thesis.  
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II. 2. d) Electrostatic interactions 
Electrostatic interactions are also known as charge-charge interactions. They are electric forces 
between molecules with the opposite or same charges (δ+ and δ-). Attractive electrostatic 
interactions exist between closely packed opposite charged molecules. Whereas, repulsive 
electrostatic interactions are present between molecules with the same charge. 
 
II. 2. e) Coordination bonds 
Coordination bonds are formed between coordinating sites of organic ligands and metal cations. 
These bonds are selective, directional and the strongest among supramolecular interactions (50-
100 kJ/mol). An organic ligand acts as Lewis base offering a lone electron pair to the metal cation, 
which acts as Lewis acid forming electrostatic attraction between the negatively polarized or 
charged donor atom of the ligand and the positively charged metal ion. Coordination bonds are the 
most popular interactions used in supramolecular engineering, due to their strength and their 
directionality, which enable them to replace multiple weak interactions.  
 
II. 3. Molecular networks 
For molecular tectonics, designing and synthesizing complementary or self-complementary 
tectons is followed by the self-assembly processes of the tectons in the crystalline phase. Playing 
on the orientation of recognition sites of tectons can lead to discrete (convergent orientation) or 
infinite (divergent orientation) architectures. As mentioned before, the approach of building 
infinite architectures is named molecular tectonics and the term molecular networks is given to 
these architectures. Molecular networks are produced by the iteration of the interaction processes 
between tectons that leads to the translation of the recognition patterns in space. Several factors 
can control the dimensionality and geometry of molecular networks, two of them being the number 
of interaction sites of a tecton and the directions of the translation process of the recognition pattern 
in space. 
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II. 3. a) Dimensionality and geometry of molecular networks 
1-D networks 
One-dimensional networks form the simplest category since the iteration process of the recognition 
pattern between tectons is translated into only one direction in space. Normally, 1-D networks are 
the result of the assembly of complementary tectons or self-complementary tectons possessing two 
divergent recognition sites. In literature, several examples of 1-D molecular networks are known, 
and they usual adopt a linear chain,13 zigzag chain,14 wavy15 or helical geometries16 (Figure 6).  
 
 
Figure 6: Schematic representation of geometries adopted by 1D networks. 
 
2-D networks 
Two-dimensional networks are generated when the iteration process of a recognition pattern 
between tectons is translated into two directions of space. 2-D networks consist of complementary 
tectons or self-complementary tectons offering at least three divergent recognitions sites forming 
recognition patterns translated in two directions in space. 2-D networks are represented as sheets 
or planes of different geometries such as planar17, sine wave18, or zigzag19 (Figure 7).  
 
Figure 7: Schematic representation of possible 2D sheets.  
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Depending on the number and orientation of recognition sites, 2D networks can display different 
motifs. For example, three recognition sites can result in a honeycomb20 arrangement while four 
recognition sites can result in a square-grid21 or a rectangular-grid22 arrangement depending on the 
orientation of the sites (Figure 8). 
 
Figure 8: Schematic representation of possible 2D motifs. 
 
3-D networks 
Three-dimensional networks are more complex architectures than 1-D and 2-D networks and it is 
more difficult to predict the final topology of such networks. 3-D networks are generated by 
complementary or self-complementary tectons having at least four divergent recognition sites, 
which allow the formation of recognition patterns translated into three non-coplanar directions in 
space. The most famous 3-D networks geometries are the cubic23 and the diamondoid24 (Figure 9). 
 
 
 
 
 
 
 
 
 
 
Figure 9: Schematic representation of 3D geometries.  
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In principle, all intermolecular interactions could be used to generate molecular networks (Figure 
5). The chemical function of the sites dictates which type of intermolecular interactions would 
assemble the tectons. Thus, designing molecular tectons and the chemical functions of their sites 
provide the ability to control the type of interactions between the tectons. The most used 
intermolecular interactions are coordination and hydrogen bonds because of their reversibility, 
directionality and relatively higher strength leading to the formation of Coordination Networks 
and Hydrogen Bonded Networks respectively. van der Waals and π-π interactions are also widely 
used in molecular tectonics, but they usually act as secondary interactions.  
 
II. 3. b) Coordination networks  
Coordination networks are generated through coordination bonds between organic tectons bearing 
coordinating sites and metallic centers. Tectons should possess at least two divergent interaction 
sites able to coordinate to the metal center, which interconnects in its turn consecutive organic 
tectons. Coordination networks are referred to as Coordination Polymers since they are “repeating 
coordination entities in 1, 2 or 3 dimensions”.25 They include pure inorganic networks and hybrid 
organic-inorganic networks or frameworks.  
The topology of coordination networks relies on the geometry of the metallic centers or complexes 
and the denticity and geometry of the organic tectons.  
 
II. 3. b) 1) Metallic centers  
For Coordination networks, metal centers act as bridges between organic tectons and form 
connecting nodes that are translated in space. The periodic table offers a variety of metals that can 
be used in building coordination networks. A metal cation can have all its coordination sites vacant 
and available to coordinate tectons or can have some of its sites vacant and others blocked by better 
coordinating ligands. Figure 10 shows the multiple geometries of metal centers. The choice of the 
metal cation is a primary factor in determining the geometry of the final assembly. Frequently used 
metallic centers are the d-block metals, due to their well-understood and predictable geometries 
and diverse properties.26 The f-block metals are also interesting due to their high coordination 
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number (up to 8 or 10) and their photophysical properties.27 Coordination networks may be based 
on one or more metal cations thus offering homo or heterometallic periodic architectures.  
 
Figure 10: Schematic representations of the geometries around a metallic center. 
 
II. 3. b) 2) Organic tectons bearing coordinating sites  
Organic coordinating tectons have the ability to coordinate various metallic cations via their 
coordinating atoms, primarily oxygen and nitrogen atoms of chemical functions such as 
carboxylates, alcohol or amine. The number and the orientation of the coordinating sites of the 
tecton control the dimensionality of the final network. As mentioned previously, organic tectons 
should have at least two divergent coordinating sites to generate an infinite architecture. The spatial 
orientation of those sites can differ from one tecton to the other resulting in different coordination 
networks. To describe the number of the sites, the term denticity is used. Figure 11 shows the 
different denticity of coordinating tectons. Monodendate, bidentate, tridentate and tetradentate 
tectons have one, two, three and four divergent coordinating sites respectively. Tectons with 
convergent coordinating sites are called chelate.  
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Figure 11: Schematic representations of possible denticity of organic coordinating tectons. 
 
The huge variety of possible combinations between organic tectons and metal cations results in 
infinite numbers of coordination networks with various features. Among widely used organic 
tectons are porphyrins because of their unique electronic structure and stable macrocyclic square 
planar geometry.28 Furthermore, they are perfect candidates for constructing 1D, 2D and 3D 
coordination networks due to their tetraaza core that has the ability to coordinate various metal 
cations, and their meso and β-pyrrolic positions that could be functionalized by peripheral 
coordinating substituents.  
An example of a tecton based on a porphyrin is the (5,10,15,20-tetrakis(4-
carboxyphenyl)porphyrin),29 TCPP, which assembles into a 2D coordination polymer upon 
complexation with Zn(NO3).2H2O. The Zn2+ ions are incorporated into the central core of the 
porphyrin and result in the formation of ZnTCPP repeating units linked by paddle-wheel Zinc-
dimers (Zn2(carboxylate)4) acting as a secondary building units (SBU) and leading to the formation 
of square grids. The Zn-TCPP-Zn flat 2D network is stabilized by the completion of the Zn2+ 
coordination sphere by water molecules, one binding the axial site of the central Zn2+ ion of 
ZnTCPP and the other two binding the two axial positions of Zn2(COO)4. The 2D sheets are 
stacked along the c axis, however no strong binding interactions are observed between the layers 
(Figure 12). 
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Figure 12: (a): The chemical structure of H2TCPP (b) 2D coordination network of ZnTCPP-connected by 
Zn dimers. (c) Successive layers along the c axis. Figure taken from reference 29. 
 
Another attractive molecular motif to build coordination polymers is the dipyrrin scaffold. 
Dipyrrin ligands are half porphyrin-like coordinating tectons with similar properties. They can 
interact with various metallic cations and they are easily substituted by peripheral coordinating 
sites. Therefore, they are suitable tecton to build 1D, 2D and 3D coordination networks.  
An example of a 1D coordination network based on dipyrrin tectons is the one obtained from 
bis(dipyrrinato)Zn(II) complex (Figure 13), which self-assembles into a 1D polymeric chains via 
the coordination of the Zn(II) center.30 
 
 
Figure 13: (Top) The formation of the 1D network based on bis(dipyrrinato)Zn(II) complex (Bottom) 
Crystal Structure of the 1D chain. Figure modified from reference 30.  
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Pyridine based tectons are often used along with their bipyridine derivatives and the terpyridine 
analogues. Numerous coordination networks have been generated through the coordination of 
pyridine based tectons to a wide range of metallic centers.  
An interesting example of such networks is the 3-dimensional polymeric network described by C. 
S. Hawes et al 31 based on ligand (L): α,α-p-xylylenebis (1-(4-pyridylmethylene)-piper-4-azine). 
The coordinating tecton (L) is an unusual long and highly flexible divergent ligand bearing two 
trans pyridine. (L) assembles into a coordination network in the presence of cadmium nitrate and 
terephthalic acid (H2TPA). The cadmium ions are coordinated by two pyridine groups of L 
molecules and two carboxylate groups of H2TPA, both acting as bridges between two metal 
centers. Bridging through (L) and TPA linkages leads to a 3-dimensionnal distorted diamondoid 
topology with an 8-fold interpenetration forming a densely packed structure stabilized by various 
van der Waals contacts and C-H···π interactions (Figure 14).  
 
 
Figure 14: (a) The crystal structure of (L). (b) The coordination environment of Cd(II) ions. (c) The single 
adamantoid cage within extended structure of (L)-Cd (c and d) Representation of a single 3D-diamondoid 
network. Figure modified from reference 31.  
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Moreover, organic tectons can have different coordination sites. For example, tecton bearing both 
pyridine (Py) and terpyridine (terPy) was previously described.32 The Py-terPy entity illustrated 
in Figure 15 is a divergent monodentate-tridentate tecton that generated a 1-D coordination 
polymer in the presence of CoCl2.6H2O. The Co(II) center is four-coordinated with the pyridine 
unit of one tecton and the terpyridine unit of another tecton forming a connecting node along the 
1D chain. The directional 1D chains are positioned in a parallel manner but oriented in opposite 
direction, thus leading to an overall non-directional system.  
 
 
 
 
Figure 15: (Top) The chemical structure of the Py-terPy tecton (Center) molecular representation of the 
directional coordination polymer (Bottom). A portion of the X-ray crystal structure of the 1-D network.32  
 
Furthermore, a more recent example published by M. W. Hosseini and P. Samori describes a 
Nickel (II) metalloporphyrin based tecton bearing pyridine and terpyridine coordination sites.33 
Periodic arrays of monometallic and heterobimetallic coordination polymers were generated on a 
highly oriented pyrolytic graphite surface (HOPG). A monometallic 1-dimensional Co(II) 
coordination network is formed though coordination of Co(II) by Py and terPy sites of adjacent 
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porphyrin tectons. Similarly, a heterobimetallic 1-D network is obtained starting from the Ni(II) 
metalloporphyrin in the presence of external Co(II). Figure 16 shows a schematic representation 
of the homometallic and heterobimetallic porphyrins and the 1-D directional coordination 
networks (Figure 16). The formation of directional networks with syn-packing were observed by 
STM.33 
 
Figure 16: The schematic representations of the homometallic (Left) and heterobimetallic (Right) Ni(II) 
porphyrin based tectons, and the 1-D directional Co(II) coordination networks in syn-orientation (top) and 
anti-orientation (Bottom). Figure modified from reference 33. 
 
II. 3. b) 3) Metal-Organic Frameworks (MOFs) 
The most famous hybrid organic-inorganic network is the Metal-Organic Frameworks or MOFs.34 
They are crystalline materials assembled via coordination bonds between multidentate organic 
tectons and transition metal cations. Their structures are characterized by an open framework that 
can be porous, therefore they are also referred to as porous coordination polymers (PCPs). In some 
cases, the MOFs are stable after eliminating the solvent and could host guest molecules making 
them interesting for gas storage, gas adsorption and separation, catalysis, sensing application and 
others. MOFs became a subject of interest for chemists after the work of R. Robson in 1989 and 
1990.35 One of the first examples is MOF-5, which is based on 1,4-benzenedicarboxylate (BDC) 
as an organic coordinating tecton and Zn (II) as a metal center.36 The structure of MOF-5 is a 
simple cubic six-coordinated net build of Zn4O-tetrahedra that are capped on each edge with a 
carboxylate group resulting in a Zn4(O)(BDC)3 clusters, which represent the vertices of the cube 
(Figure 17). These clusters are linked by 1,4-benzenedicraboxylate units acting as the edges of the 
cube and forming a 3-D intersecting channel system.  
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Figure 17: Representation of one cavity of MOF-5 as a yellow ball.36 
 
After MOF-5, numerous monometallic MOFs with stable pores were described and applied in 
different fields. Furthermore, heterometallic MOFs became the center of attraction and assembling 
metallatecton into M1M2OF dominated the literature. An example of a heterometallic MOF is the 
Cu (II)-Cd(II) imidazole-appended dipyrrin MOF reported by our group.37 This M1M2OF was built 
in two steps. Step one was the formation of the metallatecton by coordination of an imidazole-
appended dipyrrin ligand with Cu(II) forming a bisdipyrrin complex with two imidazole 
coordinating sites. Step two was to combine this Cu(II) complex with Cd(II) which lead to a 2D 
grid-type MOF offering 1D porous channels upon parallel stacking (Figure 18). 
 
 
Figure 18: The X-Ray structure of the 1D channels. Figure modified from reference 37. 
A metal organic framework based on tectons bearing different coordination sites than the examples 
above is the La-PhBTTc MOF, recently described by S. Kitagawa.38 The La-PhBTTc MOF is 
Introduction 
 
20 
 
assembled by coordination of 1,4-phenylene-benzen-1,3,5-tris(2-thiophene-5-carboxylate) ligand 
(PhBTTc) to La(III) metallic cation resulting in 1D hexagonal channels with the lewis acid sites 
aligned within the channel, making this MOF a good Lewis Acid catalyst (Figure 19). 
 
 
Figure 19: (a) The molecular structure of PhBTTc. (b) La-PhBTTc X-Ray structure viewed along the 
b axis. (c) The framework structure of La-PhBTTc. Figure modified from reference 38. 
 
Coordination sites based on pyrrolic and pyridyl rings are perfect candidates to build coordination 
networks, due to their stable structures and affinity to various metal centers. Therefore, the work 
of this thesis focuses on these coordination sites. Our aim is to synthesize a library of new tectons 
and assemble them into H-bonded coordination networks using porphyrin, dipyrrins, pyridines and 
terpyridines as coordination sites. A more detailed explanation of their properties will be discussed 
in their respective chapters. (Figure 20) 
 
 
 
Figure 20: A general representation of the coordination sites of the coming chapters: porphyrin, dipyrrins. 
pyridine, terpyridine (From left to right). 
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II. 3. c) Hydrogen bonded networks 
Nature uses non-covalent interactions to maintain well-defined 3-D biological macromolecules 
such as DNA, RNA, and proteins. Their discrete structures and biological functions are based on 
hydrogen bonds between their building blocks (nucleobase H-bonds for DNA and RNA, and 
peptide bonds for proteins) (Figure 21). Inspired by nature, chemists and engineers designed 
molecules bearing functional sites based on electronegative and labile hydrogen atoms behaving 
as proton donors (D-H), or based on electropositive atoms behaving as proton attractors (A). 
Moreover, supramolecular chemists used these molecules to generate patterns and networks 
aiming to imitate the naturally occurring hydrogen bonds in order to explore, understand and 
decode H-bonding architectures. Hydrogen bonds showed several advantages over other non-
covalent interactions such as, directionality and reversibility, and being synthetically accessible 
and responsive to external stimuli (temperature, pH, solvent, concentration etc.) making them the 
center of attraction of recent studies. 39, 40 
 
Figure 21: (Left) The DNA helix structure assembled via H-bonds between nucleobases, (Right) the 
secondary α-helix bonded by H-bonds between amide functions. 
 
To form infinite H-bonded structures, tectons should have two or more divergent sites. Self-
complementary tectons bearing both proton donor sites (D-H) and proton attractor sites (A) can 
self-assemble into homopolymers via hydrogen bonds of the self-complementary sites. Moreover, 
heteropolymers are generated through the assembly of two, three or more building blocks bearing 
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complementary recognition sites leading to di-block, tri-block or multi-block hydrogen bonded 
polymers respectively.39 More complex 2D and 3D networks are generated by self-complementary 
or complementary tectons bearing three or more recognition sites generating patterns oriented in 
two and three directions in space. Such structures are usually further stabilized by weak 
interactions such as, van der Waal, π-π stacking and electrostatic interactions.  
 
II. 3. c) 1) Hydrogen bonding patterns  
Hydrogen bonded networks are composed of tectons with sterically accessible hydrogen bonding 
moieties where the hydrogen bond interactions are perturbed minimally by competing steric or 
ionic interactions. Different functional groups show clear preferences for specific hydrogen bond 
interactions forming defined patterns throughout the network. Numerous patterns could be 
obtained leading either to finite assemblies or to infinite networks. Some examples are shown in 
the figure below.41  
 
 
Figure 22: Examples of H-bonded patterns leading to finite assemblies (a, b and f) or infinite networks (c, 
d , e, g).41  
 
Tectons with one hydrogen bond donor or/and acceptor sites can form dimers via 1 H-Bond, with 
an average energy of 12.3 kJ/mol, as in example (a) of Figure 22. Moreover, tectons can assemble 
via 2 H-bonds forming a ring geometry as in Figure 22 (b).41 The energy of the interaction of two 
tectons can vary from 4 to 63 kJ/mol according to the number of hydrogen bonds that take place 
between the two recognition sites. As the number of the H-bonds increases, the interaction is 
enhanced leading to more stable arrangements. In the above representations (Figure 22), single or 
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double H-bonds are considered, but triple, quadruple and even sextuple hydrogen bonds can be 
formed between two partners. 
Examples of Figure 22 (a) and (b) result in discrete structures since the recognition sites are 
oriented in a convergent manner. However, the location of the recognition sites in divergent 
positions could lead to infinite structures (Figure 22 (c), (d) and (e)). In Figure 22 (d), the tecton 
is self-complementary bearing a proton donor and a proton acceptor thus it self-assembles via H-
bonds between its complementary sites. In example (e), two tectons form a network where one 
bears (X = DH) proton donor sites and the other has attractor sites (Y & Z = A1 & A2). In this 
case, the H-bond formed is selective and occurs only between the best proton donor and the best 
donor acceptor (Z or A1). Many other patterns are found in the literature for example, the cyclic 
pattern (Figure 22 (f)) and the hexagonal pattern (Figure 22 (g)).41  
In addition to the number of H-bonding sites, the alternation of donor (D) and acceptor (A) groups 
also affect the strength and stability of the bond. Studies showed that AAD-DDA systems in DNA 
are significantly more stable than ADA-DAD systems, because of additional secondary 
electrostatic attractive forces present between the opposite partially charged sites of the AAD-
DDA motif 42 (Figure 23). Moreover, AAA-DDD hydrogen bonding motifs, formed by a tecton 
with only proton attractor sites and a tecton with only proton donor sites, exhibits a very high 
association constant, due to the three cumulative electrostatic attractive forces between the AAA-
DDD sites. Therefore, by avoiding alternation of donor and acceptor groups the stability of the H-
bonds can increase.39,43  
 
ADA-DAD                                AAD-DDA                                   AAA-DDD 
Ka =1.7 10
2 M-1                  Ka ~ 104 M-1                                Ka > 105 M-1 
  (in CHCl3)                               (in CHCl3)                                    (in CHCl3) 
 
Figure 23: H-bonding pairs with three hydrogen bonds.39 
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II. 3. c) 2) Examples of hydrogen bonded networks  
Numerous examples of hydrogen bonded 1-D chain networks or polymers assembled via hydrogen 
bonds are known in the literature. For example, Hawker and Meijer44 groups reported a 
supramolecular chain-end-functionalized polymers containing multiple hydrogen-bonding groups 
(ADD or DAA), which can assemble via triple hydrogen bonds. They synthesized a 
poly(benzylmethacrylate) polymer functionalized at its end chain with 2-ureido-4[1H]-
pyrimidinone (UPy) leading to a ADD tecton, and a poly(butyl acrylate) polymer, functionalized 
by a diamido-1,8-naphthyridine (NaPy) moiety, giving the complementary DAA tecton. The UPy-
NaPy triple hydrogen bonding resulted in the formation of supramolecular diblock polymers via 3 
H-bonds (Figure 24). 
 
 
 
Figure 24: Supramolecular polymer assembled via UPy-Napy quadruple H-bonds. Figure modified from 
reference 44. 
 
As mentioned previously, supramolecular chemists were interested in designing helix systems to 
imitate DNA’s 3D helical structure, aiming to explore and understand the patterns found in such a 
complex network. An example of a helix structure was designed by the group of M. W. Hosseini.45 
This network is assembled through the H-bond of two tectons: a calix[4]arene based tecton bearing 
four pyridine proton acceptor sites and 4,4’-diphenol molecule which possesses two H-bond 
donors oriented in a divergent way. The two tectons form a single stranded helical structure by 
mutual bridging via the H bonds between the pyridine sites and the OH sites. The repeating unit 
of the helix, which extends along the z-axis, is composed of 4 calixarene tectons, 4 diphenol tectons 
and 4 MeNO2 solvent molecules. Two pyridine sites located in trans positions of the calix 
backbone are hydrogen bonded to the OH groups of the diphenol tectons, and the other two 
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remaining pyridine sites participate in H-bonding with solvent MeNO2 molecules resulting in a 
single stranded helical network (Figure 25). 
 
 
Figure 25: The X-ray structure of a portion of the hydrogen bonded network formed via the H-bonds 
between the 4,4’-biphenol and the two trans pyridines sites of the calix[4]arene based tecton. The other 
pyridine trans pair are H-bonded to MeNO2 solvent molecules. Figure taken from the reference 45. 
 
Interestingly, the 1-D helical strands are associated to each other in a helical fashion leading to 
quintuple helical braids, due to van der Waals and edge-to-edge interactions between the pyridine 
rings and phenyl groups (Figure 26). Finally, the quintuple helices associate laterally into 
compacted solids as shown in the figure below.  
 
Figure 26: X-ray structure showing the formation of quintuple helical arrangement comprised of five right 
handed helical strands represented in different colors. Figure taken form reference 49. 
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In addition to helixes, H-bonded networks can have different geometries such as cyclic hexagonal 
structures. For example, Figure 27 shows a hexagonally closed packed 2-D hydrogen bonded 
network composed of a macrocyclic tecton bearing 6 phenolic groups.46 The self-assembly of the 
macrocycle via 6 H-bonds between the exterior OH groups results in a one-dimensional 
arrangement forming single layered motifs. The structure is stacked with each layer consisting of 
sheets of macrocycles H-bonded to one another forming a 2-D close packed structure. The stacking 
mode of the network is further stabilized by van der Waals and electrostatic interactions between 
aromatic rings in adjacent layers (Figure 27). 
 
 
Figure 27: (a) The molecular structure of the macrocycle bearing OH groups (b) The X-Ray structure of 
single layer motif (c) X-Ray structure of the packing of three layers. Figure modified from reference 46. 
 
Another recent example is based on catechol moieties.47 The H-bonded network is obtained by the 
self-assembly of an adamantane-based bis catechol tecton (Figure 28).  
 
Figure 28: Molecular structure of adamantane-based catechol tecton. Picture modified from reference 47. 
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In the presence of ethyl acetate, the tecton crystallizes into cyclic frameworks forming channels in 
the crystalline lattice filled with solvent molecules (Figure 29). The cyclic structures are 
constructed from two adamantane-catechol molecules linked by H-bonds between the OH groups. 
Each cyclic structure is bonded to the adjacent one through H-bonds between the hydroxyl groups 
of catechol moieties forming a 1D structure. The 1D polymers are directed into layers resulting in 
channels filled with ethyl acetate. The layers are stacked via CH-π interactions between the 
catechol rings and the adamantane parts.  
 
Figure 29: (a) side and (b) top views of the H-bonded structure. Figure modified from reference 47. 
 
As in the example above, H-bonded tectons can assemble into networks forming porous channels 
that are filled with solvent molecules. In some cases, removing the solvent molecules result in the 
collapse of the structure. Recently however, hydrogen bonded frameworks (HOFs) with permanent 
porosity have been described and explored for their different applications. 
 
II. 3. c) 3) Hydrogen bonded Organic Frameworks (HOFs) 
 
Hydrogen bonded organic frameworks (HOFs) are self-assembled through hydrogen bonding 
interactions between pure organic building blocks. Compared to MOFs, they are more fragile and 
difficult to stabilize because of their weaker interactions. Although, HOFs were proposed as 
potential porous materials about two decades ago, no example of frameworks with permanent 
porosity were described until recently. The H-bonding within HOFs resulted in a weak structurally 
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porous framework that usually collapsed upon removal of the solvent guest molecules after thermal 
and vacuum activation.48 However, HOFs are easily synthesized, purified, characterized and 
regenerated by simple recrystallization. Therefore, they attracted attention as potential porous 
materials for several applications especially gas storage, gas separation and molecular 
recognition.49 The first HOF reported with high selectivity for C2H2/C2H4 separation is the HOF-
1.48  
 
 
Figure 30: (Left) The DAT organic building block, (Center) the 3-D body centered cubic network, (Right) 
and the 1-D channels along the c axis represented by the yellow balls. Figure modified from reference 48. 
 
HOF-1 is a three-dimensional porous network assembled through H-bonds between the organic 
tecton bearing four 2,4-diaminotriazine (DAT) groups (Figure 30). Each tecton is connected to 
four neighboring ones by eight strong hydrogen bonds resulting in 8-connected nodes that form a 
three-dimensional body-centered cubic network with one-dimensional porous channel along the c 
axis. The framework is further stabilized by multiple aromatic π-π interactions among the organic 
building blocks. One of the amine groups within the 2,4-diaminotriazine moieties is not involved 
in the hydrogen bonding, and thus is exposed on the pore surfaces for potential interactions with 
gas molecules. The permanent porosity of HOF-1, activated under high vacuum at room 
temperature and then at 100 oC, was evaluated by CO2 gas adsorption, which proved the macro-
porous characteristic of this framework. In addition, the C2H2/C2H4 gas separation capacity of 
HOF-1 was examined. The studies showed that HOF-1 takes up a much larger amount of C2H2 
than C2H4, indicating that it is a very promising microporous material for the C2H2/C2H4 separation 
at an ambient temperature. At 273 K, HOF-1 can absorb acetylene up to 63.2 cm3.g-1 (STP), which 
corresponds to 2.1 mol of C2H2 absorbed per mole of HOF-1. On the other hand, HOF-1 can adsorb 
only 8.3 cm3.g-1 (STP) of C2H4. The C2H2/C2H4 molar ratio separation selectivity of HOF-1 is 
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equivalent to 7.6, which is higher than average values of previously reported MOFs. The 
collaborative size exclusive effect confined by the small narrow pores and the preferential stronger 
interactions of C2H2 with the basic amine groups of the host framework enable HOF-1 to act as an 
extraordinarily highly selective microporous material for the C2H2/C2H4 separation at ambient 
temperature. 
 
A more recent hydrogen-organic-framework is the HOF-750, which is assembled from 2,4-
diaminotriazinyl (DAT) of a functionalized ZnTDPP porphyrin compound (5,10,15,20-tetrakis(4-
(2,4-diaminotriazinyl)phenyl)porphyrinato zinc). ZnTDPP molecules self-assembled through H-
bonds involving their 4 DTA moieties generating two-dimensional supramolecular layers. The 
layers are further packed into a 3D framework via π−π interactions between the ZnTDPP 
molecules, thus generating a microporous structure (Figure 31). The permanent porosity and gas 
separation properties of the desolvated HOF-7 were examined. The studies proved the microporous 
nature of HOF-7 and demonstrated its CO2 gas adsorption ability along with moderately selectivity 
for CO2/N2 separation.  
 
 
 
Figure 31: (a and b) The X-Ray structure of HOF-7 showing the H-bonds interactions, (c) Intermolecular 
π-π interaction in HOF-7, (d) 3D packing framework of HOF-7 along the a axis. Figure modified from 
reference 50. 
 
When it comes to hydrogen bonding interactions, predicting and controlling the final topology of 
the network can be a challenge, due to their high reversibility and flexibility. Nature has provided 
nucleobases (NBs) as hydrogen bonding moieties, which are stable, reliable and predictable. Our 
goal is to build molecular networks assembled by coordination and hydrogen bonding interactions. 
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Therefore, we chose to focus on nucleobases as H-bonding motifs and to introduce them at the 
periphery of ligands such as porphyrins, dipyrrins, pyridines and terpyridines. 
 
III. Nucleobase 
 
Nucleobases (NBs) are heterocyclic nitrogenous bases found in the repeating units of DNA 
(deoxyribonucleic acid) and RNA (ribonucleic acid), which are referred to as nucleotides. The 
latter consist of three molecules: sugar, heterocycle and phosphate. The sugar, ribose or 
deoxyribose, is in a cyclic furanoside form and is connected by β-glycosyl linkage to the 
nucleobases to produce the four normal nucleosides: adenosine, guanosine, cytidine, thymidine in 
DNA and uridine in RNA.51 The pairing of DNA complementary strands is due to the unique 
molecular recognition of the natural nucleobases via Watson-Crick hydrogen bonding 
interactions.52 In addition, the formation of the duplex DNA structure is a result of intermolecular 
forces including π-π stacking, van der Waals interactions, and hydrophobic effects.53 (Figure 32)  
 
         
Figure 32: The chemical structure of DNA. 
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The five natural nucleobases are divided into two groups: the monocyclic pyrimidines and the 
dicyclic purines. The pyrimidines consist of Thymine (T) in DNA, Uracil (U) in RNA, and 
Cytosine (C). Moreover, the purines consist of Adenine (A) and Guanine (G) (Figure 33). 
 
 
Figure 33: DNA nucleobases 
 
DNA base pairing takes place between complementary pyrimidines and purines through 2 or 3 
hydrogen bonds (Figure 34). Adenine is complementary to Thymine or Uracil (X = CH3 for T, X 
= H for U) via two hydrogen bonds forming the A-T or A-U pairs (Ka ca. 102 M-1).54 Guanine is 
complementary to Cytosine via three hydrogen bonds forming the G-C pair (Ka ca. 105 M-1).55  
 
 
Figure 34: A-T and G-C Watson-Crick Hydrogen pairing. 
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III. 1. pKa values of nucleobases 
The protonation and deprotonation of nucleobases occur within a 3.5 pH shift from neutrality (from 
3.5 to 10.5). At a pH 10.5, the deprotonation occurs at the N1 position of pyrimidines (T and C) 
and at N9 of purines (A and G). A higher alkaline media will deprotonate the N3 and N1 of thymine 
and guanine respectively. At slightly acidic (pH ca. 4-5), protonation of N1 of adenine and N3 of 
cytosine is observed. More acidic conditions (pH<2) will protonate N7 of guanine and adenine. At 
sufficiently lower pH, adenine is doubly protonated at N1 and N7 positions and thymine is 
protonated at O4.57 pKa values of these protonation and deprotonation are represented in Figure 
35.56 
In all of the mentioned cases, ring nitrogen atoms are protonated rather than the amino nitrogen 
atoms (N6 of A, N4 of C, and N2 of G). This is in agreement with calculated charge densities. The 
electrostatic isopotential curves calculated for the approach of a proton or a nucleophilic agent 
demonstrate that the attack is primary at the ring nitrogen atoms and at the keto oxygen atoms, and 
not at the amino groups.57  
 
 
Figure 35: pKa values of nucleobases.56 
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III. 2. Tautomerism of nucleobases  
 
In solution, heterocyclic molecules tend to yield a mixture of species (tautomers) in equilibrium 
(Figure 36).52, 58 Tautomerism depends on the pKa of the respective heteroatoms and on the nature 
of the solvent.  
 
 
Figure 36: Prototropic tautomerism in unsubstituted adenine (A), cytosine (C), and guanine (G). 
 
These tautomeric processes in NBs change the positions of proton atoms, thus leading to new 
hydrogen bonding patterns. For example, a keto group with acceptor properties is transformed into 
a donor enol group. Similarly, a donating amino group becomes an imino group with accepting 
properties.  
The enol tautomeric forms of uracil or guanine have the same binding patterns than cytosine and 
adenine in their normal amino form respectively. Moreover, the imino form of cytosine or adenine 
can substitute the uracil and guanine respectively (Figure 37). Thus, tautomerism could be 
disastrous for base pairing and the self-replicating systems in DNA and RNA. Several studies (UV, 
IR, NMR, X-Ray) were conducted to study the possible tautomers and their stability. They 
concluded that for adenine and thymine (or uracil) the naturally occurring bases (amino and keto 
form) are dominant, with less than a 0.01 % for all other tautomers. For guanine and cytosine, less 
than 15 % of tautomeric forms are present in nature, where the keto and amino form dominates the 
base-paring motifs. In general, NBs in their major tautomeric form are found in DNA and RNA, 
and this is controlled by the different factors (sugar moieties, phosphate groups, medium in the 
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cell….) therefore the NBs are always suitable for their biological tasks except in the case of 
mutation.51,52,58 
 
Figure 37: Keto-enol and amino-imino tautomerism in NBs. Note that uracil have the same tautomers as 
thymine. Donor sites are denoted as D and Acceptor sites as A. enol G (DA) = A (DA), enol T (DAA) = 
C (DAA), imino A (AD)=  T (AD) or G (AD), imino C (ADD) = T (ADD) 
 
III. 3. Nucleobase interactions   
Complementary nucleobases interact with each other through Watson-Crick hydrogen bonding 
resulting in the most stable and dominate G-C and A-T pairs (E (G-C) = -70.25 kJ/mol, E (A-T) 
= -29.29 kJ/mol).51 However, many alternative pairing patterns are possible.51,54,55,58 For instance, 
the Hoogsteen59 interactions between adenine and thymine is another mode of bonding that occurs 
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on the opposite site of the purine nucleobases (E(A-T)Hoogsteen = -27.6 kJ/mol). Along with 
Hoogsteen interactions, other non-traditional base pairs are present in DNA, RNA and protein-
DNA interactions. They include the reverse Watson-Crick H-bonding (E(A-T)Reverse W.C = -29.2 
kJ/mol), reverse Hoogsteen H-bonding (E (A-T) Reverse Hoogsteen = -28.6 kJ/mol), Wobble or the 
mismatch form (E(G-A)Wooble = -39.3 kJ/mol, E(G-T)Wooble = -32.5 Kcal/mol).51 The reverse modes 
are defined by a trans or cis conformation of the two sugar moieties or any substituent ‘R’ on N1 
of pyrimidines and N9 of purines (Figure 38).  
Nucleobase interactions can be divided into two groups: homo pairing and hetero pairing. 
Examples of the hetero pairing are the interactions discussed previously. In addition to hetero 
pairing, homo pairing is also possible, since each NB heterocycle possesses an alternation of 
proton donor and proton acceptors sites, making them self-complementary. There are multiple 
potential homo pairs of nucleobases, for example 15 possible pairs for guanine, 11 for cytosine, 
21 for adenine and 10 for thymine or uracil.60 Not all of these homo pairing lead to stable dimers. 
The most stable homo pairing are represented in Figure 38 with interaction energy of -67.1 kJ/mol 
for G-G, -44.9 kJ/mol for C-C, -23.4 kJ/mol for A-A and -22.7 kJ/mol for T-T.51  
After several studies (DFT calculations, UV, IR, NMR, X-Ray…), potential base pairs were 
narrowed down to the most stable 28 base-pairing motifs. These 28 pairs are formed via at least 
two hydrogen bonds and include homo and hetero pairing of pyrimidines and purines assembled 
into symmetrical and non-symmetrical motifs.60 The most stable pairing is Watson-Crick G-C base 
pairing followed by the self-assembly of guanine G-G and C-C. The Watson-Crick A-T base 
paring is less stable than the G-C however it is more favorable than the self-assembly of A-A and 
T-T. The order of base pair interactions from the most stable base pair to the least stable is as 
follows: G-C> G-G> C-C> A-T> A-A> T-T.51-55, 60 
Furthermore, purines A and G can form larger aggregates due to the presence of two binding sites. 
Besides being able to form 1:1 complexes through either of their two faces, A and G can form 2:1 
aggregates with an appropriate partner, for instance the T–A–T and the G–G–C triplets. Such 
complexes are involved in the formation of triple DNA helix.61 Moreover, there exists a unique 
pairing formed between C+–G–C base-triplet. The N3 of the cytosine needs to be protonated to 
allow the donation of a hydrogen bond to N7 of guanine (Figure 38). 
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Figure 38: Watson-Crick base-pairing, as well as Reverse Watson-Crick, A-T Hoogsteen and Reverse 
Hoogsteen, G-A and G-T Wobble ( mismatch) paring, example of homo pairing, and  T-A-T, G-G-C, and  
C+-G-C Base Triplets (Hoogsteen and Watson-Crick). 
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In protic solvent, nucleobases pairing is decreased, due to competition with the solvent. They tend 
to stack in columns rather than self-assemble through H-bonding.62 Moreover, because of their 
aromatic structure, NB can self-assemble via π-π interactions. In addition, the presence of 
accessible coordinating sites in NBs, such as nitrogen and oxygen lone pairs, provide them the 
ability to bind to several metal cations (Figure 39).51,52,63 
 
Figure 39: Schematic representation of the coordination sites of the nucleobases.63  
 
III. 4. Nucleobases self-assemblies  
The four nucleobases possess several interaction sites oriented in a divergent manner, which open 
the possibility to self-assemble into different one, two or three-dimensional architectures. 
Therefore, numerous solid-state crystallographic and scanning tunneling microscope (STM) 
studies have been performed to explore the self-assembly of nucleobases from the most stable and 
complex guanine architectures to the weakest thymine assemblies.63,64 
III. 4. a) Guanine 
All nucleobases have the ability to self-assemble into dimers. However, guanine homooligomers 
are the most interesting. Guanine possesses two complementary arrays, a donor/donor site at 
positions N(1)–H and N(2)–H2 and an acceptor/acceptor site at positions O6 and N7. The aromatic 
surface of guanine and the complementarity of its sites, allow it to self-assemble via strong 
hydrogen bonds (KGG ca. 102-104 M-1 in CDCl3) into a variety of supramolecular architectures. 
Depending on the experimental conditions, guanine can self-assemble into linear tapes (ribbons) 
or macrocycles (G-quartets) (Figure 40).63-65 
Introduction 
 
38 
 
 
Figure 40: Different guanine architectures. Figure taken from reference 64.  
 
In the presence of a metal cation such as K+, Na+, Cs+ or Ba2+, guanine molecules can form G-
quartet (G4) based architectures such as octamers or columnar polymeric aggregates. These 
architecture are stabilized by metals cations and by cyclic H-bonds formed between N(2)–H···N(7) 
and N(1)–H···O(6) of neighboring guanine molecules. In the absence of metal templating center, 
guanine can self-assemble via H-bonds into ribbon-like structures in the solid state and in solution. 
Two ribbon structures with different H-bond patterns can be formed. Ribbon-A is assembled 
though cyclic N(2)–H·· ·O(6) and N(1)–H···N(7) H-bonds. G-ribbon A is thermodynamically 
more stable in the solid state but in solution it slowly undergoes a structural transition toward a 
more thermodynamically stable G-ribbon B, which is characterized by N(1)–H···O(6) and N(2)–
H···N(3) intermolecular cyclic H-bonds (Figure 40).65 
In addition to G-quartets and ribbon architectures, other assemblies were studied by scanning 
tunneling microscopy (STM) upon the deposition of guanine molecules on inert surfaces. Single-
molecular-scale STM images revealed that guanines can form ordered one- and/or two-
dimensional unique structures. For example, a 1 D guanine based chain was reported on Cu (111) 
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substrate at a low-temperature (ca. 80 K).66 This assembly is composed of guanine molecules 
linked to each other by two H-bonds on their Watson-Crick sites and two H-bonds on their 
Hoogsteen sites.60 Moreover, guanine molecules were deposited onto an inert Au (111)67 substrate 
at room temperature, which resulted in a heterochiral phase corresponding to two enantiomerically 
pure homochiral G4 based 2D networks (R and L) (Figure 41). Within the G4 based architecture, 
the molecules interact via two H-bonds: N(2)–H···N(7) and N(1)–H···O(6). The presence of N(9)–
H and N(3) sites at the exterior of the quartets made it possible to form a third binding motif. N(9)–
H···N(7) H-bonds take place between  the quartets, thus resulting in a 2D network.64  
 
 
Figure 41: STM image containing mirror phases of enantiomerically pure R (right-handed) and L (left-
handed) G4 - based 2D network self-assembled on Au(111) surfaces under UHV. Figure modified from 
reference 64. 
 
 
 
III. 4. b) Cytosine  
Cytosine possesses a unique chemical structure with two proton donors (D) and two proton 
acceptors (A), which can result in a D-A-A-D recognition pattern. Similar to guanine studies, the 
cytosine self-assembly was studied by scanning tunneling microscopy (STM) upon deposition on 
inert surfaces. Early studies demonstrated that cytosine self-assembles into a one-dimensional 
chain when deposited on Cu (111) surface. Neighboring cytosine molecules in trans conformation 
made it possible for the two D-A sites to fall in a suitable arrangement, thus extending into a 1 D 
chain through 2 H-bonds between each cytosine ring.60,66 
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Moreover, recent studies showed that cytosine can self-assemble into glass like structures with 
ribbon-like or hexameric macrocyclic geometries. Among various patterns are two ribbon 
assemblies that take place via two H-bonds: N(4)–H···O(2) and N(1)–H···N(3) or N(4)–H…N(3) 
and N(1)–H·· ·O(2). In addition, the hexameric macrocyclic arrangement assembles via 3 H-bonds 
N(4)–H···O(2), N(1)–H···N(3) and C(5)–H···N(3). The homo-pairing pattern of cytosine 
molecules is dependent on the nature of surface coverage. An example of the glassy state of 
cytosine obtained on Au(111) substrate is represented in Figure 42 (b).64 
III. 4. c) Adenine 
The self-assembly of adenine can be extremely complex. As mentioned previously, 21 possible 
dimers can be formed.60 Therefore, several one-dimensional chains can be proposed, but the most 
stable arrangement was studied by STM upon depositing adenine on a Cu (111) surface.60,66 The 
chain is formed through an alternation of Watson-Crick and Hoogsteen H-bonding between 
neighboring adenine molecules.  
In addition to 1D chains, a 2 dimensional hexagonal adenine network was observed by STM 
studies on several substrate such as Cu(110)68, graphite69 and other70. Moreover, at a much lower 
deposition rate, a double chain adenine based structure was observed.71 Therefore, adenine can 
assemble into several competing structures. Nonetheless, it has been recently shown that, when 
deposited on Au(111) substrate, adenine molecules form highly ordered 2-dimensional 
supramolecular networks stabilized by N(9)–H···N(3), N(6)–H···N(7) and N(6)–H·· ·N(1) 
hydrogen bonds (Figure 42 (c)). 72 
 
III. 4. d) Thymine and Uracil  
Thymine and uracil share similar bonding sites as all the other nucleobases. However, early STM 
studies showed that they randomly aggregate into small clusters upon depositing them on inert 
surfaces. 66 Moreover, one of the few reported assemblies of thymine deposited on Au(111) surface 
is a 1 D filament stabilized by two different pairing motifs A and B.68 Motif A assembles via three 
H bonds N(3)–H···O(2), N(3)–H···O(4), and C(6)–H···O(4). Motif B assembles through two H-
bonds N(3)–H···O(2) and N(1)–H·· ·O(4).64 In addition, the self-assembly of uracil was also 
studied by STM on several surfaces. Uracil molecules adsorbed on Ag(111) formed close-packed 
2D islands, which was driven by the formation of H-bonded dimers characterized by N(3)–
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H···O(4) pairing. Furthermore, upon depositing uracil molecules on Cu(111), deprotonation at the 
N(3) site occurs, thus leading to the formation of tiara-like structures (Figure 42 (e)). 64,67 
 
 
Figure 42: (a) The chemical structures of cytosine (C1), adenine (A1), thymine (T1), and uracil (U1), H-
bonding donor and acceptor sites are indicated in blue and red respectively.  The reference of NBs are 
kept as found in the publication (ref 64). b) STM image of a “glassy state” of C1 on Au(111). c) Self-
assembled architectures of A1 molecules on Au(111). d) Ribbon-like assembly of T1 molecules on 
Au(111). e) STM image of sub-monolayer coverage of U1 on Cu(111) showing a domain of the tiara-like 
structure. Figure taken from reference 64. 
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III. 5. Supramolecular assemblies based on NB 
Nucleobases are a targeted motif in supramolecular chemistry due to their multiple possibility of 
non-covalent interactions. Using common NBs offered the advantage of exploiting different 
building units (T, U, A, C, G).62,73 However, the solubility of nucleobases in normal aprotic 
solvents is a limiting factor for synthetic chemistry. In addition to their low solubility, tautomerism 
and non Watson-Crick binding modes resulted in many complications in terms of prediction and 
controlling the final topology of the assemblies.63,73 
Biological systems have overcome these problems due to the sugar and phosphate molecules 
linked to NBs. Inspired from nature, supramolecular chemists resolved these complications using 
different strategies. For example, Watson-Crick H-bonding could be favored by introducing bulky 
groups close or directly on certain unwanted H-bonding sites. In addition, steric hindrance with 
regard to the ribose unit can also pre-organize a certain type of assembly over others. Moreover, 
the choice of the solvent and the solute concentration can minimize the formation of non-discrete 
aggregates. The first two strategies lead to the synthesis of alkylated or substituted purines and 
pyrimidines with lipophilic tails or sugar residues functionalized with solubilizing protecting 
groups without changing the characteristics of the H-bonding sites of the nucleobases. Such 
modification resulted in interesting soluble nucleobase motifs for supramolecular chemistry.  
Furthermore, extension of NB interaction sites, by introducing additional H-bonding functions on 
the parent nucleobase, resulted in more stable paring motifs and more complex architectures.63,73  
Last but not least, supramolecular and synthetic chemistry based on nucleobases helped in 
implementing an artificially expanded genetic information system (AEGIS)74, where the number 
of nucleobases increased from 4 to 12 nucleobases. AEGIS is now used in clinic to monitor the 
load of several viruses.75  
Example of such NBs derivatives are presented in Figure 43. The modified NB (1) 76 is a guanine 
derivative than can self-assemble into a G-quartet without the presence of metal templating 
cations. Molecule (2) is a synthetic thymine derivative that results in the formation of gels.77 NB 
(3) has an extended H-bonded function on the Hoogsteen site of guanine moieties. This synthetic 
modified nucleobase can bind to guanine by four H-bonds forming a stronger G-G motif.78  
Molecules (4) and (5) are example of the AEGIS nucleobase system (Figure 43).74 
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Figure 43: Examples of modified nucleobases. 
 
III. 5. a) Nucleobase Duplex Systems 
A large library of NB based dimeric systems is found in the literature. Example of such structures 
are the four duplex systems (I), (II), (III) and (IV) by J. L. Sessler and coworkers (Figure 44). (I) 
is based on the T-A complementary pair linked by a diethynyl-anthracene spacer, via their C9 and 
C5 position respectively, resulting in a discrete duplex. To enhance the solubility of the T-A pair, 
their respective N9 and N1 positions are substituted by functionalized ribose moieties. Moreover, 
(II) is a poly(ethylene glycol) functionalized amide linked to guanine from one end and to a 
complementary cytosine from the other end. The G-C pairs are linked by their N7 and N1 positions 
respectively, thus increasing the solubility of G and C and favoring the Watson-Crick H-bonding 
patterns. However, the assembly of this molecule was relatively weak due to the flexibility of the 
linker.73,79 The ridged G-G structure (III) is held together by four hydrogen bonds between four 
modified guanine moieties. This structure is very stable and stayed in its dimeric form in all 
solution phase conditions (temperature, concentration).80 Last but not least, a unique guanine based 
structure (V) assembles into a G4-quartet without the presence of the templating cation via 
Watson-Crick and Hoogsteen G-G interactions. In addition to these duplex systems, a molecular 
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box based on adenine and thymine interactions was described by Gokel and colleagues.81 The 
assembly (V) is stabilized by Hoogsteen interactions and one N–H···O hydrogen bond.  
 
Figure 44: Structural representation of (I), (II), (III), (IV), and (V). Figure modified from reference 73. 
 
Moreover, as mentioned previously, the presence of accessible nitrogen and oxygen lone pairs in 
the aromatic heterocyclic NBs structure provides the possibility to participate in different kind of 
interactions other than hydrogen bonds. Therefore, NBs can act as metal-binding motif in the 
presence of suitable metal cations, and can stack via π-π interactions. Loeb et al. 82 designed a 
molecular receptor that uses the diversity of nucleobase interactions. The receptor is based on a 
metallo-thiocyclophane molecule that binds adenine through three simultaneous interactions. The 
first interaction is a metal-adenine coordination bond between Pd (II) metal center and the amino 
function at the N(3) position. In addition, adenine interacts with the receptor by two H-bonds 
between its N(6) position and the ethylene glycol O atom. The structure is further stabilized by a 
third interaction, which is π-π stacking between the electron poor aromatic rings of the adenines 
and the electron rich aromatic rings of the receptor (Figure 45). 
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Figure 45:Thiocyclophane metallo-receptor bonded to Adenine through π-π stacking, H-bonds and  
coordination interactions. Figure modified from reference 63. 
 
As mentioned previously, the diversity and the structure of nucleobase interaction sites make it an 
interesting building block to be used in designing polymers and supramolecular networks.  
 
III. 5. b) Nucleobase based polymers 
One of the extension of nucleobase hydrogen interactions involves the generation of 
supramolecular H-bonded polymers. NBs chain-end or side-chain functionalization of polymers 
helps the organization of polymeric assemblies into fibers, film and gels. An example of such 
polymeric systems is the cytosine bi-functional polymer which was obtained by attaching a 
functionalized cytosine to an amine terminated poly(ethyleneglycol) (Figure 46). The cytosine 
based polymer formed dimeric assemblies through four hydrogen bonds.83  
 
 
 
Figure 46: Cytosine based polymer. Figure modified from reference 83. 
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Other end chain polymers are the alkyl di-amides polymers bridging adenine and thymine 
molecules (Figure 47). These polymers resulted in different final arrangements. The bis-thymine 
polymer produced double helical ropes, while the complementary bis-adenine resulted in only 
microcrystalline solids. Moreover, the mixed adenine–thymine structure formed supramolecular 
fibers via Watson-Crick T-A H-bonds.84 
 
Figure 47: The thymine and adenine based di-amide polymers.73 
 
In addition to H-bonded polymeric assemblies, nucleobases can generate coordination systems if 
joined with a metal salts. NBs can act as a chelate or as a bidentate ligands bridging metallic centers 
thus generating polymeric assemblies. An interesting example is the Pt(II)-cytosine polymer 
obtained by reacting cis-[PtCl2(NH3)2] salt and sodium cytosinate (Na+ Cytosine−) in the presence 
of AgNO3.85 In this polymer, the Ag+ coordinates to the available N3 site of the cytosine, while 
the cis-[Pt(NH3)2]2+ moiety coordinates via the N1 position, leading to the formation of a hetero 
bi-metallic chain with the cytosine ligands in a head-to-tail orientation. The coordination sphere 
of silver ions is completed by a water molecule and intramolecular interactions with the O2 atoms 
of the cytosine base (Figure 48). 
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Figure 48: Cytosine-Pt-Ag polymers, the counter ions are removed for clarity. Figure taken from 
reference 85. 
 
Adenine has several potential coordination sites, however the Hoogsteen sites are the most favored 
to coordinate to metallic cation.86An example of such coordination pattern is the Cd(II) polymeric 
chains of chelate-tethered adenine derivative (ethylenediamine-N9-ethyladenine, A-Et-en).87 The 
structure of [Cd2Br6(A-Et-en)2] shows the metal center in two different coordination environments. 
The first metal center is an octahedral Cd(II) coordinated to four bridging halides and two adenines 
coordinated in trans position via N7. The second Cd(II) is in distorted-octahedral geometry 
coordinated to two of bridging halides, to one terminal halide, to the nitrogen atoms of the diamine 
group, and to N3 of adenine (Figure 49). 
 
Figure 49: The X-Ray structure of the polymeric chaine of [Cd2Br6(A-Et-en)2]. Figure taken from 86. 
 
III. 5. c) Nucleobase based networks  
 
Nucleobases ability to self-assemble via H-bonds, to coordinate metal centers, and to interact by 
π-π stacking provide all the means to act as interesting tectons in generating molecular networks. 
Over the past decade, nucleobase based networks became the center of attraction in the field of 
molecular tectonics, and several architectures assembled via NBs interactions were described.  
Introduction 
 
48 
 
Example of such networks is the system based on thymine reported by N. R. Champness and 
coworkers.88 Di-(N1-benzoyl)thymine and tri-(N1-benzoyl)thymine were synthesized by 
condensation reactions of thymine with 1,4-bis-(bromomethyl)benzene and 1,3,5-
tri(bromomethyl)-2,4,6-trimehtylbenzene respectively (Figure 50). 
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Figure 50: The molecular structure of the two tectons bearing thymine moieties.88 
 
Di-(N1-benzoyl)thymine tecton self-assembles into one dimensional chains through double H-
bonds between the thymine moieties. The imide carbonyl is not involved in the H-bond paring and 
makes a close contact with the hydrogen of methylene groups of the neighboring chains. The zig-
zag chains are stacked via π-π interactions into infinite columns running throughout the structure 
(Figure 51). 
 
 
 
Figure 51: (a) The X-Ray structure of di-(N1-benzoyl) thymine. (b) The X-Ray structure of the 1-D H-
bonded zigzag chains stacked above each other. Figure modified from reference 88. 
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Tri-(N1-benzoyl)thymine forms a one dimensional molecular ladder with all three thymine 
moieties binding to other thymine sites in adjacent molecules via double hydrogen bonds. The 
ladder structure is propagated along its length by interactions of independent thymine moieties 
with the ‘rungs’ being formed by a homo-dimer between the third moiety. Two 
crystallographically identical benzene molecules occupy the space between the thymine-dimer 
‘rungs’ resulting in an infinite stack of molecules running along the ladder (Figure 52).  
 
 
Figure 52: (a) The X-Ray structure of tri-(N1-benzoyl) thymine. (b) The X-Ray structure of the molecular 
ladder. Figure modified from reference 88.   
 
Another example of a tecton bearing thymine (T) molecules is the 4-tmpm (tetrakis(4-
(thyminemethyl)phenyl)methane.89 The X-Ray structure of 4-tmpm shows that three out of the 
four thyminylmethylphenyl arms (T2–4) display pseudo three-fold rotation symmetry (Figure 53). 
 
Figure 53: (a) The molecular structure of 4-tmpm. (b) The X-Ray structure of 4-tmpm showing its three-
fold rotation symmetry. (c) X-Ray structure of a hydrogen bonded dimer, one molecule is in orange and 
the other is in light purple. Figure modified from reference 89.  
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Two molecules of 4-tmpm form a dimer joined by six strong C–H⋯O hydrogen bonds between 
the thymine carbonyl groups (ortho) of one molecule and the thymine CH sites of the second 
molecule as shown in Figure 54 (right). The 4-tmpm dimer is formed thought the H-bonds between 
their T2, T3 and T4 thymine moieties leaving the T1 moieties free and perpendicular to the plane 
of the dimer. Each T2, T3 and T4 are involved in two C–H⋯O bonds resulting in the six H-bonds 
forming the dimers. All of these interactions involve only the ortho carbonyl groups, thus the N–
H sites and the para carbonyl groups of the thymine moieties are free to form interactions with 
adjacent dimers. In the dimer, the T3 rings form intermolecular H-bonds between their para 
carbonyl and NH groups. This is represented in the Figure below in the yellow zone. The dimers 
are linked to each other by two different hydrogen-bonding interactions. The first interaction is the 
double H-bonds between the T1 moieties belonging to one dimer and the T4 moieties belonging 
to the neighboring dimer. The second interaction is between the T2 rings of one dimer and the T1 
of the other dimer via one H-bond between the NH sites of T2 and the carbonyl sites of T1, which 
are not hydrogen bonded to T4. Therefore, T1 is not involved in the dimer formation. However, it 
links the dimers to each other by three N–H⋯O bonds, 2 H-bonds with T4 and one H-bond with 
T2 (Figure 54). 
 
Figure 54: (a) The crystal packing of 4-tpmp molecules.  Phenol groups are represented as sticks. The 
yellow balls represent the T3 interactions and the central core of the dimer. (b) Schematic representation 
of the packed structure through H-bonds between the dimers. Figure taken from reference 89. 
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In designing molecular networks based on nucleobase pairing, thymine is the most used one 
because of its higher solubility and least isomeric forms among the other nucleobases. However, 
several examples of networks with other NBs have been reported. For instance, the synthesis of 
9,9’-diadenine (A2A) tecton and its assembly into H-bonded network was reported.90 A2A is 
soluble only in DMSO and in HFIP solvent (1,1,1,3,3,3-hexafluoro-2-propanol), which was used 
to co-crystalize A2A molecules. The network based on A2A is self-assembled through hydrogen 
bonds between the adenine moieties into tapes decorated on both sides by HFIP molecules. Each 
A2A molecule is H-bonded to four different HFIP molecules via H-bonds between the NH or N 
sites of the adenines and the OH group of HFIP molecules as seen in the figure below (Figure 55 
and 56).  
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Figure 55: The molecular structure of the adenine based tecton A2A and HFIP solvent. 
 
 
 
Figure 56: (a) The X-Ray structure of A2A tectons assembled with HFIP solvent molecules. (b) 
Molecular packing of A2A structure viewed from a-axis. Figure modified from reference 90. 
Introduction 
 
52 
 
IV. Aim of the Project 
Synthetically modified or substituted nucleobases provide various applications when linked to 
suitable substituents. Electron and energy transfer, DNA binding, biological receptors, gel 
formation, drug delivery and other applications were reported for nucleobase containing 
systems.81,91 In addition, the field of molecular tectonics provides the essential tools to improve 
and master the design of extended supramolecular architectures. Therefore, building nucleobase 
systems for fundamental and applied studies using the concept of molecular tectonics is of wide 
interest. Similarly, we envisioned the design of NBs based architectures using different 
coordinating sites aiming to generate hydrogen bonded coordinated networks. The coordination 
sites we choose to work with are porphyrin, dipyrrin, terpyridine and pyridine. The choice of these 
ligands is based on their properties and will be presented in the corresponding chapter of this 
manuscript. Furthermore, the choice of the metal cations used to generate the metallatectons and 
H-bonded coordinated networks is according to the geometry that the metal center can adapt and 
its counter ions. Our aim is to synthesize a library of novel tectons of various geometry bearing 
four nucleobases (Figure 57), and to study their assembly into molecular networks.  
 
Figure 57: Schematic representation of targeted tectons. 
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I. Porphyrin 
 
Porphyrins are one of the tetra-pyrrolic macrocyclic molecules found in biological systems.1 For 
example, porphyrin iron complexes are found in the Heme, the red pigment in red blood cells and 
the cofactor of Hemoglobin. Porphyrin scaffolds present in hemoglobin and myoglobin are 
involved in the transport and storage of oxygen. Porphyrin’s unique chemical and physical features 
and biological applications made them one of the most studied molecules in history. Moreover, 
investigations to ameliorate the synthesis of porphyrin and to functionalize them into molecules 
with applications in different fields (Catalysis2, Photovoltaic3, molecular materials4, molecular 
tectonics5…) are still of current interest. 
 
I. 1. Structure and nomenclature 
Porphyrins consist of four pyrrole rings linked by four methylene bridges with a principal plan 
(P24) composed of 20 carbon atoms (8 beta, 4 meso, and 8 alpha) and four nitrogen atoms (Figure 
1). Following the IUPAC nomenclature, the macrocycle is numbered from 1 till 20 and the four 
pyrrole rings are labeled from A to D. Porphyrin has 12 positions (8 β-pyrrolic and 4 meso) that 
may be functionalized, an aromatic structure with 18 π electrons, and a tetraaza core able to 
coordinate various metal centers.  
 
Figure 1: The chemical structure and nomenclature of porphyrin. 
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I. 2. Synthesis 
The first method to synthesize a porphyrin started in the 1930 by Fischer6 and Rothemund.7 As 
previously mentioned, a porphyrin possesses four meso and eight β-pyrrolic positions that can be 
functionalized. In our case we are interested in functionalizing the meso positions, more precisely 
A4 and trans-A2B2 porphyrins (Figure 2).  
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Figure 2: Representation of meso substituted porphyrins. 
 
I. 2. a) A4 
The A4 type porphyrin possesses the same substituents in the four meso positions, a famous 
example is the tetraphenylporphyrin (TPP). TPP was synthesized under harsh conditions with low 
yields, by reacting pyrrole and benzyladehyde at 220 oC for 48 hours in air, which acts as an 
oxidizing agent (Figure 3).7 
 
Figure 3: Synthesis of TPP. 
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Later in 1967, Adler and Long ameliorated the synthesis of TTP. 8 They developed a new method 
using propionic acid as a solvent and refluxing pyrrole with benzaldehyde for 30 minutes (Figure 
3). TPP was obtained in a shorter time and higher yields compared to the Rothemund method. 
However, the use of an acidic medium at high temperature, limited the nature of aldehydes that 
could be used.  
Lindsey et al. 9 then developed a new strategy using milder conditions, in which the ring closure 
of the tetrapyrrole and the oxidation of the porphyrinogen are two separate steps (Figure 4). In this 
method, the pyrrole and the aldehyde are reacting at room temperature in chloroform or 
dichloromethane in the presence of an acid catalyst: boron trifluoride etherate (BF3.Et2O) or 
trifluoroacetic acid (TFA). This step leads to the formation of the porphyrinogen, which is 
subsequently oxidized into the porphyrin by the addition of an oxidizing agent, such as 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and p-chloranil.  
 
 
Figure 4: The two-step reaction to synthesize TPP. 
 
I. 2. b) Trans-A2B2 
Trans-A2B2 type porphyrin bears two different substituents in trans meso positions. The first 
attempts to synthesize such porphyrins were developed by Little et al10, who adapted the Adler 
and Longo’s method based on refluxing pyrrole in propionic acid as a solvent in the presence of 
two different aldehydes. This method was named “the mixed aldehyde method”, and it produces 
six different porphyrins (Figure 5). The separation of the six porphyrins is difficult and time 
consuming. 
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Figure 5: Mixture of porphyrins generated by the "mixed aldehyde method". 
 
MacDonald et al. 11developed a more selective method for the synthesis of porphyrins using a two-
step procedure. The first step consists of synthesizing a dipyrromethane (DPM) derivative from 
one aldehyde (A-CHO) and an excess of pyrrole in the presence of an acid catalyst. The second 
step is a [2+2] condensation reaction between the DPM and the second aldehyde (B-CHO) in the 
presence of an acidic catalyst followed by an oxidation reaction (Figure 6). 
 
 
Figure 6: Synthesis of trans-A2B2 porphyrin by [2+2] condensation reaction. 
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Moreover, A2B2 porphyrins could also be obtained following the Adler method, by reacting the 
DPM with a second aldehyde in propionic acid under reflux.12 Both methods are feasible, however 
the choice depends on the nature of the aldehyde and the stability of the DPM. 
The disadvantage of the [2+2] condensation reaction is related to a phenomenon called 
“scrambling”. DPM in acidic media can undergo fragmentation and recombination with 
unconsumed starting material leading to the formation of a mixture of six porphyrins. The mixture 
is usually hard to separate, and could be avoided by playing on the concentration of the reactants 
and the nature of DPM used. Lindsey et al13 reported that low concentration (10Mm) and the use 
of a sterically hindered DPM usually lower the degree of scrambling.  
Another approach to synthesize meso-substituted porphyrins was inspired by the developments in 
metal-mediated cross-coupling reactions.14 This method consists of using a halogenated meso 
porphyrin in metal catalyzed cross-coupling reactions. To synthesize A2B2 porphyrins, four steps 
are followed. The first two steps are the synthesis of the porphyrinogen and its oxidation into a 
porphyrin bearing two substituents in trans meso-positions, following the [2+2] condensation 
method. The third step is to halogenate the porphyrin, in the other two trans positions, using 
halogenating agents such as N-Bromosuccinimide (NBS). This step results in a porphyrin bearing 
two meso-halogenated sites that could be used as a starting material in Suzuki, Sonogashira, Stille 
or other cross coupling reactions. Examples of such coupling reactions will be further explained 
later in this chapter.  
 
I. 3. Characterization 
The aromatic structure of porphyrins provides unique properties that can be characterized by 
different techniques such as 1H-NMR and UV-Vis.  
 
I. 3. a) 1H-NMR 
The cyclic conjugated π-electron system of porphyrins causes a large magnetic anisotropy. The 
external magnetic field going through the aromatic rings sets up a current of mobile π-electrons 
that gives rise to a secondary magnetic field coming from the center of the macrocycle with strong 
anisotropic effect, thus leading to the shielding of the protons inside the ring and the deshielding 
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of the protons located outside the ring. Therefore, the 2 NH protons located in the cavity of the 
porphyrin appear highly shielded (around -2 ppm) and as a large broad peak. Conversely, the 8 β-
pyrrolic protons appear downfield shifted, usually between 8 and 10 ppm, and their multiplicity 
being representative of the symmetry of the porphyrin.  
 
I. 3. b) UV-Visible Spectroscopy  
Porphyrins have distinctive UV-Vis absorption spectra due to π-π* transitions. The absorption 
spectra shows two different bands located in different zones. The first zone is located around 420 
nm and corresponds to the Soret band, a very intense band (ε ~ 105 L. mol-1.cm-1), due to the 
transition between the fundamental state So and the singlet excited state S2. The second zone is 
located between 500 and 700 nm and corresponds to the Q bands (Figure 7). Those bands are of 
lower intensity (ε ~ 103 - 104 L. mol-1.cm-1) and are due to the transition between the fundamental 
state So and the singlet excited state S1. The Q bands are responsible for the color of the porphyrin 
and are affected by its symmetry and by the geometry of its core. A free base porphyrin with a D2h 
symmetry shows four Q bands, while only two Q bands are observed for a metallated porphyrin 
with a D4h symmetry. 
 
Figure 7: UV-Vis spectrum of a free base meso-substituted porphyrin. 
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I. 4. Complexation and geometry  
The porphyrin core acts as a tetradentate ligand, which coordinates various metal cations after the 
deprotonation of the two inner NH groups. Porphyrin’s central cavity has an ideal size to 
accommodate first row transition metals, while the metal cations with higher volume are located 
out of the cavity often causing deformation of the porphyrin core (Figure 8). Moreover, metal 
cations can have additional ligands coordinated in the axial positions to complete their 
coordination sphere. 
 
 
Figure 8: Schematic representation of the position of the metal center with respect to its size. 
 
The macrocyclic structure of porphyrins can be distorted, depending on the nature of the 
substituents on the meso and β-positions, and depending on the metal cation present in the 
porphyrin cavity. In the solid-state, several conformations were identified as shown in Figure 9.  
 
 
Figure 9: Schematic representations of porphyrin deformation.  
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Due to their aromatic systems, porphyrins can self-assemble via π-π interactions leading to two 
assemblies in the solid state: the H or J aggregates. The H aggregate consists of porphyrin 
molecules stacked vertically one over the other through face-to-face π-π interactions, and the J 
aggregates corresponds to porphyrins stacked in a shifted manner above each other (Figure 10).  
 
 
Figure 10: Schematic representations of H and J aggregates. 
 
II. Porphyrin Bearing Nucleobases 
The porphyrin backbone is of high interest in supramolecular chemistry and molecular tectonics, 
5especially for the formation of coordination networks. It can be functionalized by a wide range of 
coordinating groups and can accept numerous metal cations in its cavity. Moreover, it may self-
assemble through π-π interactions. An additional interesting feature of porphyrins is the possibility 
to introduce H-bonding recognition sites at the periphery of the macrocycle, in order to design 
tectons that assemble into stable architectures via hydrogen, coordination and π-π interactions. 
Nucleobases are the most famous H-bonding moieties due to their biological importance and their 
strong and selective propensity to form H-bonds. Both porphyrins and nucleobases are naturally 
occurring molecules, and linked together they should lead to supra-molecules with a wide range 
of properties and applications.  
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II. 1. Examples of Porphyrin Bearing Nucleobases (NB) 
J. S. Sessler et al.15 described several dimeric assemblies based on guanine and cytosine bearing 
porphyrin scaffolds forming photo antennas for photo-induced energy transfer. The three systems 
shown in the Figure 11 are examples of NB-porphyrin based assemblies via Watson-Crick H-
bonds between guanine and cytosine, leading to an energy transfer from the Zn-porphyrin to the 
free base porphyrin. 
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Figure 11: Representation of dimeric and trimeric G-C Watson-Crick H-bonded energy transfer systems 
based on zinc-porphyrin donors and porphyrin acceptors.15, 16 
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The porphyrins present in the assembly I 16 were prepared by alkylation of a nucleobase derivative 
with an electrophilic porphyrin to provide the targeted molecules that assembled into dimeric 
systems through Watson-Crick hydrogen bonding. Following the irradiation of the dimeric 
assembly, only photoinduced triplet-triplet energy transfer was observed. Unfortunately, no 
singlet-singlet energy transfer occurred, due to the flexibly of the linkage between the porphyrins 
and the NBs. To overcome this limitation, more rigid molecules were synthesized (Figure 12 and 
13). The dimeric assembly II is composed of a Zn(II) guanine-porphyrin that serves as the energy 
donor, and of a free base cytosine-porphyrin acting as the energy acceptor. The two porphyrins are 
arranged side by side linked through the three H-bonds between G and C (Figure 11). Assembly 
III, is a trimeric assembly composed of a central free base porphyrin bearing two cytosine in trans 
meso positions linked by H-bonding to two Zn (II) guanine based porphyrins (Figure 11). The zinc 
porphyrins funnel energy into the central free base porphyrin which serves as an energy trap.  
 
Figure 12: Synthesis of porphyrins bearing guanine for assemblies II and III, (a) (i) TFA, CH2Cl2, argon, 
room temperature, 4 h; (ii) NaOAc, 30 min; (iii) p-chloranil, room temperature, 6 h. (b) NH3/MeOH, 
room temperature, 36 h. (c) TBDMS-C1, imidazole, DMF, room temperature, overnight, (d) Zn(OAc)2, 
MeOH, reflux, 30 min.16 
 
The porphyrins assembly II and III were synthesized by condensation of a mixture of 1 equivalent 
of nucleobase-benzaldehyde and 1 equivalent of benzaldehyde with 2 equivalents of 4,4-dimethyl-
3,3'-dibutyldipyrrylmethane. The guanine and cytosine aldehydes were obtained by Stille cross-
coupling reactions that involved the Pd-catalyzed coupling between an organostannyl 
benzaldehyde derivatives and halogenated nucleobases. The reaction lead to a mixture of three 
porphyrins composed by the mono-substituted porphyrin, the di-substituted porphyrin, and 5,15-
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diphenylporphyrin (Figure 12 and 13). Subsequent deprotection of the NBs and the selective 
reprotection of the sugar moieties gave rise to the unmasked cytosine and guanine porphyrins. The 
latter compounds were converted into their corresponding zinc porphyrins.17  
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Figure 13: Synthesis of porphyrin bearing cytosine for assemblies II and III, (a) (i) TFA, CH2Cl2, argon, 
room temperature, 7 h; (ii) NaOAc, 1 h; (iii) p-chloranil, room temperature, overnight, (b) NH3/MeOH, 
room temperature, 36 h. (c) TBDMS-C1, imidazole, DMF, room temperature, overnight.16 
 
Uracil-functionalized porphyrins were described by C. M. Drain et al.18 The primary objective was 
to synthesize porphyrin building blocks bearing complementary triple hydrogen bonding moieties 
represented in Figure 14. One of the porphyrins was functionalized by alkylated uracil moieties 
and the other by a pyridine derivative that binds uracil via 3 H-bonds. The functionalized 
porphyrins were prepared following the Adler19 synthesis by reacting two different aldehydes with 
pyrrole that resulted in a mixture of 6 different porphyrins (Figure 15). This method was used 
because the five compounds bearing the H-bonding moieties are interesting building blocks to 
design potential self-assembled arrays. 
 
Figure 14:  Schematic representation of potential assemblies of porphyrin building blocks via 
complementary H-bonding substituents. Figure modified from reference 18. 
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The targeted uracil-aldehyde, 1-butyl-6-formyluracil, was obtained by the protection of the 
aldehyde function of 6-formyluracil, followed by an alkylation of the N1 site with n-butylbromide, 
and then the deprotection of the aldehyde function. 1-butyl-6-formyluracil was reacted with 4-tert-
butylbenzaldehyde and pyrrole in a mixture of nitrobenzene and acetic acid in the presence of zinc 
acetate (Figure15). This reaction resulted in six different porphyrins, which were separated by 
column chromatography. To increase the yield of the four porphyrins bearing U, the number of 
equivalent of 1-butyl-6-formyluracil was increased, the concentration of the mixture was 
decreased, and 4-tert-butylbenzaldehyde was added 10 minutes after adding the uracil aldehyde to 
pyrrole.  
 
 
Figure 15: Reaction scheme for porphyrin bearing uracil. Figure taken from reference 18. 
 
The solubility of the cis disubstituted porphyrin is expected to be less than that of the trans isomers 
due its greater polarity. However, the disubstitued cis uracil-porphyrin was found to be more 
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soluble than the trans isomer. This could be due to the self-complementary H-bonded assembly of 
linear polymeric tapes formed between the trans isomers vs the closed tetrameric squares assembly 
of the cis isomers. The cis isomer bearing complementary hydrogen bonding sites forms a 
tetrameric square assembly proven by 1H-NMR and ESI-MS analysis. Moreover, these studies 
showed that  the complementary interactions between the uracil and pyridyl moieties are stronger 
than their self-complementary interactions (Figure 16).  
 
 
Figure 16: The tetrameric square assembly formed from the cis isomers. Figure taken from reference 18. 
 
Other strategies such as Pd-catalyzed cross coupling reactions have been used to introduce 
nucleobases into the meso positions of porphyrins. An example reported by J. L. Sessler20 
described the Sonogoshira cross coupling reaction between a porphyrin bearing a triple bond and 
an iodinated cytosine derivative. 5-iodocytidine (a cytosine substituted by a sugar moiety at the N1 
position) and 5-(4-ethynylphenyl)-10,15,20-triphenylporphyrin were reacted with palladium tetra-
triphenyl phosphine (Pd(PPh3)4) and copper iodide (CuI) in toluene in the presence of 
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trimethylamine (Et3N) at 50 
oC, resulting in the targeted cytosine functionalized porphyrin. The 
latter was used to generate a dyad, with a guanine functionalized fullerene C60, that undergoes 
photoinduced electron transfer (PET) (Figure 17). The dyad was assembled via three H-bonding 
between C and G, where the electron transfer takes place from the zinc porphyrin to the fullerene 
through the G-C Watson Crick H-bonding.  
 
Figure 17: (Top) The self-assembly of the dyad through G-C interaction. (Bottom) The reaction Scheme 
of the porphyrin synthesis. Figure taken from reference 20. 
 
Another pathway could be followed to introduce nucleobases into the meso positions of 
porphyrins, via Sonogashira coupling, which is to react a halogenated porphyrin with a nucleobase 
bearing a triple bond. This procedure was used by M. Balaz21 in order to synthesize DNA-
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templated porphyrin nanoassemblies.22 The porphyrin functionalized by 2,6-diaminopurine 
(DAP), an adenine derivative, which has an extra amine function on position 2, interacts with 
thymine via 3 H-bonds instead of the 2 H-bonds between T-A (Figure 18).  
 
 
Figure 18: a) Hydrogen bonding between porphyrin–diaminopurine conjugate (2HPor-DAP) and 
thymidine. (b) representation of right-handed DNA-templated multiporphyrin nanoassembly. Figure taken 
from reference 21.  
 
The 12-steps synthetic pathway is depicted in Figure 19. The  first step is to protect the N9 position 
of DAP in order to avoid any by-products and to increase its solubility. The DAP was deprotonated 
by NaH and reacted with triethylene glycol monomethyl ether tosylate to produce N-
triethyleneglycol–DAP, which was then brominated by N-bromosuccinimide (NBS) in the C8 
position. The brominated DAP was reacted with mono(trihexylsilane)acetylene under Sonogashira 
cross-coupling conditions (Pd2(dba)3, PPh3, and CuI in piperidine) to yield the trihexylsilane-
diaminopurine– acetylene conjugates. In parallel, the Zn (II) porphyrin was prepared by Lindsey’s 
acid-catalyzed condensation of dipyrromethane with substituted 3,4-dihydroxy-benzaldehyde, 
followed by a metalation with zinc acetate. The bromination of the porphyrin was performed using 
NBS. The trihexylsilane protection group on the DAP was removed with TBAF to give the 
diaminopurine–acetylene that was coupled with the bromoporphyrin, under Sonogashira cross-
coupling conditions, resulting in the diaminopurine-porphyrin conjugate ZnPor-DAP. The 2HPor-
DAP was obtained after demetallation of ZnPor-DAP using TFA.  
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Figure 19: Synthesis of porphyrin–diaminopurine conjugates. (i) 1) NaH, DMF, 60 oC, 2 h, 2) 2-(2-(2-
methoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 0 oC, 7 h. (ii) N-bromosuccinimide (NBS), 
CH3CN, RT, 1.5 h. (iii) Pd2(dba)3, Ph3P, ethynyltrihexylsilane , CuI, piperidine, 40 oC, 4 h. (iv) tetra-n-
butylammoniumfluoride (TBAF), CH2Cl2, RT, 30 min. (v) triethylene glycol monomethyl ether tosylate, 
K2CO3, CH3CN. (vi) trifluoroacetic acid (TFA), then 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ); 
(vii) Zn(OAc)2·2H2O, CHCl3, CH3OH, RT. (viii) NBS, CHCl3, C5H5N.(ix) 4, Pd2(dba)3, PPh3, CuI, DMF, 
triethylamine (TEA), 40 oC, 15 h. (x) TFA, CH2Cl2, RT, 4 h. (xi) Ni(OAc)2·4H2O, DMF, 120 oC, 4 h. 
Figure taken from reference 21. 
 
N. R. Champness et al 23 have reported the synthesis and the surface based assembly of thymine 
functionalized porphyrin tecton. The targeted tectons is a tetra-(phenylthymine)porphyrin (tetra-
TP) for surface-based self-assembly studies, and a mono-thymine-tri-(3,5-di-tert-butylphenyl) 
porphyrin (mono-TP) was used as a model compound to probe the nature of intermolecular 
interactions in solution.  
The tetra-TP was synthesized by reacting a protected thymine derivative, 1-formylphenyl-3-benzoyl-
thymine, with a large excess of pyrrole using TFA to initiate the reaction, followed by an oxidation with 
DDQ. The deprotection 24 of the thymine moieties was performed using NH4OH in THF to yield the 
targeted tecton (Figure 20). 
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Figure 20: Synthetic route used for the preparation of tetra-TP. Figure taken from reference 23.  
 
The thymine moieties were linked to the porphyrin core by phenyl groups so that the porphyrin 
and the thymine could be co-planar and parallel to the surface, on which the molecules will be 
deposited. A small quantity of saturated solution of tetra-TP was deposited onto a HOPG substrate. 
STM images showed the self-assembly of tetra-TP molecules displaying square-grid like networks 
stabilized by inter-thymine H-bonds (Figure 21).  
 
Figure 21: (a) 2D tetra-TP self-assembled network at the TCB–HOPG liquid–solid interface. (b) Large 
scale STM image of tetra-TP network. Figure taken from reference 23. 
 
Mono-TP was synthesized in two steps (Figure 22). The first step involved the reaction of 1-
formylphenyl-3-benzoyl-thymine (protected thymine) with a large excess of pyrrole in the 
presence of InCl3, and afforded the desired dipyrromethane. The latter was reacted with a suitable 
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tert-butyl functionalized carbinol species, using Lindsey's approach,25 in the presence of TFA, and 
then oxidized by DDQ. A subsequent deprotection of the benzoyl-protected thymine was achieved 
using NH4OH. The tert-butyl functionalized appendages increases the porphyrin’s solubility and 
allow studies in solution. (Figure 22) 
N
NH N
HN
tBu
tBu
tBu tBu
tBu tBu
NH
N O
O
N HN
OO
tButBu
tBu
tBu
tBu
tBu
N
N O
O O
O
H
NH HN
N
N
O
O
O
i) pyrrole
ii) InCl3
 ii)NaBH4
iii) CF3COOH
iv) DDQ
1) i)
2) NH4OH, THF
 
Figure 22: Synthesis of Mono-TP.  
 
The crystal structure of the mono-TP (Figure 23) shows the nature of the intermolecular interactions 
between thymine-substituted porphyrins. A double hydrogen-bonding interaction is observed between 
thymine moieties of adjacent molecules. The thymine approaches in a coplanar fashion the porphyrin 
core. As for the phenyl ring between the porphyrin and the thymine, it adopts an orientation that 
approaches in an orthogonal mode the porphyrin plane. Moreover, adjacent molecules pack via π–π 
interactions between a thymine moiety of one molecule and a pyrrole of an adjacent molecule.  
 
Figure 23: The single crystal X-ray structure of mono-TP illustrating the formation of the thymine double 
hydrogen-bonding interaction. Figure taken from reference 23. 
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II. 2. Aim of the Project    
The aim of the project is to synthesize a library of new di or tetra-functionalized NB porphyrin 
based tectons (Figure 24). As discussed previously, several strategies could be followed to prepare 
porphyrin bearing nucleobases. We focused on two strategies based on Pd-catalyzed cross 
coupling reactions and alkylation reactions between appropriate starting materials, linking the 
porphyrin and the nucleobases through C-C or C-N bond respectively. 
 
Figure 24: Schematic representation of the targeted tectons. NB1 and NB2 are complementary nucleobases 
and R is a solubilizing substituent. 
Nucleobases are known for their complementary base pairing property and their self-assembly into 
polymeric architectures. Playing on the nature and the number of NBs on a porphyrin scaffold can 
result in several potential molecular networks. Introducing NBs in two trans positions could lead 
to 1D polymeric assemblies, and introducing them into the four meso positions could even lead to 
2D architectures formed by NB H-bonding (Figure 25). NBs have low solubility in aprotic solvent, 
therefore some solubilizing substituents (represented by R) are used to increase the solubility of 
the final targeted porphyrin tectons.  
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Figure 25: Schematic representations of 1D (top) and 2D (bottom) H-bonded networks using the targeted 
tectons. 
 
Moreover, metallation of the porphyrin scaffold can assist in the formation of more complex 
networks of higher dimensionality, by introducing for example bidentate coordinating ligand in 
the apical position of the metallic center. 
 
II. 3. Porphyrin Bearing NB via C-C bond 
 
To synthesize the targeted tectons, we focused on strategies involving Pd-catalyzed cross coupling 
reactions (either Suzuki or Sonogashira) as key steps, thus leading to the formation of a C-C 
linkage between the NBs and the porphyrin scaffolds. A three-part procedure was considered to 
generate the trans A2B2 final tectons (Figure 26). The first part consists in the synthesis of the 
corresponding meso-substituted starting porphyrins: either a porphyrin bearing two boron moieties 
in trans positions or a trans meso-bisethynylporphyrin for Suzuki and Sonogashira cross coupling 
reactions respectively. In both cases, the two remaining trans positions were occupied by C5 alkyl 
chains in order to increase the solubility of the final porphyrin. The second part deals with the 
halogenation of the nucleobase and the protection of the N1 position of pyrimidines and the N9 
position of purines to increase their solubility in aprotic solvents, and to avoid secondary reactions. 
The third and last part is the coupling of the porphyrins and the nucleobase derivatives under 
Suzuki or Sonogashira conditions. 
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Figure 26: Retrosynthesis of trans-A2B2 porphyrin bearing NBs following Suzuki and Sonogashira C-C 
coupling. 
 
First we attempted to connect NB to porphyrins via Suzuki Coupling (Figure 26). 10,20-dipentyl-
porphyrin was synthesized, then brominated and reacted with 4,4,5,5-tetramethyl-1,3,2-
dioxaborolane leading to a mixture of mono-boronated and diboronated porphyrins (Figure 27).26 
The first attempt was made by using the commercially available 5-bromouracil (Br-U). The latter 
was protected by a benzylhydryl group following a known procedure, which will be discussed later 
in detail.32 The Suzuki cross coupling reaction between the protected Br-U and the mono-
boronated porphyrin was performed under different conditions. For example, Pd(PPh3)4 and 
Pd(OAc)4 catalysts were used in DMF, dioxane or in a mixture of THF: MeOH: H2O in the 
presence of a base, such as K2CO3, KOAc or Cs2CO3. Unfortunately, the coupling was never 
successful. By following the reactions by TLC, we could observe in all cases the deboronation of 
the porphyrin instead of the formation of a new product. 
Since Suzuki cross coupling reaction was not successful, we focused on the coupling of porphyrins 
bearing ethynyl substituents in meso positions with NB derivatives under Sonogashira cross 
coupling conditions (Figure 26). TMS protected ethynyl porphyrins were synthetized and reacted 
with NB under a one-pot procedure.  
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Figure 27: Synthesis and boronation of 10,20-dipentyl-porphyrin. 
 
II. 3. a) Synthesis of Zn(II)[5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin](Zn-Po1)  
 
The synthesis of the targeted porphyrin following the Macdonald27 [2+2] condensation was 
performed following a procedure described for similar diethynyl-porphyrins.28 The starting 5-
pentyl-dipyrromethane (C5-DPM) was synthesized following the procedure described by J. S. 
Lindsey.29 Hexanal was reacted with an excess of pyrrole in the presence of TFA under argon at 
room temperature to yield 47 % of C5-DPM. The latter was reacted with ethynyltrimethylsilane 
and BF3.Et2O in dichloromethane (DCM) then oxidized with DDQ leading to 5,15-dipentyl-10,20-
(trimethylsilylethynyl)porphyrin (Po1) in 38 % yield. The metallation of the porphyrin was 
performed in 90% yield, upon addition of zinc acetate in methanol to a solution of Po1 leading to 
the Zn(II) [5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin] (Zn-Po1) (Figure 28).  
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Figure 28: Synthetic scheme of Zn-Po1. 
 
II. 3. b) Protection of 5-iodoUracil 
 
Commercially available 5-iodouracil (I-U) is insoluble in usual organic media. Moreover, the 
tautomeric forms and the low solubility of uracil might affect the yield of the final cross coupling 
reaction.30 Therefore, the insertion of a solubilizing protecting group in the N1 position is 
necessary in order to increase the solubility of the halogenated NB. Direct substitution of uracil 
could lead to a mixture of monosubstituted and disubstituted products, which blocks the Watson-
Crick H bonding sites.29, 31 Hence, the choice of the protecting group should fit certain criteria, 
such as a regioselective insertion on the targeted N1 site that is not involved in the Watson-Crick 
H-bonding and mild conditions for the protection and deprotection steps. The protection of 5-
iodouracil with benzylhydryl group, described by D. F. Weaver et al.32 fits these criteria. The 
substitution of benzylhydryl group is selective to the most active and least hindered amine site, 
which is in our case the targeted N1 site. In acidic medium, the deprotection is quantitative and 
fast without any effects on the functional groups of the uracil analogue. Therefore, we proceeded 
with the protection of uracil by benzylhydryl group (Figure 29). 
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I-U was reacted with bis(trimethylsilyl)actamide (BSA) in acetonitrile, followed by the treatment 
with benzylhydryl bromide in the presence of a catalytic amount of I2 to yield 55 % of N1-
(benzylhydryl)-5-iodouracil (I-U-Ph2) which was characterized by 1H-NMR and 13C-NMR.  
  
 
Figure 29: Synthesis of I-U-Ph2. 
 
II. 3. c) Synthesis of Zn(II) [5,15 -di(N1-(benzylhydry)uracil)- 10,20-dipentylporphyrin] (T1) 
 
Sonogashira cross coupling is based on a Pd-catalyzed reaction in the presence of a base and CuI. 
However, other conditions were proven to be as effective as the classical conditions.33 To 
synthesize the targeted porphyrin bearing uracil tecton, we first followed a modified version of the 
one pot Sonogashira coupling reactions.34 Pd(PPh)2Cl2 was used as a catalyst and AsPh3 as a co 
catalyst instead of CuI, to avoid any metallation of the porphyrin core. One equivalent of Zn-Po1 
and 2.2 equivalent of I-U-Ph2 were treated with 1 M TBAF solution in THF. The deprotection of 
the TMS functions proceeded instantly and was confirmed by TLC. Then AsPh3 (1.2 eq.) and a 
catalytic amount of  Pd(PPh)2Cl2 (0.25 eq.) were added under argon to the mixture (Figure 30). 
The targeted porphyrin T1 is formed after 3 hours under reflux and isolated in 88% yield. T1 was 
characterized by different means such as NMR, UV, IR, HRMS. Moreover, many attempts to 
crystalize T1 aiming to grow single crystals suitable for X-Ray diffraction were performed using 
different conditions. Unfortunately, single crystals suitable for X-Ray analysis were not obtained.  
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Figure 30: Synthesis of T1. 
 
II. 3. d) Deprotection of T1 
 
Then, we proceeded in deprotecting the uracil moieties targeting a less hindered tecton that can 
self-assemble into H-bonded networks (Figure 31). 
Following a procedure reported to deprotect uracil, T1 was treated with 10 % of triflic acid in TFA 
solution at 0 oC for 2 hours.31 Upon adding ice to the reaction, a green precipitate of 5,15-diuracil-
10,20-dipentylporphyrin (T2) was formed with a yield of 80 %.  
 
Figure 31: Deprotection of the Uracil moieties of T1, and formation of T2.  
 
Due to the strong acidic conditions, demetallation of the porphyrin cavity occurs during the course 
of the reaction, leading the free base porphyrin T2. The UV-Vis spectrum of T2 compared to T1 
is shown in Figure 32. Moreover, upon addition of HCl vapor to a solution of T2, its UV-Vis 
spectrum shifts verifying that T2 is a neutral free base porphyrin.  
Chapter I: Porphyrins bearing Nucleobases 
 
85 
 
 
 
 
The poor solubility of T2 in CDCl3 and d6-DMSO made it impossible to acquire a clear NMR 
spectrum. However, T2 was successfully characterized by HRMS, IR and UV-Vis. Due to its 
poor solubility, all the attempts to grow single-crystals of T2 failed. 
 
II. 3. e) Iodination and Alkylation of NBs 
To functionalize a porphyrin with cytosine and adenine, the iodination of the nucleobases was 
performed using described procedures.31 Moreover, the benzylhydryl group used to protect the N1 
site of uracil was replaced by a C6 alkyl chain, in order to decrease the steric hindrance around the 
NBs H-bonding sites and also to increase the solubility of the targeted tectons. Alkylation reaction 
of the nucleobases was accomplished using reported conditions with the highest yields.31  
 
II. 3. e) 1) Alkylation of 5-iodouracil 
The reported procedure is to react one equivalent of 5-iodouracil with 1.2 equivalent of 1-
iodohexane (I-C6) with Cs2CO3 in dry DMF resulting in the formation of the N1-alkylated uracil 
in 16% yield.31 In order to increase the reported yield, we tried to modify the described procedure. 
First, Br-C6 was used instead of I-C6 following the reported conditions. The reaction resulted in a 
mixture of mono-substituted and di-substituted products that were separated by column 
chromatography to yield 21 % of N1-hexyluracil and 48 % of N1, N3-dihexyluracil. Second, 5-
iodouracil was used in excess and bromohexane was used as limiting reagent. Two equivalents of 
Figure 32: UV-Vis analysis of Po1, T1, and T2 
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iodouracil was reacted with 1.3 equivalent of Cs2CO3 and 1 equivalent of 1-bromohexane in dry 
DMF at 40 oC to yield 94 % of the targeted product I-U-C6 (Figure 33). 
 
Figure 33: Synthesis of I-U-C6. 
 
II. 3. e) 2) Iodination and alkylation of cytosine 
To synthesize 5-iodo-N1-hexylcytosine (I-C-C6), we reproduced the described two-step 
procedure.31 Cytosine was treated with 1.5 equivalent of iodine and 1.4 equivalent of iodic acid in 
acetic acid to result in 94 % of 5-iodo-cytosine (Figure 34). The latter was reacted with 
bromohexane in DMF in the presence of K2CO3 to yield 40 % of the targeted I-C-C6. The yields 
obtained are similar to those reported.  
 
Figure 34: Synthesis of I-C-C6. 
 
II. 3. e) 3) Iodination and alkylation of Adenine 
The alkylation of adenine followed by its iodination was reported to be more effective and resulted 
in a higher yields.31 Therefore, to synthesize N9-hexyl-8-iodoadenine (I-A-C6), we followed the 
described two-step procedure reported for the alkylation and iodination of similar compounds (I-
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A-C2 and I-A-C10). Adenine was first reacted with one equivalent of 1-bromohexane in the 
presence of 1.2 equivalent of K2CO3 in dry DMF to yield 90 % of N9-hexyladenine. The alkylated 
adenine was then treated with one equivalent of periodic acid (H5IO6) and catalytic amount (0.38 
eq.) of I2 in dry DMF to result 60 % of the final targeted I-A-C6 (Figure 35). 
 
Figure 35: Synthesis of I-A-C6. 
 
II. 3. f) Synthesis of Zn(II) [5,15 -di(N1-hexyluracil)- 10,20-dipentylporphyrin] (T3) 
 
Zn(II)[5,15-di(N1-hexyluracil)-10,20-dipentylpoprhyrin (T3) was synthesized following the same 
one-pot procedure used to synthesize T1. Zn-Po1 was reacted with I-U-C6, Pd(PPh3)2Cl2 and 
AsPh3 in 1 M TBAF solution in THF under argon for 3 hours heated under reflux (Figure 36). 
After purification by column chromatography and on bio-beads, T3 was isolated in 80 % yield. 
 
 
Figure 36: Synthesis of T3. 
T3 was characterized by NMR, UV-Vis, IR, and HRMS. Due to the poor quality of the crystals, 
we did not obtain the crystal structure of T3 by X-Ray diffraction. Unfortunately, we faced a 
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problem in reproducing the cross coupling reaction between Zn-Po1 and I-U-C6 because of the 
high reactivity of Zn-Po1, which undergoes side reactions. During trails to reproduce T3, the 
reaction was followed by TLC, which showed the gradual disappearance of the starting material 
(Zn-Po1) and the appearance of a dark polar product with a large different polarity than the 
targeted T3 porphyrin.  
 
II. 3. g) Cross coupling reaction of I-C-C6 and Zn-Po1 
We proceeded to introduce the second pyrimidine, cytosine, to the meso position of porphyrin by 
reacting I-C-C6 with Zn-Po1 following the same conditions used for T1 and T3 (Figure 37). The 
reaction was followed by TLC, which showed the disappearance of the spot corresponding to Zn-
Po1. After 3 hours, several dark polar spots were observed by TLC. The reaction was stopped and 
treated following the same procedure as for T1 and T3. The crude was then purified by column 
chromatography using polar solvents to give several fractions. The 1H-NMR spectrum of the 
fractions revealed that the targeted product was not produced. Instead, the NMR showed peaks 
attributed to the porphyrin with unprotected triple bonds and other porphyrins that we were not 
able to identified. Moreover, unreacted I-C-C6 was observed in one of the fractions. Therefore, we 
deduced that the cross coupling reaction of I-C-C6 and Zn-Po1 was not successful under these 
conditions.  
 
Figure 37: Synthetic strategy to introduce cytosine to Zn- Po1.  
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We thus run a test reaction using similar procedure, but replacing the Zn-Po1 by a cheaper reactant 
with the similar reactivity: ((4-methoxyphenyl)ethynyl)trimethylsilane (CH3O-Ph-TMS). The first 
step was to verify that the deprotection of the triple bond using TBAF in THF was effective. 
Therefore, the deprotection and the coupling reactions were achieved in two separate steps. The 
reaction of CH3O-Ph-TMS with TBAF leads to the formation of the unprotected product: CH3O-
Ph treated in almost quantitative yield, as proven by the complete disappearance of the peak 
attributed for the TMS protecting group in the 1H-NMR spectrum. In order to optimize the coupling 
reaction and test other conditions, we reacted CH3O-Ph with I-C-C6 in the presence of Pd(OAc)2 
/PPh3 (Figure 38). Under those conditions, the targeted molecule was obtained in 30 % yield. The 
low yield could be explained by the interaction of the Pd catalyst with cytosine, thus decreasing 
its ability to catalyze the coupling reaction and modifying the reactivity of I-C-C6.  
 
Figure 38: Test reaction for Sonogashira coupling with I-C-C6. 
 
We applied the same conditions to Zn-Po1 and I-C-C6. Unfortunately, we obtained a mixture of 
porphyrins that appeared to be difficult to purify. Moreover, the 1H-NMR spectrum of the mixture 
did not show any peaks that could correspond to the presence of I-C-C6 at the periphery of the 
porphyrin. One explanation can be that the deprotection of the triple bond leads to a highly reactive 
porphyrin, which undergoes side reactions.  
Since Sonogashira couplings between Zn-Po1 and the I-U-C6 or I-C-C6 was not as efficient as 
expected, we tried to reverse the reactive sites, by introducing the triple bonds on the NBs, instead 
of introducing it on the porphyrin, and then to couple them with a 5,15-dibromoporphyrin (Figure 
39). Following the known procedure for introducing a triple bond on DAP reported by M. Balaz 
(Figure 18 and 19),21 we tried to react 8-Iodo-N9-hexyladenin with trimethylsilylacetylene 
(TMSA) in the presence of CuI and Pd2(dba)3 in piperidine for 24 hours (Figure 39). The reaction 
was followed by TLC, which showed the synthesis of a new product. Unfortunately, 1H-NMR and 
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MS showed that the new product is not the targeted adenine derivative; instead, it was the N9-
hexyladenine. Other conditions were used to obtain the targeted product, for example I-A-C6 (1eq) 
was reacted with TMSA (2 eq.) in the presence of Pd(PPh3)2Cl2 (0.1 eq.) and CuI (0.2 eq.) in a 
mixture of THF: Et3N (4:1) at 40 
oC for 24 hours. Unfortunately, under these conditions, the de-
iodination took place as well. 
 
Figure 39: Reaction between I-A-C6 and TMSA. 
 
Since the Pd-catalyzed cross coupling reaction was not successful, we focused on more 
straightforward strategies to introduce nucleobases in the periphery of porphyrins and explore the 
possibility to link NBs to porphyrin via a C-N bond. 
 
II. 4. Porphyrin Bearing NB via C-N bond 
 
The substitution of N1 sites of pyrimidines and N9 sites of purine with different alkyl substituents 
were reported by various laboratories.35 Moreover, the success we encountered in alkylating 
thymine, cytosine, and adenine inspired us to explore a new strategy, based on connecting the NBs 
at the periphery of porphyrins via C-N bonds. We first checked the procedure by reacting thymine 
with bromomethylbenzene (Figure 40). The latter was reacted in stoichiometric amount in the 
presence of K2CO3 in DMF resulting the targeted product with a yield of 60 %.  
 
Figure 40: Test reaction of thymine substitution. 
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The test reaction proved that the substitution of thymine with an aromatic reagent bearing a 
bromine site can be successful. Therefore, we aimed to introduce either 2 or 4 NBs to a porphyrin 
bearing 2 or 4 meso (p-bromomethylphenyl) following the same strategy (Figure 41). 
 
Figure 41: Retrosynthesis of the targeted tectons. 
 
To synthesize porphyrins with meso-bromobenzyl groups, 4-(bromomethyl)benzaldehyde (Ald-
Br) was reacted with phenyl-dipyrromethane (Ph-DPM) or pyrrole to produce di or tetra 
substituted porphyrins respectively. Ph-DPM was synthesized following known procedures,36 and 
Ald-Br was obtained upon reduction of the commercially available 4-(bromomethyl)benzonitrile 
by DIBAL-H (Figure 42). 37  
 
Figure 42: Synthesis of Ald-Br. 
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II. 4. a) Synthesis of 5,15-di(4-(bromomethyl)phenyl)-10,20-diphenylporphyrin (Po2) 
5,15-di(4-(bromomethyl)phenyl)-10,20-diphenylporphyrin (Po2) was synthesized  by reacting 
stoichiometric amount of Ph-DPM and Ald-Br in the presence of BF3.Et2O in chloroform at room 
temperature, then oxidized by p-chloranil (Figure 43). Unfortunately, these conditions led to the 
formation of a mixture of porphyrins due to scrambling. The mixture was purified on column 
chromatography, however only A4, the tetraphenylporphyrin (TPP), could be isolated as pure 
compound. The cis and trans A2B2, A3B, and AB3 porphyrins have close polarity and their 
separation was difficult. We thus reacted the mixture with excess of thymine, aiming to synthesize 
thymine functionalized porphyrins with different polarities, and thus facilitating their separation.   
 
 
Figure 43: Synthesis of Po2. 
 
II. 4. b) Substitution of Po2 mixture 
The mixture of porphyrins Po2 was reacted with an excess of thymine in the presence of K2CO3 
in DMF to give a mixture of thymine substituted porphyrins (Figure 44). The crude was separated 
by column chromatography using a gradient of eluents. The A3B porphyrin, 5-(N1-
methylphenylthymine)-10,15,20-triphenylporphyrin (T4), was successfully isolated and 
characterized by NMR, IR, HRMS and UV. Unfortunately, the separation of cis-A2B2, trans-A2B2, 
and AB3 porphyrins was not successful.  
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Figure 44: Synthesis and Isolation of T4. 
 
II. 4. c) Synthesis of 5,15-di(4-(bromomethyl)phenyl)-10,20-dimesitylporphyrin (Po3) 
To decrease the degree of scrambling, we followed the conditions described by Lindsey et al.38 
that consist of: increasing the steric hindrance of the meso-substituent on the DPM, using an acid 
with a lower Lewis acidity, and decreasing the concentration of the reactants. Therefore, we 
focused on reacting Ald-Br with mesityl-DPM in the presence of TFA instead of BF3.Et2O 
following an optimized procedure described for similar products (Figure 45).38 (a)  
 
 
Figure 45: Synthesis of Po3. 
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Mesityl-DPM was obtained in 30% yield following a reported procedure.39 Then Ald-Br was 
reacted with Mesityl-DPM in the presence of TFA to produce 5,15-di(4-(bromomethyl)phenyl)-
10,20 dimesitylporphyrin (Po3) in 15 % yield without any scrambling. We thus reacted Po3 with 
the 4 different NBs in order to generate four new trans-A2B2 tectons.  
 
II. 4. d) Synthesis of 5,15-di(N1-methylphenylthymine)-10,20-dimesitylporphyrin (T5) 
 
Po3 was reacted with an excess of thymine in the presence of K2CO3 in dry DMF at 40 
oC. The 
reaction was followed by TLC to verify the disappearance of the starting material. After 24h, one 
major product is formed together with other minor products. The crude was extracted, and then 
purified by column chromatography to yield 72 % of the targeted T5 tecton bearing thymines in 
the trans meso-positions (Figure 46). 
 
 
Figure 46: Synthesis of T5. 
 
T5 was characterized by NMR, HRMS, IR, and UV-Vis. The 1H-NMR spectrum of T5 showed 
that the peaks corresponding to the CH2 protons are affected by the nature of the deuterated solvent 
used. In CDCl3, the signals of the CH2 functions appear as two peaks, each corresponding to 2H 
with a ∆δ = 0.25 ppm. Upon the addition of CD3OD, the peaks shift close to each other and ∆δ 
decreases to 0.07 ppm. In d6-DMSO, the signal corresponding to the CH2 function appears as one 
singlet integrating for 4 protons. We can deduce that, in chloroform hydrogen bonding interactions 
take place between the molecules that result in a dissymmetric porphyrin, where the CH2 functions 
are not equivalent. Upon addition of methanol, the H-bonding between the thymine moieties is 
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interrupted, thus the CH2 are almost equivalent. DMSO is able to destroy all the H-bonding 
between the tectons, therefore in d6-DMSO the porphyrin is symmetrical and the CH2 functions 
are equivalent.  
 
II. 4. e) Synthesis of 5,15-di(N9-methylphenyladenine)-10,20-dimesitylporphyrin (T6) 
 
The same procedure was followed to synthesize T6. Po3 was reacted with an excess of adenine 
and K2CO3 in dry DMF leading to the targeted T6 tecton in 54 % yield. In addition, a minor by-
product T6’ was isolated with a yield of 5 % (Figure 47). 
 
 
Figure 47: Synthesis of T6 and T6'.  
 
NMR, HRMS, IR and UV-Vis characterization confirmed the structure of T6 bearing 2 adenine 
connected in trans-positions via their N9 amine sites. The MS of the byproduct T6’ showed the 
same mass as T6, however its 1H-NMR and the 13C-NMR spectra were different. The 1H-NMR of 
T6’ showed: two peaks for the CH2, two different peaks for the protons at the C7 position of the 
adenine (each integrating for 1 H), more peaks for the meso-phenyl protons proving that they are 
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not equivalent, and more peaks corresponding to the β-pyrrolic hydrogens, thus indicating a lower 
symmetry for T6’ when compared to T6. We conclude that the by-product is a porphyrin bearing 
two adenines, one via its N9 site (similar to the its isomer T6) and the other via its N7 site, which 
is possible because of the tautomeric forms of adenine. Moreover, T6’ is more soluble and less 
polar than T6 since H-bonding between adenines in T6’are less favored.  
 
II. 4. f) Synthesis of 5,15-di(N1-methylphenylcytosine)-10,20-dimesitylporphyrin (T7) 
 
To introduce cytosine to the meso position of a porphyrin, Po3 was reacted with cytosine in the 
presence of K2CO3 following the previous reaction conditions. However, the yield was very low. 
Cytosine’s pKa is higher than adenine’s and thymine’s,30 therefore we decided to use a stronger 
base to deprotonate the N1 site of the cytosine. Po3 was reacted with an excess of cytosine and 
NaH leading to the formation of T7 in 37% yield (Figure 48). The yield is lower than that of the 
previous substitution reactions because of the low solubility and high polarity of T7 that affected 
the purification of the crude material.  
 
 
Figure 48: Synthesis of T7. 
 
T7 was characterized by NMR, UV-Vis, IR and HRMS. The 1H-NMR spectrum of T7 showed 
two broad peaks integrating 2 H each that corresponds to the two non-equivalent NH of the two 
cytosine moieties. This is a characteristic of the tautomeric form of the cytosine moieties of T7 in 
solution.  
Chapter I: Porphyrins bearing Nucleobases 
 
97 
 
II. 4. g) Synthesis of 5,15-di(N9-methylphenylguanine)-10,20-dimesitylporphyrin (T9) 
 
The fourth nucleobase, guanine, was reacted with Po3 in the presence of K2CO3 following the 
same conditions used for T5 and T6. Unfortunately, the reaction did not produce the targeted 
tecton. We were able to deduce from the TLC analysis that only highly polar products were 
obtained and their isolation was difficult. Moreover, the NMR and MS of the crude did not show 
the peaks corresponding to the presence of guanine in the periphery of the porphyrin. 
We decided to use 2-amino-6-chloropurine (P) as a precursor of guanine (G) since it is more 
soluble, and it is described in the literature as more reactive than guanine. Moreover, P can be 
transformed into G by a hydrolysis under acidic conditions.31 Therefore, we reacted an excess of 
P with of Po3 and K2CO3. The reaction was followed by TLC that showed the formation of two 
products. The crude was extracted and purified by column chromatography to yield 80 % of 5,15-
di(N1-methylphenyl-2-amino-6-chloropurine)-10,20-dimesitylporphyrin (T8) as a major product 
and a minor product T8’ with a yield of 8%. T8 and T8’ have the same MS but differ by NMR. 
T8 is the desired tecton, while T8’ is its isomer bearing two non-equivalent P connected in trans 
meso-positions of the porphyrins, one via its N9 site and another via its N7 site (Figure 49). 
 
 
Figure 49: Synthesis of T8 and T8'. 
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T8 was then hydrolyzed using HCl aqueous solution to yield T9, a porphyrin bearing two guanines 
in its two meso positions (Figure 50). The hydrolysis reaction was followed by TLC that indicated 
a large difference in polarity between T8 and T9. When the oxidation was over, the crude was 
treated with a basic solution leading to the formation of a precipitate of T9 in 98 % yield. 
 
 
Figure 50: Oxidation of T8 into T9. 
 
T8 and T9 were characterized by NMR, HRMS, IR and UV. We were able to verify the success 
of the oxidation by comparing the MS of T8 and T9. In addition, the IR spectra of T8 and T9 were 
compared to the IR of guanine and 2-amino-6-chloropurine. The IR of P and T8 shows a signal at 
1628 cm-1 that corresponds to the C=N stretching. However, a signal found at a higher value 
equivalent to 1682 cm-1 is present in the IR spectrum of G and T9, which corresponds to the C=O 
stretching. Moreover, the appearance of a broad peak in the 1H-NMR of T9 corresponding to the 
NH function of G, which is absent in T8, was an additional proof of a successful oxidation.  
 
II. 4. h) Synthesis of 5,10,15,20-tetrakis(4-(bromomethyl)phenyl)porphyrin (Po4) 
 
To introduce four NBs, 5,10,15,20-tetrakis(4-(bromomethyl)phenyl)porphyrin (Po4) was 
synthesized following a known procedure yielding the targeted Po4 in 70 % yield 40 (Figure 51).  
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Figure 51: Synthesis of Po4. 
 
II. 4. i) Synthesis of 5,10,15,20-tetrakis(N1-methylphenylthymine)porphyrin (T10) 
To introduce thymine in the 4 meso positions, Po4 was reacted with an excess of thymine in the 
presence of K2CO3. The reaction was stired overnight and was followed by TLC to verify the 
disappearance of Po4. When the reaction was completed, the crude was dried, then triturated with 
water. The precipitate was filtered and dried to yield 93 % of the targeted T10 (Figure 52). NMR, 
UV-Vis, IR and HRMS were performed to characterize and confirm the structure of T10.  
 
 
Figure 52: Synthesis of T10. 
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II. 4. j) Substitution of Po4 with Adenine and Cytosine 
Aiming to introduce cytosine and adenine to the porphyrin backbone, Po4 was reacted in DMF 
with an excess of A and C in the presence of K2CO3 and NaH respectively (Figure 53). 
Unfortunately, in both cases, precipitates were formed in the reaction media, and the crudes were 
insoluble in all organic solvents. Characterization of the products by NMR was limited by their 
low solubility. MS analysis showed that the substitution of the four sites was not complete. 
Therefore, we deduced that substituting the four meso positions by A and C will lead to insoluble 
products, due to the strong self-assembly processes between the porphyrins via H-bonds oriented 
in different directions.  
 
Figure 53: Substitution reaction between Po4 and A or C. 
 
III. Conclusion and Perspective 
Our objective was to generate H-bonded networks based on porphyrins bearing nucleobases. In 
order to synthesize the building units, two strategies were studied. The first strategy is based on 
the connection of NBs to a porphyrin backbone via C-C bonds. Suzuki and Sonogashira cross 
coupling reactions were tested to connect NBs moieties to the corresponding porphyrin derivatives. 
Unfortunately, the Suzuki cross coupling reaction between a boronated porphyrin and a 
halogenated uracil was not successful. Therefore, we focused on Sonogashira cross coupling 
reactions between Po1 and uracil derivatives, I-U-Ph2 and I-U-C6, to produce T1 and T3 
respectively. The uracil of the T1 tecton was deprotonated resulting in T3. Moreover, a cross 
coupling reaction between Po3 and I-C-C6 was performed under both, different and similar 
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conditions. Unfortunately, the coupling was not successful, and the synthesis of T1 was not 
reproducible. The complications of the cross coupling reactions shifted our attention to another 
strategy that proved to be more effective.  
The second strategy is based on connecting NBs to porphyrins by C-N bonds via their NH sites. 
Substitution of the N1 site of pyrimidines and N9 site of purines with aromatic substituents bearing 
reactive bromine sites was successful in the presence of a base. Using this strategy, we were able 
to introduce T, A, C, P and G in the periphery of the porphyrin macrocycle generating five new 
trans-A2B2 porphyrin based tectons T5-T9. Moreover, the tetra-functionalized Po4 porphyrin was 
successfully substituted with thymine to yield T10. However, the substitution of cytosine and 
adenine produced insoluble products that could not be isolated nor characterized.  
As a conclusion, 10 new porphyrin based tectons bearing H-bonding NBs sites were synthesized 
and fully characterized (Figure 54). Our main perspective is to study the self-assembly of each 
tecton by X-Ray diffraction. Furthermore, we aim to design molecular networks based on the 
assembly of complementary tectons, such as T5 and T6 or T7 and T9. Unfortunately, no single 
crystals suitable for X-ray analysis are yet obtained. Therefore, the attempt to crystalize the tectons 
using different combinations is still under investigation. Moreover, metal cations can be introduced 
in the azacore of the porphyrins, which could result in the formation of  H-bonded metalla- 
porphyrin networks. Moreover, the introduction of an additional coordinating bidentate ligand, 
such as 4,4’-bipyridine, during the diffusion process could lead to an increase of the dimensionality 
of the final network by the coordination of the bidentate ligand in the axial position of the metal 
present in the porphyrin cavity.  
 
Figure 54: Schematic representation of all tectons T1-T10. 
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I. Dipyrrins 
Dipyrrins, known since 1920,1 have received a wide interest over the past years in supramolecular 
and coordination chemistry.2 Under basic conditions, bis-pyrrolic dipyrrins form monoanionic 
chelating ligands that coordinate to various metal centers. In addition, the dipyrrin backbone can 
be functionalized to incorporate additional interaction sites, such as coordination and/or H-
bonding sites, affording a series of interesting tectons.3 Therefore, dipyrrin based tectons are used 
to design 1D, 2D and 3D molecular networks assembled via several interactions. Moreover, the 
dipyrrins are well known for their ability to form helical structures4 and for their luminescent and 
fluorescent boron complexes, BODIPY.5 
 
I. 1. Structure and nomenclature 
The dipyrrin is a bis-pyrrolic molecule, which may be regarded as a half-porphyrin. It is 
constituted of two conjugated coplanar pyrrole rings linked by a methylene bridge. Dipyrrins are 
the oxidized form of dipyrromethanes (starting material of porphyrins), that is why they are also 
known as dipyrromethenes. The nomenclature and numbering system of dipyrrins (IUPAC) is 
similar to that of porphyrins. The positions 1 and 9 are regarded as  α-positions, positions 2, 3, 7 
and 8 as β-positions and position 5 as meso-position. (Figure 1) 
 
Figure 1: The structure and numbering of dipyrrins 
 
Dipyrrins can exist in three different conformations, according to the rotation of the pyrrole units 
around the methylene linkage, the E-syn, E-anti and Z-syn (Figure 2 (a)). In addition, under either 
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acidic or basic conditions, the dipyrrin molecule can exist in the cationic, neutral or anionic states 
(Figure 2 (b)).   
 
Figure 2: (a) The three conformations of the dipyrrin molecule. (b) The dipyrrin acid-base equilibrium  
 
I. 2. Synthesis  
 
The synthesis of dipyrrins has been first developed by Hans Fischer in 1937.6 In 1960, the 
Macdonald coupling reaction was reported for the synthesis of dipyrromethanes as intermediates 
of porphyrin, in addition to the synthesis of dipyrromethenes (dipyrrins).7  The Macdonald 
coupling consisted of a condensation reaction between 2-formylpyrrole and α-unsubstituted 
pyrrole, in the presence of an acid, such as POCl3 or HBr.8 This method affords meso-
unsubstituted dipyrrins, which can be substituted at their α- and β-positions depending on the 
starting materials. Therefore, symmetrical or non-symmetrical dipyrrins can be synthesized 
following this method. In addition, the products isolated are dipyrrin salts, which are more stable 
than free dipyrrins (Figure 3 (a)).   
Following the synthetic strategy developed by Dolphin et al., symmetrical meso-unsubstituted 
dipyrrins can be synthesized by reacting two equivalents of pyrrolylester and formic acid.9 The 
latter is involved in the release of the leaving group of pyrrolylester, besides being the carbonyl 
synthon affording the meso-unsubstituted dipyrrins. (Figure 3 (b)) 
 
Symmetrical meso-substituted dipyrrins can be synthesized by reacting 2 equivalents of α-
unsubstituted pyrrole with an acyl halide (Figure 3 (c)). In addition, symmetrical dipyrrins can be 
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synthesized following the two-steps procedure reported by J. S. Lindsey.10 The α-unsubstituted 
pyrrole is reacted with an aldehyde in the presence of an acid catalyst, such as TFA or InCl3, 
affording the dipyrromethane (Figure 3 (d)).11 The latter is less stable than dipyrrins and sensitive 
to light, thus the reaction is performed under argon, at room temperature, and always protected 
from light. The dipyrromethane intermediate is then oxidized into the targeted dipyrrin by DDQ 
or p-chloranil. The symmetrical dipyrrins can be functionalized by a wide range of substituents 
depending on the aldehyde used. Moreover, this method can be used to synthesize both α- and 
meso-unsubstituted dipyrrins, depending on the used aldehyde and pyrrole (Figure 3(d)).  
 
 
Figure 3: The synthesis of (a) non-symmetrical and (b) symmetrical meso-unsubstituted dipyrrins.        
(c) The synthesis of meso-substituted dipyrrins via acyl halides. (d) The two-step synthesis of meso-
substituted or unsubstituted dipyrrins. R1-6 represent any substituent including an H atom (unsubstituted 
site). 
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I. 3. BODIPY 
Dipyrrins can act as monoanionic chelate ligands under basic conditions, having the ability to 
form metal complexes. In addition, the dipyrrins have a conjugated π-system, therefore they have 
an intense absorption band in the visible region of the electromagnetic spectrum.3(b),4(a)   This leads 
to complexes with interesting photophysical properties. For instance, the BF2 complexes BODIPY 
(4,4-difluoro-4-bora-3a,4a,-diaza-s-indacene, boron dipyrromethene), are well known for their 
luminescent properties. BODIPY are prominent dyes and are stable luminescent species with high 
quantum yields and tunable emission wavelength with applications in photodynamic therapy, 
solar cells, light harvesting and imaging.12  
The BF2 complexes and their fluorescent properties were first reported in 1968.13 The BODIPY’s 
chemical structure is a zwitterion (B- and N+) and its numbering system differs from that of 
dipyrrins (Figure 4).  
 
Figure 4: The structure and nomenclature of BODIPY.  
 
BODIPY dyes can be easily functionalized by different substituents, in order to introduce 
additional recognition sites or to modulate their optical properties. Depending on their peripheral 
substituents, BODIPYs can act as chemical sensors14, as transition metal recognition sites15 and 
as light harvesting materials16 (Figure 5). 
Chapter II: Dipyrrins bearing Nucleobases 
 
111 
 
 
Figure 5: Examples of BODIPY and their applications. (a) The anilino based BODIPY complex acting 
as a chemical sensor for NO molecules, and its transformation yielding luminescent adducts.14 (b) The 
BODIPY photosynthetic combined antenna-reaction center model system.15 
 
I. 4. Dipyrrin complexes  
 
Under basic conditions, dipyrrins form mono-anionic chelates that can coordinate to various metal 
centers including transition metals and semimetals.3(b), 4(a), 17  Dipyrrins can form homoleptic 
M(dipyrrin)2 or M(dipyrrin)3 complexes depending on the metallic cation and its oxidation 
number. (Figure 6)  
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Figure 6: The formation of homoleptic M(II)(dipyrrin)2 and M(III)(dipyrrin)3 complexes.  
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The M(dipyrrin)2 complex is usually synthesized by reacting 2 equivalents of dipyrrin ligands with 
one equivalent of metal(II) acetate in methanol. The latter is used as a solvent. Since the formed 
dipyrrinato complex is not soluble in methanol, the complex can be easily isolated by precipitation 
and filtration. Metal acetate salts are preferred for the complexation reaction, since acetate counter 
ions can also act as a base to deprotonate the dipyrrin ligand. Metal cations such as Ni(II)18, 
Cu(II)19, Cd (II)20, Pd(II)21 and Zn(II) 22 are used to form M(II)(dipyrrin)2 complexes, which 
usually adopt a deformed tetrahedral or square planar coordination geometry (Figure 7).  
 
 
Figure 7: Examples of homoleptic dipyrrinato M(II) complexes. (a) The crystal structure of Cd(II) (5-
mesityldipyrrin)2. Figure modified from reference 20. (b) The crystal structure of Zn(II) (1,9-dimethyl-4-
mesityldipyrrin)2. Figure modified from reference 22 (b).  
 
The M(dipyrrin)3 complexes are formed by reacting metal cations in +2 oxidation state, which will 
be oxidized during complexation, or by reacting metal cations in the +3 oxidation state, for 
example Co(III)23, Fe(III)24, In(III)25 and Ga(III)26, with three equivalents of a dipyrrin ligand. The 
metal cation of a tris(dipyrrinato)complex is in an octahedral coordination geometry and the meso 
substituents of three dipyrrin ligands are in a pseudo-3-fold symmetric environment with respect 
to the metal center. An example of such geometry is shown in Figure 8 (a).  
Moreover, neutral dipyrrin molecules can also be regarded as monodentate ligands via their imine 
nitrogen, however few examples of complexes with neutral dipyrrins are described (Figure 8(b)).27 
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Figure 8: (a) The crystal structure of Co(III)(dipyrrin)3 complex, Figure taken from reference 23 (a).     
(b) The crystal structure of a neutral monodentate Ag(I) dipyrrinato. Figure taken from reference 27. 
 
The M(II)(dipyrin)2 and M(III)(dipyrin)3 are homoleptic complexes incorporating the same type 
of ligands around the metal center. In addition, dipyrrin heteroleptic complexes, incorporating at 
least two different ligands, are also accessible.28 Such complexes are formed by reacting one 
equivalent of a dipyrrin ligand with one equivalent of a metal salt. An example of such complexes 
is the 5-pyridinedipyrrin metallotecton, Cu(II)(Py-dipyrrin)(acac), represented in Figure 9.29 
 
 
Figure 9: The crystal structure of a heteroleptic Cu(II)(Py-dipyrrin)(acac) complex and its 1-D chain. 
Figure taken from reference 29. 
 
In addition, the dipyrrin backbone can be functionalized in its periphery by other binding units, 
affording a dipyrrin metallotecton with secondary coordinating sites (Figure 10).2 It can self-
assemble into homo- or hetero-metallic coordination polymers upon their reaction with the same 
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or with different metal cations. Figure 10 shows two examples of Zn(II)dipyrrin metallotectons 
bearing additional coordinating sites. Upon, introducing CdCl2 salt, the metallotecton self-
assembles into a 2D grid like network via the coordination of the secondary coordination sites 
(pyridine and imidazole) to the second metal center (Cd(II)).4(a),30 
 
 
Figure 10: Heterometallic 2D grid type MOFs, obtained by the assembly of Zn(II)dipyrrin complex with 
CdCl2. Figure modified from reference 4(a).  
 
In addition to meso-, α- and β-substituted dipyrrins are also well known.31 For example, pyridyl 
moieties were introduced at the β-positions of a BODIPY complex to design rod-like bidentate 
ligands.32 The assembly of the pyridyl-BODIPY ligands in the presence of  Pd(II) metal center 
afforded two macrocyclic architectures with triangular and square geometries as represented in 
Figure 11. The two forms are in equilibrium in solution, and their ratio depends on the solvent. In 
less polar solvents (dichloromethane and chloroform), both the triangular and square species are 
present. The use of more polar solvents (acetone, dimethyl sulfoxide and methanol) afforded only 
the triangular complex, which is entropically favored. 
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Figure 11:  β-substituted dipyrrin and the assembly of its Pd(II) complex in the triangular and square 
macrocyclic forms. Figure taken from reference 2 (a).  
 
As previously discussed, dipyrrin based tectons are well known for their self-assembly into 
discrete and infinite supramolecular architectures. In addition, 2,2’-bisdipyrrins possess the 
ability to form helical arrangements held by coordination bonds.33 The assembly of 
bis(dipyrrinato)metal(II) complexes into  double-stranded helicates, linked by rigid or flexible 
spacers, has been reported.33,34 Examples of such architectures are represented in Figure 12. 
Furthermore, dipyrrin-based helicates display interesting properties, for instance visible light 
emission and unique cation-π interactions (Figure 12).35  
 
Figure 12: Examples of dipyrrin helical assemblies. (a) The structure of double helicates based on bis- 
dipyrrin metallotecton connected with flexible alkyl chains.33 (b) The chemical structure of a double 
helical complex with rigid aromatic linkers.34(a) (c) The structure of triple-stranded M2L3 complexes. 34(b) 
Figure modified from reference 2(b). 
Chapter II: Dipyrrins bearing Nucleobases 
 
116 
 
In addition, the assembly of a 2,2’-bisdipyrrin Zn(II) complex bearing peripheral benzonitrile 
moieties into helical architectures, in the presence of silver salts AgX (X= TfO-, BF4-, SbF6-) was 
reported by our lab.36 The effect of the solvent and the counter ions used on the final organization 
of the tectons was discussed. To synthesize the Ni(II) bis-dipyrrin complex (2) shown in Figure 
14,  the ligand (1) was reacted with Ni(OAc)2. Subsequent oxidation by DDQ followed by 
demetallation in the presence of  HCl afforded the 2,2’-bisdipyrrin ligand (4). The latter was then 
reacted with Zn(OAc)2 to yield the targeted helical complex, which was studied by X-Ray analysis 
(Figure 13). The structural investigation showed that the dipyrrin strands are arranged into a 
double helical structure maintained by the coordination of the Zn(II) to the two bis-dipyrrin, and 
that the metal cation adopts a distorted tetrahedral geometry (Figure 13). 
 
Figure 13: The synthetic pathway of helicate (5) and the crystal structures of compounds (1)-(5). Figure 
taken from reference 36.  
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I. 5. Dipyrrin complexes in hydrogen bonded networks 
 
As previously discussed, the dipyrrin backbone can be functionalized by hydrogen bonding sites 
in addition to the coordination sites. Dipyrrins bearing peripheral hydrogen bonding 
donor/acceptor sites, for example amides, carboxylic acid and diaminotriazine, have been 
reported.37 Such dipyrrins are interesting tectons as they offer two different interaction poles, the 
coordinating mono-anionic dipyrrin site and the H-bonding site. The former coordinates to metal 
centers resulting in a bisdipyrrinato complex (metallotecton) (Figure 14 (a)). The latter forms H-
bonding interactions between the proton donor and proton acceptor groups, which result in the 
self-assembly of the metallotecton (Figure 14 (b)). The H-bonding sites can be involved in several 
H-bonding interactions, and thus forming 2D and 3D H-bonded networks (Figure 14 (c)).38, 39  
 
Figure 14: (a) Schematic representations of a dimer formed upon combination of two dipyrrin tectons 
bearing H-bonding sites with a tetracoordinated metal ion, (b) and its extension into 1D (c) and 2D 
networks through H-bonds. Figure taken from reference 38.  
 
Examples of such metallotectons are the L138 and L239 metallotectons represented Figure 15. L1 
and L2 are synthesized in a three-step procedure, by reacting the corresponding aldehyde with 
pyrrole in the presence of a catalytic amount of TFA (acid catalyst), resulting in the 
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dipyrromethane intermediate, which is then oxidized into the targeted dipyrrin using DDQ. 
Furthermore, the dipyrrin ligands are mixed with several metal salts (Ni(OAc)2, Cu(OAc)2 and 
Zn(OAc)2), affording metallotectons bearing H-bonding sites (Figure 15).  
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Figure 15: The synthesis of L138 and L239 metallotectons. The H-bonding sites are represented in purple.  
 
The ligand L1 forms a homoleptic complex in the presence of Cu(OAc)2, which crystallizes in 
the monoclinic space group C2/c. The copper atom, lying on a two-fold axis, is tetra-coordinated 
and adopts a distorted tetrahedral geometry. L1-Cu(II) complex forms two hydrogen-bonding 
motifs,  thus leading to a 2D hybrid network with a parallel H-bonded ladder-like structure 
connected by the metal nodes (Figure 16).38  
 
 
Figure 16: The crystal structure of the 2D network of L1-Cu metallotecton. Only the hydrogen atoms 
involved in H-bonds are depicted. Figure take form reference 38.  
Chapter II: Dipyrrins bearing Nucleobases 
 
119 
 
The L2 ligand was mixed with Ni(OAc)2, Cu(OAc)2 and Zn(OAc)2 metal salts, affording three 
different metallotectons. The Cu(II) and Zn(II) metal centers, coordinate two dipyrrin ligands, 
and adopt a tetrahedral conformation. However, the Ni(II) metal center adopts a square planar 
geometry. The three complexes self-assemble into a 1D chain via H-bonds between the azaindole 
sites (Figure 17). However, the formation of a 2D network in this case was not observed, since 
the azaindole only behaves as a single hydrogen bonding site.39  
 
 
Figure 17: The crystal structure of the 1D hydrogen bonded networks of (a) L2-Zn (II) complex, (b) L2-
Cu(II) complex (c)  L2-Ni(II) complex. Only the NH hydrogen atoms are shown for clarity. Figure taken form 
reference 39. 
 
II. Dipyrrins bearing nucleobases  
 
Introducing peripheral coordination or H-bonding sites into the dipyrrin scaffolds results in highly 
attractive tectons, which may be used to design molecular networks assembled via different 
intermolecular interactions. The dipyrrin ligands can be easily functionalized at the meso or α- 
positions by a wide range of H-bonding moieties, for instance the nucleobases. One must mention 
that only few examples of dipyrrin bearing nucleobases are known in the literature. However, a 
wide variety of dipyrrins bearing H-bonding motifs, very similar to the four nucleobases found in 
DNA, are reported along with their self-assembly.  
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II. 1. Some examples of dipyrrins functionalized by NBs 
A recent example of a BODIPY complex bearing guanine is reported, and its self-assembly into 
a 2D network is described.40 The G-BODIPY was synthesized by a Sonogashira cross-coupling 
reaction between iodo-BODIPY and 8-ethynyl guanine (Figure 18) . 
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Figure 18: The synthesis of G-BODIPY.40 
 
The G-BODIPY crystalizes in a triclinic space group P-1. The guanine sites of two adjacent 
molecules self-assemble by hydrogen bonding interactions, resulting in a G-ribbon structure with 
the dipyrrin moieties attached at both sides of the ribbons. The G-ribbons were further packed 
into a double-layered pattern via π-π interactions between two guanine moieties (Figure 19). 
 
Figure 19: (a) The crystal structure G-BODIPY. (b)  The packing of G-BODIPY. (c) The double-layer 
ribbon-like assembly of G-BODIPY. Figure modified from reference 40.  
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The diaminotriazinyl (DAT) H-bonding motif has similar H-bonding properties as NBs. A 
metallotecton bearing three DAT molecules and its assembly into a H-bonded network has been 
reported.23(a),41 The complex has a pseudo-octahedral Co(III) core, where the three DAT groups 
are crystallographically nonequivalent (Figure 20 (b)). Each tecton participates in a total of 10 N-
H···N hydrogen bonds, which fall into two categories corresponding to supramolecular synthons 
I and II in Figure 20 (a). The hydrogen-bonding motif forms S-shaped chains of six DAT groups, 
which in turn generate an open two-dimensional network (Figure 20 (c)). 
 
 
Figure 20: (a) The intermolecular H-bonding between two DAT molecules. (b) The coordination sphere 
around the Co(III) metal center (c) The 2-D network. The three DAT groups of each tecton are shown in 
different colors (blue, green, and red). Figure taken from reference 23 (a).    
 
II. 2. Aim of the project 
Nucleobases are well known for their H-bonding properties, while dipyrrins have the ability to 
form either discrete or infinite coordination assemblies. Together, nucleobases and dipyrrins, 
represent interesting moieties that, when combined, could afford interesting tectons for the 
formation of novel networks. Therefore, the main objective of this study is to synthesize dipyrrin-
based tectons bearing the four nucleobases (T, A, C and G), to metallate them with various metal 
centres and to subsequently design molecular networks assembled via NB’s H-bonding and 
dipyrrins’ coordination interactions (Figure 21). 
Chapter II: Dipyrrins bearing Nucleobases 
 
122 
 
 
Figure 21: An example of a supramolecular network that could form via H-bonding interactions between 
(a) two complementary homoleptic bisdipyrrin complexes or (b) a heteroleptic self-complementary 
bisdipyrrin complex. 
  
II. 3. Synthesis of dipyrrins bearing NBs 
Dipyrrins are easily functionalized at the meso position, by reacting the corresponding aldehyde 
with pyrrole in the presence of an acid catalyst. We first decided to follow a procedure similar to 
the one used to introduce NBs at the meso position of porphyrins, as described in the previous 
chapter. The procedure aimed to synthesize a dipyrrin bearing an active bromine site, which will 
be used a starting material for the substitution reactions with the NBs to afford the targeted tectons 
(Figure 22). 
 
Figure 22: A possible retrosynthetic pathway of the targeted tectons. 
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Following known procedures for similar compounds,3(a), 42 an excess of pyrrole (40 eq.) was 
reacted with an equivalent of 4-(bromomethyl)benzaldehyde (Ald-Br) and 2 drops of TFA, in 
order to synthesize the targeted dipyrromethane bearing an active bromine site. The excess of 
pyrrole in this case was used to avoid polymerization reactions.42 The crude was purified by 
column chromatography, and the product was analyzed by NMR and MS, which proved the 
formation of a byproduct instead of the targeted dipyrromethane. Indeed, the number of peaks 
and their integration in the 1H-NMR spectrum did not correspond to the targeted product. In 
addition, the MS showed a mass of 242.28 (M+1) +1 instead of 315.04 (M+1)+1, and the isotopic 
profile is not compatible with the presence of a Br atom in the molecule. 
The use of unsubstituted pyrrole might lead to secondary reactions, which form several 
byproducts. Therefore, pyrrole was replaced with 2,4-dimethylpyrrole aiming to favor the 
formation of the targeted dipyrrin. Two equivalents of 2,4-dimethylpyrrole were reacted with an 
equivalent of Ald-Br and a catalytic amount of TFA. The dipyrromethane was directly oxidized 
by DDQ, following known procedures.2(b), 43 Unfortunately, MS and NMR analysis of the purified 
product were not compatible with the desired dipyrrin.  
The chemical structure of the formed product, in both reactions, was not elucidated. However, it 
was certain that the bromine group was not present and that it was involved in a secondary 
reaction. To avoid the loss of the bromine active site, another synthetic strategy was explored 
(Figure 23). Br-Ald was first reacted with the nucleobases in order to synthesize nucleobases 
bearing an aldehyde function. The latter was then reacted with 2,4-dimethylpyrrole in the 
presence of TFA to afford the targeted tectons. The 2,4-dimethylpyrrole was used to synthesize 
the dipyrrin tectons, instead of pyrrole, to increase solubility of the final products and to prevent 
possible polymerization process. 
 
Figure 23: The retrosynthesis of the targeted tectons. 
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II. 3. a) 1,3,7,9-tetramethyl-5-(N1-methylphenylthymine)-dipyrrin (T-dipyrrin) (T11) 
 
In order to connect benzaldehyde to thymine (T), one equivalent of Br-Ald was reacted with 2 
equivalents of T in the presence of 1.5 equivalents of K2CO3.44,45 The reaction yielded two 
products, the targeted monosubstituted 4-(N1-methylthymine)benzaldehyde (T-Ald) together 
with the disubstituted bis-4-(N1,N3-methylthymine)benzylaldehyde. The side reaction was 
expected, since the deprotonation of both amine functions of thymine is possible with K2CO3.45,46 
However the conditions used lead to a minimum amount of side product, while making the target 
one the major compound. The crude was purified by column chromatography to yield 57 % of T-
Ald and 5% of the di-substituted product (Figure 24). 
In a second step T-Ald was reacted with pyrrole following procedures described for similar 
compounds.2(b), 43 One equivalent of T-Ald was reacted with 2 equivalents of 2,4-dimethylpyrrole 
in the presence of a catalytic amount of TFA (2 drops) in dichloromethane. The formed 
dipyrromethane was not isolated, and the direct oxidation by DDQ (0.9 eq.) was performed. The 
crude was purified by column chromatography to yield 53 % of the targeted T-dipyrrin (T11) 
(Figure 24). The chemical structure of T11 was confirmed by NMR and MS analysis. In addition, 
T11 was analysed by IR and UV spectroscopies. 
 
Figure 24: The synthesis of T-dipyrrin. 
 
II. 3. b) 1,3,7,9-tetramethyl-5-(N9-methylphenyladenine)-dipyrrin (A-dipyrrin) (T12) 
 
The same procedure was followed to introduce the second NB, adenine (A). Br-Ald (1 eq.) was 
reacted with 2 equivalents of adenine and 1.5 equivalents of K2CO3 to afford the targeted A-Ald 
with a yield of 45%. Subsequently, the A-Ald was reacted with 2,4-dimethylpyrrole in the 
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presence of a catalytic amount of TFA in DCM. The crude was oxidized by DDQ (0.9 eq.) to 
yield 26 % of A-dipyrrin (T12) (Figure 25). 
The low yield, compared to the synthesis of T11, can be attributed to the low solubility and high 
polarity of the formed A-dipyrrin, which affected the ease of the purification process. An eluent 
with higher polarity (5% MeOH and 1% ammonia in DCM) was needed to elute the product. A-
dipyrrin was characterized by NMR, HRMS, UV and IR, which confirmed the chemical structure 
of the final tecton.  
  
 
Figure 25: The synthesis of A-dipyrrin (T12) 
 
II. 3. c) 1,3,7,9-tetramethyl-5-(N1-methylphenylcytosine)-dipyrrin (C-dipyrrin) (T13) 
 
To introduce cytosine (C) to the dipyrrin backbone, Br-Ald (1 eq.) was reacted with 2 equivalents 
of cytosine and 1.5 equivalents of NaH to afford the targeted C-Ald (T13) with a yield of 45%. 
As discussed in chapter I, the deprotonation of the N1 position of cytosine by K2CO3 results in a 
poor yield, thus a stronger base, NaH was used. C-Ald was then reacted with 2,4-dimethylpyrrole 
in the presence of a catalytic amount of TFA in DCM. The obtained crude was oxidized by DDQ 
(0.9 eq.) to yield 20 % of C-dipyrrin (T13) (Figure 26). This is the lowest yield obtained out of 
all the synthesis of the dipyrrins bearing nucleobases. Cytosine is known to form stable dimers 
via 2 H-bonds resulting in its lower solubility and reactivity compared to thymine and adenine.46 
Moreover, an eluent with higher polarity (5% MeOH and 5% ammonia in DCM) was needed to 
purify C-dipyyrin. The synthesis was repeated several times to optimize the yield. Unfortunately, 
the obtained yields were lower or close to 20% (Figure 26). 
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C-dipyrrin was characterized by NMR, HRMS, UV and IR analysis, which confirmed the 
chemical structure of the final tecton. The 1H-NMR of T13 showed the characteristic peaks of 
cytosine, with two broad singlets at 7.02 and 7.10 ppm, integrating each for one proton and 
corresponding to the tautomeric form of cytosine present in solution.  
 
 
Figure 26: The synthesis of C-dipyrrin (T13) 
 
II. 3. d) 1,3,7,9-tetramethyl-5-(N9-methylphenylguanine)-dipyrrin (G-dipyrrin) (T15) 
 
The final nucleobase to be introduced to the dipyrrin backbone is guanine (G). From the past 
experiences, reacting guanine will afford a low soluble product, due to the H-bond interactions 
between guanine moieties. Therefore, 2-amino-6-chloropurine (P) was used instead, in order to 
afford a more soluble dipyrrin intermediate, which can be oxidized to the targeted tecton (T15) 
(Figure 27). 
Two equivalents of P and one equivalent of Br-Ald were reacted in the presence of 1.5 
equivalents of K2CO3, to afford 43% of the targeted P-Ald. The latter was reacted with 2 
equivalents of 2,4-dimethylpyrrole and a catalytic amount of TFA. Subsequent oxidation by DDQ 
was performed, which yielded 33% of P-dipyrrin (Figure 27). T14 was characterized by NMR, 
IR, UV and HRMS.  
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Figure 27: The synthesis of P-dipyrrin (T14). 
 
A solution of P-dipyrrin in methanol was stirred with a 0.1 M HCl aqueous solution. The acid 
hydrolysis of P-dipyrrin afforded G-dipyrrin (T15) with a yield of 80% (Figure 28).  
T15 was characterized by IR and HRMS. Unfortunately, 1H and 13C NMR for G-dipyrrin was 
difficult to perform, due to its low solubility in dichloromethane, chloroform or DMF. In such 
cases, the NMR is performed in d6-DMSO, or in a mixture of CDCl3 and MeOD or in deuterated 
1,1,1,3,3,3-hexafluoro-2-propanal (HFIP)47. Unfortunately, T15 is also poorly soluble in all these 
deuterated solvents and no clear NMR spectrum could be obtained. 
The success of the acid hydrolysis was proven by the IR and MS analysis. The IR spectrum of P-
dipyrrin showed a vibration at 1609 cm-1 corresponding to the C=N stretching of P. In G-
dipyrrin, this band shifted to 1682 cm-1, which corresponds to the C=O stretching present in G. 
Moreover, the success of the acid hydrolysis was proved by the change of the [M+1]+1 peak in 
MS from 458.18 for P-dipyrrin to 440.22 for G-dipyrin.  
 
 
Figure 28: The hydrolysis of P-dipyrrin (T14) into G-dipyrrin (T15). 
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III. H-bonded network based on Zn(II)(T-dipyrrin)2  
 
Numerous attempts to grow single-crystals of these five new dipyrrin ligands (T11-T15) ,  in 
order to characterize them by X-Ray diffraction, were performed. Different techniques such as 
liquid diffusion, slow evaporation, or vapour diffusion were explored, but with no success yet. 
Moreover, we also tried to crystallize the assembly of complementary tectons such as T-dipyrrin 
with A-dipyrrin and G-dipyrrin with C-dipyrrin, but no single crystal has been isolated yet.  
The aim of this part is also to generate H-bonded network based on bis-dipyrrin complexes. Thus 
the tectons were mixed with different metal salts (M(OAc)2, M= Zn (II), Cd (II), Cu(II), Ni(II), 
Ru(II), Pd(II)). Single crystals were only obtained for T11 (T-dipyrrin) in the presence of 
Zn(OAc)2.2H2O. The structure obtained revealed that the metallation of the dipyrrin moiety 
occured, resulting in the formation of a bis-dipyrrin zinc complex, T-dipyrrin-Zn(II), that self-
assembled into a complex H-bonded network (Figure 29-31). 
 
Figure 29: The crystal structure of the 4 complexes (I, II, III and IV). For description of I, II, III and IV 
see the text bellow. 
 
T-dipyrrin-Zn(II) crystallizes in the monoclinic P21/n space group. Two dipyrrin moieties are 
coordinated to a zinc ion, forming a H-bonded tetramer involving four nonequivalent bis-dipyrrin 
complexes (I, II, III, IV) (Figure 29 and 30). The zinc cations are all four coordinated, adopting 
a deformed tetrahedral geometry, with Zn-N distance close to 2.0 Å (Figure 29).  
Chapter II: Dipyrrins bearing Nucleobases 
 
129 
 
The four complexes differ in the crystal by the orientation of their thymine peripheral sites, which 
is dictated by the interactions between the thymine moieties. The four complexes are connected 
via H-bonds between the thymine moieties forming a chain (I-II-III-IV) (Figure 30). 
 
Complex I and II are connected by two H-bonds between their thymine moieties with an average 
distance of 2.90 Å (dO6-N8 and dO4-N12). Moreover, the two complexes are connected via a C-
H···O interaction between the carbonyl (O2) of the thymine belonging to complex I and the π-
CH (C100H100) of the thymine belonging to complex II with a distance of 3.07 Å (dC100-O2) 
(according to crystallographic numbering) (Figure 30). In addition to conventional H-bonds (N-
H···O), NBs can be involved in weak H-bonds denoted as CH·· ·O. Such interactions are found 
in biological assemblies, for example between the nucleic acids of DNA and between proteins.48 
Complex II and III are connected by two H-bonds between the thymines with a distance of 2.82 
Å (dN16-O10 and dO8-N20).  From the other side, complex III is connected to the complex IV 
via two H-bonds between the thymines with an average distance close to 2.80 Å (dO11-N28 and 
dN24-O13) (Figure 30). 
 
 
Figure 30: The crystal structure of the H-bonded chain. Hydrogen atoms not included in H-bonding are 
omitted for clarity.  
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Each tetramer interacts with two adjacent tetramer through CH---O interaction involving C125 of 
complex III and O16 of complex IV of another tetramer, with a C125-O16’’ or C125’-O16 
distance of 3.196 Å, thus leading to the formation of a 1D H-bonded ribbon (Figure 31).  
 
 
Figure 31: The Crystal Structure of the 1D ribbon.  
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IV. Conclusion and Perspectives 
 
Introducing H-bonding sites, such as nucleobases, into dipyrrins affords interesting molecular 
tectons that can self-assemble via several intermolecular interactions. The five NBs T, A, C, P 
and G were introduced at the meso-position of dipyrrins, following a procedure similar to the one 
used in chapter I for the porphyrins. As a result, five new tectons T11-T15 were synthesized and 
characterized (Figure 32). 
The aim of the project was to design molecular networks assembled via Watson-Crick H-bonding 
between the self-complementary and the complementary tectons. Indeed, the self-assembly of 
T11 (T-dipyrrin) in the presence of Zn(II) resulted in a 1D network through coordination bonds 
of the metal center and via different T-T interactions, the Watson-Crick and C-H···O H-bonds 
(Figure 31). 
 
 
Figure 32: The chemical structure of T11-T15. 
 
 
Furthermore, the attempt to design other molecular networks based on the self-assembly of  single 
tecton or by combining complementary tectons, such as T-dipyrrin and A-dipyyrin or C-
dipyrrin and G-dipyrrin, were performed. Unfortunately, no single crystals suitable for X-ray 
analysis were obtained yet. Therefore, among many options, the first perspective is to pursue our 
attempts at crystallizing the tectons with different metal salts. Instead of this one pot procedure, 
another possibility would be to proceed in a two-step procedure, the first step focusing on the 
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synthesis and characterization of homo or heteroleptic bis-dipyrrin complex and then to study 
their assembly in the solid state.  
The second perspective is to study the luminescent properties of the T-dipyrrin-Zn(II) complex. 
Moreover, the project can be extended to the synthesis of BODIPY complexes bearing NBs, and 
the study of their luminescence properties (Figure 33).  Last but not least, introducing additional 
NB in the α-position of the tetramethyl-dipyrrin backbone is possible, by reacting the NB-dipyrrin 
with the corresponding NB-aldehyde in the presence of p-toluenesulfonic acid.49 This will afford 
tectons bearing three NBs that have a high potential to form networks via 3 H-bonding sites 
(Figure 33). 
 
 
Figure 33: Schematic representation of future tectons. 
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I. Heterocyclic amines 
 
Heterocyclic amines (HCAs) are molecules that contain ring moieties with at least one amine 
function.1 Furthermore, HCAs are abundant molecules in nature, commonly found in vitamins, 
agrochemicals, pharmaceuticals and other compounds. Pyrrolic rings along with purines and 
pyrimidines (NBs), discussed in previous chapters, are examples of HCAs. In addition, the six-
membered ring, pyridine, and its derivatives, bipyridines and terpyridines, are HCAs with different 
chemical and biological applications.2 They are used in the synthesis of dye and fragrances,2(c) 
pharmaceuticals2(d) and agrochemicals2(c). Pyridine based ligands, such as terpyridine, have been 
extensively used in coordination chemistry and scarcely in molecular tectonics as coordinating 
building blocks.3 In this chapter, we will focus on pyridine (Py) and terpyridine (terPy) derivatives 
(Figure 1).  
 
Figure 1: Chemical Structure of pyridine and tepyridine. 
 
I. 1. Pyridines
 
Pyridines (Py) are heterocyclic organic compounds discovered in the 18th century that are used as 
solvents and reagents in numerous organic synthesis.4 Py are planar molecules with a six π-electrons 
conjugated system. The electron lone pair of the nitrogen atom of pyridines are not involved in the 
aromatic ring, thus Py is a base with similar chemical properties to those of tertiary amines and a 
pKa of ca 5.25.4(a) Pyridines are relatively electron deficient, due to their electronegative nitrogen 
atoms. Therefore, they are readily involved in electrophilic aromatic substitution reactions. 
However, Py are more prone to nucleophilic substitutions and metallation of their ring to various 
metal centers, which makes them widely used in coordination and supramolecular chemistry.5 In 
Chapter III: Pyridine and Terpyridine bearing Nucleobases 
 
140 
 
addition, several synthetic procedures are known for the functionalization of pyridine by other 
coordinating6 or hydrogen bonding sites7. Moreover, its planar aromatic structure leads often to π-
π stacking intyeractions. All of these properties make pyridines attractive tectons for designing 
molecular networks.8  
 
I. 2. Terpyridines 
 
Terpyridines (terPy) (2,2';6',2"-terpyridine or 2,6-bis(2-pyridyl)-pyridine) are a heterocyclic 
compound derived from pyridine. They were first discovered by Morgan and Burstall.9 The terPy 
are interesting tridentate ligands used in coordination chemistry. 10  The use of terPy increased in 
recent years due to their attractive DNA-binding ability11, together with their potential 
photochemical and photophysical properties12.  
 
I. 2. a) Terpyridine complexes 
 
Terpyridine ligands bind a wide variety of metal centers. They mostly act as tridendate ligands but 
some bidentate terPy complexes [M(CO)(terPy)X] (M =Mn (I), X = Br; M = Re (I) X = NO) have 
been isolated and characterized.13 Moreover, terpyridine based complexes with Mg(II), Ca(II), 
Ba(II), Al(III), Sn (II), As and Pb (II) have been reported, but the most popular are with 3d or 4d 
metal cations such as Fe(II), Zn(II), Cu(II), Ni(II), Ru(II), Pd(II), Co(II), Co(III) and Fe(III). The 
majority of transition metal complexes incorporate metal ions in the +2 and/or +3 oxidation state 
in octahedral, or square planar geometries.14  
Upon coordination to a metallic center, terPy based ligands undergo a number of changes. The 
main difference is the constrained co-planar orientation of the three pyridine cycles with the lone 
pairs of three nitrogen atoms oriented in a convergent fashion. Moreover, terPy ligands in a planar 
tridentate mode, coordinated to metal centers, exhibit a reduced interannular angle between the 
central and terminal pyridine rings, and display slight differences in bond length compared to the 
free ligand (Figure 2).14  
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Figure 2: The distortion experienced by a terpyridine ligand upon coordination to a metal ion in a planar 
tridentate mode.  
 
The terPy commonly behave as chelating tridentate ligands, in the majority of complexes 
exhibiting 1:1 or 1:2 metal:ligand ratio depending mostly on the metal cations and the counter-ions 
(Figure 3 and Figure 4). The 1:1 mono-terpyridine complexes usually exhibit distorted trigonal-
bipyramidal or square-pyramidal geometries. The 1:2 bis-terpyridine complexes are based on an 
octahedral geometry around the metallic center, and they frequently exhibit a D2d local symmetry. 
In order to prepare exclusively non symmetrical complexes such as [Mn+(terPy1)(terPy2)]n+, the 
two ligands are introduced in a two-step procedure (via a mono-terPy complex intermediate). 
Suitable metals for this strategy are ruthenium and osmium.15 
 
 
 
Figure 3: The chemical structure of a 1:1, symmetrical and asymmetrical 1:2 metal: terPy complexes. R1 
and R2 represent two different substituents and M represents metal centers. 
 
Terpyridines have been widely proposed as analytical reagents for the detection of iron in biological 
and other materials. The terPy are very sensitive to the presence of iron cations and immediately 
form pinkish complexes. The purple complex cation [Fe(terPy)2]2+ and its blue oxidized product 
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[Fe(Terpy)2]3+ have been discussed since the first description of terPy. In the presence of 
coordinating counter ions, iron complexes of 1:1 stoichiometry [Fe(terPy)X2] (X = Br, I, or NCS) 
adopt a trigonal-bipyramidal geometry, with the Fe(II) being five coordinated,. In the presence of 
more labile ligands, a 1:2 stoichiometry is achieved as shown in the crystal structural analysis of 
[Fe(terPy)2][ClO4]2.H2O, with a distorted octahedral geometry around the Fe(II).16 Terpyridine–
ruthenium complexes of the type [Ru(terPy)2X2] (X = Cl-, ClO4-, PF6-) are well-known.17 The Ru 
(II) metal center in this 1:2 bis-complex is hexacoordinated, and has a distorted octahedral 
geometry.18 A main characteristic of such complexes is the strength of the metal–ligand 
coordination bond, due to the strong metal–ligand (d–π*) back donation. Furthermore, a strong 
chelate effect is present.14,15  
 
In the presence of Cu(II), Zn(II) or Co(II) cations, terpyridine ligands readily forms mono-terPy 
complexes.19 Such structures adopt usually distorted square-pyramidal or distorted trigonal-
bipyramidal geometries. Bis-terPy Cu(II) complexes are prepared in the presence excess of  
terpyridine ligands. In these complexes, the distorted geometry around the metallic center causes 
the two terPy ligands to become nonequivalent.20 The terPy ligands can also coordinate to 
lanthanides (Ln) forming 1:1, 1:2 or 1:3 complexes. The 1:1 Ln-terPy complexes are the most 
widely investigated, which are nine-coordinate and readily adopt a monocapped square-
antiprismatic or nine-coordinate tricapped trigonal-prismatic geometry.21 
A huge library of terpyridine-based ligands is present in the literature, and their coordination to a 
large variety of metal cations are described together with potential applications. For example, Ru 
(II)22, Ir (III)23 and Os(II)24 complexes are known for their luminescent features and photo-physical 
applications, Fe(III) and Co(II) complexes can act as oxidizing agents,25 and Cu(II) and Zn(II) 
complexes are known for their DNA-binding properties.11, 26 
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Figure 4: The crystal structure of 1:2 complexes with (a) Ru(II)17(a) complex, (b) Fe(II) complex16(a) and 1:1 
complexes with (c) Zn(II)19(a) complex, (d) Cu(II)19(b) complex, (e) Co(II)16(a) complex.  
 
I. 2. b) Synthesis of terpyridine based ligands 
 
Several methods may be followed to synthesize terpyridine based ligands. For example, 4’-
functionalized terpyridines can be synthesized via the pyridine and 4’-chloroterpyridine route.27 
The 4’-chloroterpyridine intermediate can then react with alcohols bearing the targeted substituent 
using a base catalyst, such as KOH. In addition, the cross-coupling of alkynes with bromo-
terpyridines is another frequently used method to obtain various functionalized terpyridine ligands 
(Figure 5). 28 
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Figure 5: The synthesis of terPy ligands via the chloro-terpyridine or bromo-terpyridine and Pd-catalyzed 
cross-coupling reaction.15  
 
Moreover, the 4’-functionalized terpyridines are readily obtained by the condensation of 
benzaldehyde, or by substituted benzaldehyde, with two equivalents of 2-acetylpyridine to give 1,5-
diketone.29 The latter can then be isolated prior to the aza ring closure followed by an oxidative 
dehydrogenation using ammonium acetate (Figure 6). A second method consists in reacting the 
starting material in a one-pot synthesis (Figure 6). In our group, the starting material, 4'-(4-tolyl)-
2,2':6',2"-terpyridine (4-tolyl-terpy or tolyl-terPy) was obtained following the second method.  
 
 
Figure 6: The synthesis of 4’-functionalized terpyridines by condensation of 2-acetylpyridine and an 
aldehyde.15 
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II.   Heterocyclic Amines functionalized by NBs 
 
Pyridine derivatives, as mentioned previously, have the ability to coordinate to various metal 
centers, and to be functionalized by different substituents. Introducing H-bonded sites to 
heterocyclic amines (HCA), results in promising molecules for supramolecular chemistry and 
molecular tectonics. Many pyridine-based molecules functionalized with nucleobases (NBs) are 
known in the literature, with applications such as DNA binding or photo-activity.11, 26 
 
II. 1. Examples of Heterocyclic Amines functionalized by NBs 
 
Numerous examples of building units based on NBs and N-heterocycles have been reported. This 
part focuses on one typical example of such ligands either with pyridine, bipyridine or terpyridine. 
The self-assembly of a pyridine ligand bearing isocytosine iC-Py and its complex iC-Py-Pt were 
investigated recently at the solid/liquid interface of an HOPG substrate (Figure 7).30 STM 
characterization showed that iC-Py forms supermolecular ribbon-like motifs, which is in agreement 
with previous observations of isocytosine substituted compounds.31 This proves that 
functionalization of cytosine with a pyridine moiety does not affect its self-assembly propensity.  
 
 
Figure 7: Chemical Structures of iC-Py, CF3-Pt and iC-Py-Pt.30 
 
The self-assembly of iC-Py-Pt complex on HOPG substrate changes due to the incorporation of 
the sterically demanding CF3-Pt moiety. The STM images of the complex reveal the formation of 
6 discrete supramolecular cyclic architectures: trimers (iC3), tetramers (iC4), pentamers (iC5), half 
Chapter III: Pyridine and Terpyridine bearing Nucleobases 
 
146 
 
of hexamers (1/2 iC6) and hexamers (iC6) (Figure 8). Statistical analysis, DFT calculations, 
simulated STM images and calculated dissociation energy of the cyclic architectures prove that the 
six molecular motifs co-exist, and that the most stable and dominant (80 %) are the ½ iC6 and iC6. 
The latter are formed through hydrogen bonds between the cytosine moieties of type N(6)-H···O(3) 
and N(5)-H···N(4), and have the highest dissociation energy. iC3, iC4 and iC5 are stabilized by the 
electrostatic interactions present between isocytosine moieties of adjacent molecules.  
 
 
Figure 8: (Left) The STM images of different iC-Py-Pt- motifs. (Middle) Simulated structures on graphene. 
(Right) Simulated STM images of different motifs. Picture taken from reference 30. 
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Another example of HCAs bearing nucleobases are the described luminophores NB-polypyridyl 
metal complexes: A-biPy-Ru, T-biPy-Os, T-biPy-Re, C-biPy-Ru and G-biPy-Os.32,33 As 
previously discussed in chapter I and II, functionalization of NBs could be achieved by alkylation 
of the active NH site. The nucleobase-bipyridine (biPy) ligands were synthesized by reacting the 
respective NB with 5-bromomethyl-2,2’-bipyridine (Br-biPy) in the presence of a suitable base 
(Figure 9). The synthesis of A-biPy (N9-2,2’-bipyridineadenine) was performed by reacting one 
equivalent of adenine with 2 equivalent of K2CO3 and 2.5 equivalents of Br-biPy, in the presence 
of catalytic amount of KI, which yielded 47 % of A-biPy. The T-biPy (N1-2,2’-bipyridinethymine) 
was synthesized by reacting an excess (4 eq.) of thymine, to avoid disubstitution of T, with 2 
equivalents of K2CO3  and 0.8 equivalents of Br-bipy in the presence of a catalytic amount of KI 
to result in 37% the monosubstituted T-biPy  (Figure 9).32 
C-biPy (N1-2,2’-bipyridinecytosine) was obtained by reacting one equivalent of cytosine with 1 
equivalent of NaH and 1 equivalent of Br-biPy in the presence of a catalytic amount of KI to yield 
62 % of the targeted C-biPy ligand. To synthesize G-biPy (N9-2,2’-bipyridineguanine), one 
equivalent of 2-amino-6-chloropurine (P) was reacted with 2 equivalents of K2CO3  and 1 
equivalent of Br-biPy in the presence of a catalytic amount of KI to result in 64 % of P-biPy. The 
latter was then oxidized by 0.1 M HCl into the targeted G-bipy with a yield of 77% (Figure 9).33  
 
 
Figure 9: The synthesis of T-biPy, A-biPy, C-biPy, P-biPy and G-biPy.32, 33 
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The A-biPy ligand was reacted with [Ru(biPy)2Cl2] in ethylene glycol and then precipitated by 
addition of KPF6 to result in [Ru(biPy)2(A-biPy)][PF6]2. The crystal structure of the complex shows 
its self-association via the Watson-Crick H-bonds N(80B)-H·· ·N(76A) between the adenine 
moieties (Figure 10).32  
 
 
Figure 10:   The crystal structure showing the association by H-bonding of two metal complex cations 
[Ru(biPy)2(A-biPy)]2+. Figure taken from reference 32. 
 
This structure shows that the H-bonds between adenines are the dominant intermolecular 
interactions between the metal-polypridyl complexes in the solid state. However, in solution this 
H-bonding interaction makes the complex unsuitable for solution analysis and luminescent studies, 
because it is only soluble in polar solvents, such as DMF or DMSO. Therefore, the synthesis of a 
more soluble complex, [Ru(dbbiPy)2(A-biPy)][PF6]2 (A-biPy-Ru), was performed by the reaction 
of A-biPy with [Ru(dbbiPy)2Cl2] bearing solubilizing di-4,4’-tertbutyl-2,2’-dipyridine (dbbiPy) 
ligands (Figure 11).32  
 
Figure 11: The crystal structure of Ru(dbbiPy)2(A-biPy) (A-biPy-Ru). Figure taken from reference 32. 
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The A-biPy-Ru self-assembles in a different pattern when compared to the previous complex. The 
adenine moieties are involved in two pairs of hydrogen bonds to two neighboring adenine groups, 
forming a H-bonded ribbon. The stronger H-bond, N(75B)-H· · ·N(78D), takes place between NH2 
of one adenine and the tertiary amine at position N3of the adjacent adenine. The weaker interaction, 
C(66D)-H· · ·N(76B), is between the tertiary amine N1 of adenine and the CH2 fragment of the 
adjacent dbbiPy molecule. The key factor in forming the ribbon is the hydrogen bonding pattern, 
since it maximizes the separation between the positively charged metal complex units, which 
explains why the bipy fragments are disposed alternately above and below the ribbon (Figure 12).32  
 
 
Figure 12: The self-assembly of A-biPy-Ru into H-bonding ribbon. Figure taken from reference 32. 
 
 
The metal-complexes, T-biPy-Os and T-biPy-Re, were synthesized by reacting T-biPy with 
[Os(dbbiPy)2Cl2] and [Re(CO)2Cl] respectively. The reported crystal structure of T-biPy-Os 
reveals the self-association of the complex via two H-bonds between the thymine moieties, N(73A)-
H···O(74 B) , which is in agreement with the Watson-Crick thymine-thymine interaction (Figure 
13).32  
Chapter III: Pyridine and Terpyridine bearing Nucleobases 
 
150 
 
 
Figure 13: The crystal structure of T-biPy-Os. Figure taken from reference 32. 
 
The formation of Ru-biPy-C· · ·G-biPy-Os association (Figure 14) via Watson-Crick H-bonding 
between cytosine and guanine moieties were demonstrated by comparing the luminescence spectra 
of a 1:1 mixture of C-biPy-Ru and G-biPy-Os in CH2Cl2 before and after the addition of ethanol. 
The addition of ethanol causes an increase of the C-biPy-Ru luminescence intensity in the Ru-
biPy-C· · ·G-biPy-Os pair. Adding ethanol to a mixture of the C-biPy-Ru and biPy-Os has no 
effect on the C-biPy-Ru luminescence intensity. This proves that in Ru-biPy-C· · ·G-biPy-Os pair, 
the Ru-based emission is quenched. Upon addition of ethanol, the H-bonds between G and C were 
interrupted, thus the quenching of the C-biPy-Ru luminescence does not take place anymore. In 
the mixture of C-biPy-Ru and biPy-Os no H-bonding occurs, therefore no change is observed 
before and after the addition of ethanol. This implies that an electron exchange takes place from C-
biPy-Ru complex to G-biPy-Os complex via the G-C Watson-Crick H-bonding.33 
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Figure 14: The chemical structure of biPy-Os and Ru-bipy-C· · ·G-bipy-Os assembly.33 
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The synthesis of a terpyridine functionalized with nucleobases, T-terPy was performed by reacting 
T with an excess of hexamethyldisilazane to give an intermediate silyl enol ether, which was treated 
with 4’-(4-bromomethylphenyl)-2,2’:6’,2”-terpyridine in dichlorethane (Figure 15).34 The 
interaction of T-terPy with adenosine was investigated by NMR spectroscopy. The NH protons of 
thymine and adenine are shifted by 3.18 and 4.04 ppm respectively, which proves the H-bonding 
interaction between the thymine and adenine moieties. In addition, low temperature NMR spectrum 
clearly shows that the two NH protons of the adenine are not equivalent, indicating that the 
interaction between A and T is a Watson-Crick H-binding and not a Hoogsteen interaction. T-terPy 
was coordinated to [RuCl3(terPy)] to result in a T-terPy-Ru(II) complex, which was mixed with 
adenosine to probe the H-bonding interaction of a metallated terpyridine (Figure 15). The proton 
NMR analysis proves that similar behaviors are present between adenine and thymine moieties, 
since the NH signals shift to lower filed. The calculated stability constant is several orders of 
magnitude greater than that expected for simple adenosine-thymine interactions (logK = 1.49), 
proving that H-bonding interactions are enhanced when one of the components is coordinated to a 
cationic metal center.34 
 
Figure 15: The synthesis of T-terPy and T-terPy-Ru. (i) hexamethyldisilazane, (ii) 4’-(4-
bromomethylphenyl)-2,2’:6’,2”-terpyridine, C2H4Cl2, Bu4NF, THF, H2O, (iii) [RuCl3(tpy)], MeOH, N-
ethylmorpholine.34 
 
Furthermore, bipyridine and terpyridine ligands and their respective complexes with transition 
metals possess unique electrochemical and photophysical properties, which can be used in 
luminescent labeling of biomolecules.35 Moreover, functionalizing these complexes with 
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nucleobases have been extensively studied as luminescent probes for DNA hybridizations and 
charge transfer through DNA.26,36 The synthesis of thymine and cytosine based bipyridine and 
terpyridine conjugates was reported following Sonogashira and Suzuki cross coupling reactions 
between appropriate starting materials (Figure 16).37 The photophysical studies (UV-Vis, 
Fluorescence…) conducted on these compounds showed that they all possess luminescent 
properties and in particular, the 5-linked biPy derivatives that exert the highest luminescence.  
 
 
Figure 16: The synthesis of T and C based biPy and terPy. (i) Pd(OAc)2, TPPTS, CuI, (iPr)2NEt, DMF, 
75oC, 2h. (ii) Pd(OAc)2, TPPTS, Cs2CO3, H2O-MeCN, 90 oC.37 
 
In addition, molecules containing both nucleobases and DNA intercalators, as terPy, exhibit 
interesting DNA-binding properties that can be used to promote DNA-drug interactions. Adenine-
terPy complexes were reported to have DNA-binding abilities.38, 39 The synthesizes of such 
complexes were performed by reacting 4’-bromomethylphenyl-2,2’:6,2’’-terpyridine (Br-terPy) 
and adenine in the presence of a base (NaH or K2CO3) to afford the targeted adenine-terPy ligand. 
The latter was reacted with one equivalent of Cu(NO3)2.3H2O and 0.5 equivalents of 
Zn(NO3)2.6H2O to yield the A-terPy-Cu38 and the A-terPy-Zn39 complexes respectively (Figure 
17).  
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Figure 17: The chemical structure of A-terPy-Cu38 and A-terPy-Zn.39 
 
The A-terPy-Cu complex was characterized by X-Ray diffraction that revealed the self-assembly 
of the complex via Watson-Crick H-bonding between the adenine moieties (Figure 18). The copper 
center adopted a distorted square pyramidal coordination geometry with one A-terPy acting as a 
tridentate equatorial ligand. The basal plane of the Cu center is occupied by the three nitrogen atoms 
of terPy and an oxygen atom from the nitrate counter ions. In addition, an oxygen atom from water 
is coordinated to the copper center at its apical position. The phenyl and terpyridine planes are 
almost coplanar, and the adenine moiety is almost perpendicular to the terPy mean plane.38  
 
 
Figure 18: Crystal Structure of A-terPy-Cu. Picture taken from reference 38. 
. 
To investigate the DNA-binding affinity of the A-terPy complexes and the effect of adenine 
moiety, the studies were compared with those of Cu(II) and Zn(II) with 4’-p-tolyl-2,2’:6,2”-
terpyridine,  (tolyl-terPy) complexes, tolyl-terPy-Cu and tolyl-terPy-Zn.38, 39 
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The intercellular DNA binding of A-terPy-Cu and tolyl-terPy-Cu were studied by treating human 
cells with both complexes, and then isolating the DNA from the cells and measuring its 
concentration. ICP-MS analysis revealed that the copper content in isolated DNA treated with A-
terPy-Cu was 6 times higher than in those treated with tolyl-terPy-Cu, proving that the presence 
of adenine moiety increases the intercellular DNA-binding of the terPy complex. In addition, UV-
Vis spectra were used to investigate the DNA binding ability of the complexes. The UV-Vis 
absorption spectrum of A-terPy-Cu exhibits a more pronounced bathochromic shift than that of 
tolyl-terPy-Cu, proving its DNA-binding ability. Several other studies were conducted to prove 
the affinity of the complexes to DNA, such as CD analysis, influence of DAPI (DNA binding agent) 
on the terPy complexes’ affinity, DNA-EB replacement experiment (ethidium bromide, DNA 
intercalator) and molecular simulations. These analyses revealed that A-terPy-Cu and tolyl-terPy-
Cu complexes bind to DNA simultaneously with other binding agent, and that A-terPy-Cu is a 
better intercalator than tolyl-terPy-Cu. Molecular simulations of A-terPy-Cu and tolyl-terPy-Cu 
interactions with an oligonucleotide duplex showed that A-terPy-Cu binds to the minor groove of 
the oligonucleotide with the intercalation group parallel to the pseudo dyad axis of the 
oligonucleotide. The adenine moiety was located in the DNA’s major groove due to its large steric 
effect. However, tolyl-terPy-Cu has no preference for the minor groove-binding with its 
intercalation group being perpendicular to the pseudo dyad axis (Figure 19). The A-terPy-Cu 
complex exhibited more evident intracellular DNA-binding ability than the tolyl-terPy-Cu 
complex.38 
 
 
Figure 19: The structures of A-terPy-Cu and tolyl-terPy-Cu bounded to an oligonucleotide. Figure taken 
from reference 38. 
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The DNA binding ability and nuclease activity of A-terPy-Zn was also studied and compared to 
those of tolyl-terPy-Zn.39  The analyses proved that the presence of adenine increased the structural 
change of DNA and DNA cleavage activity of the terpyridine zinc complex.39   
 
II. 2. Aim of the project  
 
Nucleobases (NBs) functionalized with Heterocyclic Amines (HCAs) are interesting building 
blocks for the design molecular networks assembled via coordination bonds and Watson-crick H-
bonding. The aim of this chapter is to introduce NBs into pyridine following described procedures 
for similar products. (32,33,38,39) In addition, we aim to extend the study to terpyridines, and introduce 
all four NBs on 4’-tolyl-2,2’”6,2”-terpyridine (tolyl-terPy). The NB-Py and NB-terPy tectons are 
synthesized via a substitution reaction between their bromine derivatives, 4-bromomethylpyridine 
and of 4’-p-bromomethylphenyl-2,2’,6’,2”-terpyridine (Br-terPy) and the nucleobases (Figure 20).  
 
 
Figure 20: The retrosynthesis of targeted tectons. 
 
The final aim is to assemble theses 8 tectons with various metal salts in order to generate molecular 
architectures based on NBs H-bonding and Py and terPy coordination interactions.  
Numerous combinations are accessible. For example, pyridine bearing complementary NBs can 
self-assemble via Watson-Crick H-bonding. In addition, NBs are self-complementary, therefore the 
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self-assembly of the tectons bearing the same NB is also possible.40 Figure 21 represents possible 
assembly of NB-Py complexes.  
 
 
 
Figure 21: A schematic representation of possible NB-Py-M assemblies. 
 
Similarly, NB-terPy networks can be assembled via self-complementary bis-terpyridine 
complexes, such as A-terPy-M1-terPy-T, or via two complementary bis-terpyridine complexes, 
such as A-terPy-M2-terPy-A with T-terPy-M3-TerPy-T. Figure 22 shows a schematic 
representation of possible assemblies. Moreover, similar combinations can be achieved via the G-
C assembly.  
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Figure 22: A schematic representation of possible assemblies of A-terPy-M1-terPy-T, and A-terPy-M2-
terPy-A with T-terPy-M3-terPy-T. 
 
 
Furthermore, by changing the metal cation and using both Py and terPy ligands, it is possible to 
extend this strategy to networks based on the assembly of heteroleptic complexes, for instance the 
assembly of self-complementary complexes such as T-terPy-M6-Py-A, or the assembly of 
complementary heteroleptic complexes, for example A-terPy-M4-Py-A with T-terPy-M5-Py-T 
(Figure 23).  
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Figure 23: A schematic representation of possible assemblies of heteroleptic complexes A-terPy-M4-Py-A 
with T-terPy-M5-Py-T, or self-complementary T-terPy-M6-Py-A. 
 
II. 3. Pyridine bearing NBs 
 
To connect a pyridine to the active amine function of the nucleobases (N1 for pyrimidines (T and 
C) and N9 for purines (A and G)), the commercial 4-(bromomethyl)pyridine hydrobromide (Br-
Py.HBr) was used as a starting material for all the targeted NB-Py tectons. Br-Py.HBr was reacted 
with NBs in the presence of a base chosen with respect to the nucleobase used. All reactions were 
performed in DMF at 40 oC and kept stirring for 12 hours. Increasing the temperature resulted in a 
faster consumption of the limiting reagent (Br-Py), however the obtained product was a mixture of 
di- and mono substituted pyrimidines or N7- and N9-substituted purines. Thus catalytic amount of  
KI was added to the reaction media in order to increase the rate of the reaction without increasing 
the temperature.32,33 Purification of the crude products was achieved using column chromatography 
with appropriate eluent gradient. All products were characterized by NMR, HRMS, IR. In addition, 
single-crystals of T-Py, A-Py, and C-Py were obtained by slow evaporation of a 1:1 
dichloromethane: cyclohexane solution and analyzed by X-ray diffraction.  
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II. 3. a) Synthesis of 4-(N1-methylthymine)pyridine (T-Py) (T16) 
 
T-Py was obtained by reacting thymine with Br-Py.HBr in the presence of 2.5 equivalents K2CO3 
and a catalytic amount of KI in dry DMF (Figure 24). The base was added to neutralize the 
hydrobromide present in the starting pyridine and to deprotonate the nucleobase. Thymine can be 
di-substituted. Therefore, thymine was added in excess (3 eq.) to favor the mono substitution, and 
decrease the yield of the di-substituted thymine. The reaction yielded the mono-substituted T-Py 
(T16) as a major product with a yield of 45% and the di-substituted T16’ as a minor product (10%), 
after purification by column chromatography. T16 is a polar product, therefore part of it might be 
retained on the column, which affected the yield of the reaction.  
 
Figure 24: Synthesis of T-Py (T16). 
 
Single-crystals of T16 suitable for X-Ray diffraction were obtained and characterized. T-Py 
crystallizes in the monoclinic space group P 21/n. Within the ligand, the pyridine ring is almost 
perpendicular to the thymine mean plane with an angle of 89°. Tectons self-assemble through a H-
bond between the NH of the thymine and the nitrogen of a pyridine of an adjacent tecton with a 
distance N2-H2·· ·N3 of 2.85 Å, thus leading to a 1D zig-zag network (Figure 25 (b)). The zigzag 
chains are stacked into infinite antiparallel rows above each other by π-π stacking forming a two 
dimensional molecular network. The π-π interaction between pyridine rings display a centroid-
centroid separation of 3.50 Å. Moreover, two consecutive and much weaker π-π interactions with 
a centroid-centroid separation of 4.09 Å are present between the thymine and the pyridine rings 
(Figure 25 (b)). 
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Figure 25: The crystal structure of T-Py (a) T-Py (b) A portion of the 1D zig-zag chains formed by the H-
bond between Py and T moieties and the π-π stacking between the chains.  
 
II. 3. b) Synthesis of 4-(N9-methyladenine)pyridine (A-Py) (T17) 
 
The synthesis of A-Py was achieved following the same conditions used for the synthesis of T16. 
Adenine (2 eq.) was added in excess with respect to the Br-Py (1 eq.) in the presence of K2CO3 (1.5 
eq.). The pyridine was substituted successfully in the targeted amine position  (N1 according to the 
crystallographic numbering, with a yield equal to 53 % of T17 (Figure 26). 
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Figure 26: The synthesis of A-Py (T17). 
 
A-Py was characterized by X-ray diffraction as well. In this case, the predicted Watson-Crick H-
bonding40 was observed between the adenine moieties, and the pyridine is not involved as a 
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hydrogen bond acceptor. T17 crystallizes in the monoclinic space group P 21/c. The angle between 
the pyridine plane and the adenine mean plane is close to 76°. A-Py self-assembles into a H-bonded 
dimer via two hydrogen bonds between the adenine moieties with a distance of 3.01 Å (dN3-N5) 
(Figure 27 (a)). Additional π-π interactions between dimers are present: each adenine are in 
interactions through π-π interaction between adenine rings of an adjacent dimer (Figure 27 (b)). 
The centroid-centroid separation is 3.5 Å. Moreover each pyridine interacts with another pyridine 
of an adjacent dimer, the distance between the centroid of the pyridines is ca 3.6 Å (Figure 27 (c)).  
 
Figure 27: The crystal structure of A-Py (a) The structure of dimers formed via Watson-Crick H-bonding. 
(b) The assembly of the dimers via by π-π interactions between adenine and (c) between pyridines.  
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II. 3. c) Synthesis of 4-(N1-methylcytosine)pyridine (C-Py) (T18) 
The reaction between cytosine and Br-Py in the presence of K2CO3 leads to a very low yield. Thus, 
deprotonation of C at the N1 position was tried by using stronger bases for example, NaH or 
tBu4NOH.41 The best condition to synthesize C-Py was to react an excess of cytosine (3 eq.) and 
Br-Py (1 eq.) in the presence of NaH (2.5 eq), and a catalytic amount of KI in dry DMF (Figure 
28). The reaction resulted in C-Py in a yield of 30 %. The lower yield compared to the previous 
reactions, can be due to the lower solubility of C-Py, and thus a more difficult purification by 
column chromatography than A-Py or T-Py.  
1H-NMR is in agreement with the tautomeric form of C-Py with the presence of the two 
characteristic NH peaks (instead of NH2 peak) that appeared as two broad singlets at 7.08 and 7.21 
ppm each integrating for one hydrogen.41  
 
 
Figure 28: The synthesis of C-Py (T18). 
 
Monocrystals of C-Py suitable for X-Ray diffraction were obtained and characterized. C-Py 
crystallizes in the monoclinic space group P 21/c (Figure 29 (a)). Within a molecule, the angle 
between the pyridine and the cytosine mean plane is closed to 85°. The molecules of T18 are linked 
as predicted by hydrogen bonds between the cytosine moieties, and organized into a one 
dimensional chain. The pyridine are not involved in the H-bonded network. Figure 29 (b) shows 
the H-bonds between the cytosine within the chain. Each cytosine acts as two-H-bond donor 
(through its NH2 site) and two-H-bond acceptor (through O1 and N2 lone pairs, and it is in 
interaction with three adjacent cytosine rings by four different H-bonds. The N3-H3···O1 distance 
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is equal 2.89 Å (dN3- O1), whereas the N3-H3A···N2 distance is equal to 3.02 Å (dN3- N2) (Figure 
29).  
 
Figure 29: The crystal Structure of C-Py. (a) The structure of one molecule. (b) The H-bonding Assembly 
of the cytosine.  
 
Consecutive chains are stacked via π-π interactions between the cytosine rings that are located 
above each other with a centroid-centroid separation of 3.48 Å. Figure 30 shows a side view of the 
chain and its translation in space.  
 
 
Figure 30: A side view of Cy-Py, showing π-π stacking between the cytosine moieties. 
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II. 3. d) Synthesis of 4-(N9-methylguanine)pyridine (G-Py) (T20) 
 
Initially we tried the direct substitution of guanine with Br-Py in the presence of K2CO3, however 
the product was poorly soluble and difficult to purify and the resulting yield was low. Instead, 2-
amino-6-chloropurine (P) was used as in previous chapters. The synthesis of the last Py targeted 
tecton (G-Py) was achieved in two steps. First, P was reacted with Br-Py in the presence of K2CO3, 
which yielded 30% of P-Py (T19). The latter was hydrolyzed by 0.1 M HCl aqueous solution 
producing the guanine tecton G-Py (T20) with a yield of 96 % (Figure 31). The success of the acid 
hydrolysis was proved by the shift of the [M+1]+1 peak in MS from 261.07 for P-Py to 243.09 for 
G-Py, and by the shift in IR spectrum from 1613 cm-1 to 1672 cm-1 which represent the C=N 
stretching of P-Py and the C=O stretching of G-Py respectively. In addition, the appearance of the 
broad NH peak of G-Py at 10.94 ppm in 1H-NMR, which was not present in 1H-NMR of P-Py, 
proves the hydrolysis of P-Py into G-Py, and that the substitution took place at position N9.33, 41 
 
Figure 31: The synthesis of P-Py (T19) and G-Py (T20). 
 
Crystallization attempts were made with G-Py using different conditions. Unfortunately, all 
attempts resulted in the formation of amorphous powders, due to the fast precipitation of G-Py that 
exhibited a lower solubility than the other tectons.  
Moreover, crystallization of complementary tectons such as A-Py with T-Py and C-Py with G-Py 
was also tried, but no single crystals suitable for X-Ray diffraction analysis was isolated yet. In a 
second step, crystallization of all the tectons with different metal salts was launched, the aim was 
to generate stable assemblies based on coordination and H-bonds. The crystallization of A-Py and 
C-Py with metal salts resulted in the formation of molecular networks assembled via the 
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coordination of the pyridine Py to metal cations, while the NBs are involved in H-bonding or 
coordination interactions.  
 
II. 4. Coordination networks based on A-Py (T17) 
 
The tecton was crystallized with several metal salts: Co(II), Cd(II), Ag(II), Cu(II), Pd(II), Ni(II), 
Zn(II) and others. Single crystals were isolated in the presence of Cd(II) and Hg(II) and 
characterized by X-Ray diffraction. Single crystals of A-Py-Cd(II) were obtained by slow diffusion 
of a solution of Cd(NO3)2.2H2O in acetonitrile into a chloroform solution of A-Py. For A-Py-
Hg(II), crystals were obtained by slow diffusion of a solution of HgCl2 in ethanol into a chloroform 
solution of A-Py. In both cases, the pyridine coordinates to the metallic cation while the adenine is 
either involved in H-bonds in of A-Py-Cd(II) or is interacting with Hg(II) in A-Py-Hg(II) (Figure 
32).  
 
Figure 32: A general view of the different interactions of T17 with Cd(II) or Hg(II). 
(a) in A-Py-Cd(II) (b) in Ad-Py-Hg(II). 
 
II. 4. a) A-Py-Cd(II) network 
  
The A-Py-Cd(II), complex crystallizes in the monoclinic C2/c space group. The tectons are 
organized in a periodic architecture linked by two types of interactions: the coordination of Cd(II) 
metal center to A-Py, and the trans Watson-Crick hydrogen bonds between the adenine moieties 
(Figure 33 (b)). Cd(II) is coordinated by four nitrogen atoms, from two pyridine moieties in trans 
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position and two adenine groups in trans position, forming a slightly distorted square planar 
geometry. The two apical positions of Cd(II) are occupied by two nitrates: one acting as a bidentate 
ligand, while the second being disordered and acting as a monodentate ligand (Figure 33 (a)). The 
Cd(II) is coordinated in the basal plane to four different A-Py ligands. Two trans adenine are 
coordinated to the Cd (II) via their N3 nitrogen (according to crystallographic numbering) with a 
Cd1-N3 distance of 2.40 Å. The other trans ligands are coordinated from their pyridine sites with 
a Cd1-N1distance of 2.32 Å (Figure 33 (a)).  
 
 
Figure 33: The crystal structure of A-Py-Cd(II). (a) The coordination sphere around Cd(II) center. (b) A 
side view showing H-bonding between Adenine moieties.  
 
Each A-Py tecton acts as a bridging ligand between two adjacent Cd(II) and the angle between the 
pyridine plane and the adenine mean plane is close to 72°. A-Py coordinates a Cd(II) via its adenine 
site (N3) and coordinates a second metallic center from its pyridine site (N1), each Cd(II) being 
coordinated to four different A-Py ligands, resulting in a 1D ribbon-like coordination network with 
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a 2:1 metal: ligand ratio as represented in Figure 34 (a). The ribbons are linked by hydrogen bonds 
between the adenine free sites following a trans Watson-Crick orientation (Figure 34 (b)) with a 
distance of 2.98 Å (dN5-N6). The final 2 D H-bonded and coordination network is represented in 
Figure 34 (b).  
 
Figure 34: The crystal structure of (a) the 1D ribbon-like coordination network, and (b) the final 2D 
network of A-Py-Cd(II). 
 
II. 4. b) A-Py-Hg(II) network 
The A-Py-Hg(II) complex crystallizes in the monoclinic space group P 21/c (Figure 35 (a)). The 
tecton adopts a helix-like structure, as shown in Figure 35 (b) and (c). A-Py tectons coordinates 
two non-equivalent mercury cations: Hg1 and Hg2 (according to crystallographic numbering) 
(Figure 35 (a)). The connectivity around Hg1 leads to the formation of a helix (Figure 35 (b) and 
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(c)). Indeed, Hg1 is connected to two nitrogen atoms from two A-Py (N1 and N5, according to 
crystallographic numbering), and two chlorides (Cl1 and Cl2) adopting a distorted tetrahedral 
geometry around the metallic cation. In the helical structure, A-Py is acting as a bidentate ligand 
involving the coordination of the pyridine (N1) and the adenine (N5 ) with Hg-N1 and Hg-N5 
distances equal to 2.34 Å and 2.38 Å respectively (Figure 35 (a)). The Hg-Cl distances are equal to 
2.40 Å. Within a ligand, the angle between the pyridine and the mean plane of the adenine is close 
80°. 
 
Figure 35: The crystal structure of A-Py-Hg(II). (a) The coordination sphere of Hg1 and Hg2. (b) 
A side view showing the packed 1D chain. (c) The 1D helix chain.  
 
An additional mercury cation, Hg2, is bonded to the adenine (N3) with a Hg-N3 distance equal to 
2.56 Å, leading to a final A-Py: Hg stoichiometry of 1:2. Two additional chlorides (Cl3 and Cl4) 
are connected to Hg2 with a distance of 2.32 Å. To complete its coordination sphere Hg2 interacts 
with Cl1 of an adjacent helix (Figure 36) with a Hg-Cl distance of 2.88 Å. 
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Figure 36: The crystal Structure of the 2 D helix structures linked by a Cl1 atom coordinated to Hg1 of one 
helix and one Hg2 of the adjacent helix.  
 
II. 5. Coordination networks based on Cy-Py (T18) 
 
Cy-Py was crystallized with many different metal salts: Co(II), Zn(II), Cu(II), Cd(II), Ni(II), Ru(II), 
and others. Single crystals were obtained by slow diffusion of an acetonitrile solution of 
Zn(NO3)2.6H2O or Cd(NO3)2.4H2O into a chloroform solution of Cy-Py resulting in the formation 
of C-Py-Zn(II) and C-Py-Cd(II) based networks respectively. In both cases, the pyridine 
coordinates to the metallic cation, and the cytosine forms either coordination bonds with Cd(II) or 
both coordination and H bonds with Zn(II) as depicted in Figure 37. 
 
 
Figure 37: A general view of the interactions of T18 with Zn(II) and Cd(II). 
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II. 5. a) C-Py-Zn(II) network 
 
C-Py-Zn(II) crystallizes in the monoclinic space group P21/n. The Zn(II) cation is four coordinated 
with two different C-Py ligands and two nitrates adopting a deformed tetrahedral geometry (Figure 
38 (a)). Zn (II) is coordinated to one C-Py from its pyridine site (N1, according to crystallographic 
numbering) with a distance of 2.01 Å (dZn1-N1) and to a second C-Py from its cytosine site (N3) 
with a distance of 2.04 Å (dZn1-N3). The N1-Zn1-N3 angle is equal to 112.10°. The coordination 
sphere of the metal cation is completed by two nitrates with Zn-O distances close to 2.0 Å. Two C-
Py are connected to two Zn2+ in a convergent fashion, thus leading to the formation of a Zn2(C-
Py)2 dimer and a Zn2+to ligand ratio of 1:1 (Figure 38(a)).  
 
Figure 38: The crystal structure of Zn(II)-C-Py. (a) Zn2(C-Py)2 dimer. (b) 2D Network formed by H-
bonds between the dimers. Nitrate counter ions are omitted for clarity. 
 
The tertiary amine (N3) of the cytosine is coordinated to the metal cation, consequently it is not 
involved in H-bonding interactions. However, the carbonyl and NH2 groups of the cytosine moieties 
are free to undergo hydrogen bonds with adjacent cytosine rings. Each Zn2(C-Py)2 dimer is 
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composed of two cytosine rings, and thus a total of two carbonyl groups and two NH2 groups. These 
4 groups are all interacting with 4 adjacent dimers via four H-bonds between the O1 of the carbonyl 
and H4B of the NH2 functions of the cytosine rings with a distance of 3.01 Å (dO1-N4) as shown 
in Figure 38 (b). Furthermore, H4A is H-bonded to O5 of a nitrate within a dimer. In this structure, 
the cytosine sites exhibit coordination interactions and H-bonding, known characteristic for all 
nucleobases.40,42 
 
II. 5. b) C-Py-Cd(II) network 
  
C-Py-Cd(II) crystallizes in the orthorhombic space group Pbcn. The organization of the complex 
is similar to the zinc dimer described above, since it forms a Cd2(C-Py)2 dimer with the pyridine 
and the cytosine coordinated to the Cd(II) (Figure 39). However, in this structure, cytosine acts as 
a chelate ligand with N1 and O1 coordinated to the Cd cation. Cd1-N1 and a Cd1-O1 distances are 
equal to 2.31 Å and 2.51 Å respectively (Figure 39 (a)). Moreover, the geometry around the Cd(II) 
is different when compared to the Zn dimer. Indeed, Cd(II) is 7-coordinated, since it coordinates to 
two nitrogen atoms, one from the pyridine site with a Cd1-N4 distance equal to 2.27 Å and the other 
from the cytosine site (N1), to one oxygen of the cytosine (O1), and to three nitrates, one acting as 
a chelate ligand with Cd-O distances equal to 2.38 Å and 2.45 Å while the other two nitrates are 
acting as bridging ligands with two other Cd(II) from two adjacent dimers (Cd1-O5 and Cd1-O7 
distances of 2.31 Å and 2.35 Å) (Figure 39 (b)). Within the dimer, the pyridine-Cd-cytosine angles 
are close to 108 and 84 ° for N4-Cd-N1 and N4-Cd-O1 respectively, while for C-Py ligand the 
angle between the pyridine and the mean plane of cytosine is close to 74°. In the structure, the only 
hydrogen bond observed is an interaction within a dimer involving  hydrogen of N2 (H3A) and an 
oxygen atom of a bridging nitrate (O6), with a N·· ·O distance of 3.0 Å (Figure 39 (b)).  
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Figure 39: The crystal Structure of C-Py Cd(II) (a) Structure of the Cd2(C-Py)2 (NO3)4 dimer.(b) The 
coordination network formed through the two  nitrate bridging ligands. The chelate  NO3 molecules are 
omitted for clarity.  
 
II. 6. TerPyridines bearing NBs 
 
As mentioned previously, terPy based ligands and complexes are well known compounds. 
Introducing NBs to terPy will result in interesting molecular tectons (NB-terPy) bearing one 
tridentate coordinating site and one H-bonding recognition site. NB-terPy may coordinate to a 
metal center (M) forming a NB-terPy-M complex that can assemble via Watson-Crick H-bonding. 
Moreover, two equivalents of NB-terPy can coordinate around a metal center (M) forming a 
complex bearing two NBs in trans positions NB-terPy-M-terPy-NB, which can further self-
assemble into a network via H-bonding interactions (Figure 22). In addition, the aromatic structure 
of terPy will result in π-π interactions that can further stabilize the network and result in 2D or 3D 
architectures.  
The synthesis of T-terPy and A-terPy was already described.34,38,39 It was reproduced and extended 
to the synthesis of C-terPy and G-terPy. The common strategy to introduce NBs at the 4’ position 
of terPy is to use 4’-(4-bromomethylphenyl)-2,2’:6’,2”-terpyridine (Br-terPy) as starting material, 
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which is obtained from the bromination of 4’-tolyl-2,2’:6’,2”-terpyridine (tolyl-terPy). Br-terPy 
was thus reacted with all NBs in the presence of the suitable base in DMF at 40 oC. We performed 
reactions with and without KI, but the presence of KI did not increase the yield nor decreased the 
time. The tectons were characterized by NMR, IR and HRMS. Many attempts to crystallize NB-
terPy tectons were made either alone or as a mixture of complementary tectons in order to be 
analyzed in X-Ray diffraction but with no success yet.  
 
II. 6. a) Synthesis of 4’-(4-bromomethylphenyl)-2,2’:6’,2”-terpyridine (Br-terPy) 
 
Tolyl-terpy was brominated with NBS in benzene under a lamp of 120 Watts to give 60 % of Br-
terPy (Figure 40).43  
 
Figure 40: Synthesis of Br-terPy. 
 
II. 6. b) Synthesis of 4’-( N1-methylphenylthymine)-2,2’:6’,2”-terpyridine (T-terPy) (T21) 
 
T-terPy was obtained by reacting an excess of thymine (3 eq.), to prevent di-substitution of 
thymine, and Br-terPy (1 eq.) in the presence of K2CO3 (1.5 eq) in dry DMF. The reaction yielded 
40% of the targeted T-terPy (T21) (Figure 41).  
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Figure 41:  The synthesis of T-terPy. 
 
II. 6. c) Synthesis of 4’-(N9-methylphenyladenine)-2,2’:6’,2”-terpyridine (A-terPy) (T22) 
A-terPy was synthesized following the same procedure as for T-terPy. Adenine was added in 
excess (2 eq.) with respect to the Br-Py (1 eq.) in the presence of K2CO3 (1.5 eq.). T22 is obtained 
in 54% yield (Figure 42). 
 
Figure 42: The synthesis of A-terPy.  
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II. 6. d) Synthesis 4’-( N1-methylphenylcytosine)-2,2’:6’,2”-terpyridine (C-terPy) (T23) 
 
The substitution reaction between cytosine and Br-terPy was performed in the presence of NaH 
instead of K2CO3, which proved to be unsuitable for the deprotonation of C. The reaction yielded 
79 % of C-terPy (T23) (Figure 43).  
 
 
Figure 43: The synthesis of C-terPy. 
 
II. 6. e) Synthesis of 4’-(N9-methylphenylguanine)-2,2’:6’,2”-terpyridine (G-terPy) (T25) 
 
To introduce guanine in the 4’ position of terPy, 2-amino-6-chloropurine (P) was reacted with Br-
terPy in the presence of K2CO3 to yield 43 % of P-terPy (T24). The latter was hydrolyzed by 0.1 
M HCl aqueous solution producing G-terPy (T25) with a yield of 96 % (Figure 44). The success 
of the acid hydrolysis was proved by the shift of the [M+1]+1 peak in MS from 491.15 for P-terPy 
to 473.18 for G-terPy, and by the shift in the IR spectrum from 1629 cm-1 to 1716 cm-1, which 
represent the C=N stretching and the C=O of P-terPy and G-terPy respectively. In addition, the 
appearance of the broad NH peak of G-terPy at 10.68 ppm in 1H-NMR, which was not present for 
P-terPy, confirms the hydrolysis.33, 41 
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Figure 44: The synthesis of P-terPy and G-terPy. 
 
II. 7. Structural characterization of complexes based on T-terPy (T21) 
 
The T21-T25 tectons were crystallized with several metal salts, for example Fe (II), Ru(II), Cu(II), 
Co(II), Ni(II), Pd(II), Cd(II) using 1:1 or  1:2 metal: ligand ratio. Unfortunately, most of the attempts 
lead to amorphous powder. Nevertheless, monocrystals suitable for X-Ray diffraction were 
obtained from T-terPy with Cu(OAc)2 and T-terPy with Cd(NO3)2.4H2O  resulting in the formation 
of mono-terPy complexes T-terPy-Cu(II) and T-terPy-Cd(II). The crystals were obtained by 
slow diffusion of a solution of the metal salts in acetonitrile into a solution of T-terPy in 
dichloromethane for T-terPy-Cu(II), and in chloroform for T-terPy-Cd(II). The metallation of 
the terpyridine occurs during the diffusion process. The characterization by X-Ray diffraction 
revealed the formation of H-bonds between thymine in both cases. Molecular networks were 
assembled via the coordination of the terPy moiety to the metal center (Cu(II) and Cd(II)) and via 
H-bonding of the thymine moieties.  
 
II. 7. a) T-terPy-Cu(II) network 
 
The T-terPy-Cu(II) complex crystallizes in the triclinic P-1 space group. The terPy is acting as a 
tridentate ligand around Cu(II) with a Cu-N distances close to 2.0 Å. One acetate and one chloride 
(from the dichloromethane) are present in the coordination sphere of the metal cation with Cu1-O3 
and Cu1-Cl3 distances equal to 1.93 and 2.53 Å respectively. Furthermore, the second oxygen, O4 
(Figure 45 (a)) of the acetate is in close proximity to the Cu(II) with a distance of 2.78 Å. By 
neglecting this additional Cu-O interaction, the geometry around the Cu(II) is a distorted square 
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pyramidal geometry with the chloride ion in the apical position. Within the complex, the angle 
between the mean plane of the terpyridine and the mean plane of the thymine is close to 82°. T-
terPy-Cu(II) self-assembles into a H-bonded dimer via two hydrogen bonds involving the thymine 
moieties with a distance of 2.84 Å (dN5-O2) (Figure 45 (b)). Each dimer interacts with two other 
dimers by π-π interactions between the terPy moieties with mean plane separation of 3.56 Å (Figure 
45 (b)).  
 
 
Figure 45: The crystal structure of T-terPy-Cu(II). (a) The coordination sphere of Cu(II). (b) A view of 
H-bonds between T and the stacking of the resulting T-terPy dimers. Chloride and acetate are omitted for 
clarity. 
 
II. 7. b) T-terPy-Cd(II) network 
 
The T-terPy-Cd(II) complex crystallizes in the monoclinic Cc space group. Cd(II) is surrounded by 
four different ligands, and its coordination sphere is composed of: the terpyridine, two nitrates and 
a water molecule. The terpyridine is acting as a tridentate ligand with Cd-N distances close to 2.35 
Å (Figure 46 (a)).  In addition, two nitrates are present, one is a monodentate ligand with a Cd-O 
distance of 2.40 Å, while the second is located approximately in the same plane of the terpyridine 
and acts as a bidentate ligand with Cd-O distance of 2.40 and 2.48 Å (Figure 46 (a)). A water 
molecule occupies the trans position of the monodentate nitrate with a Cd1-O12 distance of 2.31 Å 
(Figure 46 (a)). The angle between the mean plane of the terpyridine and the mean plane of the 
thymine is close to 62° and 20 ° less than in T-terPy-Cu(II). Each complex is H-bonded to two 
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adjacent complexes via two H-bonds involving the thymine moieties. The thymine moieties are 
linked to one another by one hydrogen bond between their amine site (N5) and carbonyl site (O1) 
with a distance of 3.07 Å (dO1-N5) (Figure 46 (b) and (c)). Furthermore, the terpyridine moieties 
are packed by weak π-π interactions (centroid-centroid separation equals to 3.97 Å). 
 
 
Figure 46: The crystal Structure of (a) T-terPy-Cd(II)  (b) A view of H-bonds between thymine moieties. 
(c) View of the network. The counter ions are omitted for clarity. 
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III. Conclusion and Perspectives 
Pyridine and terpyridine molecules are used for different chemical and biological applications. As 
previously discussed, Py-based compounds are used as reagents in production of dyes, 
agrochemicals and pharmaceuticals.2 Moreover, the study of the DNA-binding ability of terPy-
based complexes and their photophysical properties have proved the importance of such complexes 
in luminescent labeling of biomolecules.11,12 In addition, Py and terPy are extensively used in 
coordination chemistry and in molecular tectonics.10 Introducing H-bonding sites, such as 
nucleobases, to Py and terPy affords interesting molecular tectons that can self-assemble via 
several intermolecular interactions. Therefore, we synthesized a library of Py and terPy bearing 
NBs, and our main objective was to study their self-assembly in the presence or absence of 
additional metal cations. The nucleobases T, A, C, P and G were introduced in the Py and terPy 
backbone generating 10 tectons T16-T25 (Figure 47). Three of them T-Py (T16), A-Py (T17), and 
C-Py (T18) were characterized by X-Ray diffraction. The Watson-Crick H-bonding between the 
NBs moieties were observed for A-Py (T17) and C-Py (T18). However, for T-Py (T16) H-bond 
interaction between the pyridine and thymine is observed instead of T-T interactions. Moreover, 
tectons A-Py (T17), C-Py (T18), and T-terPy (T21) formed single crystals suitable for X-Ray 
analysis with different metal salts, resulting in the A-Py-Cd(II), A-Py-Hg(II), C-Py-Zn(II), C-Py-
Cd(II), T-terPy-Cu(II) and T-terPy-Cd(II) complexes. The metal complexes are formed via 
coordination bonds between the metal cation and Py or terPy sites, in addition to NBs’ H-bonding 
or coordination interactions that occur in the crystal.  
Moreover, crystallization of complementary tectons such as A-Py with T-Py and C-Py with G-Py 
was also tried, but no single crystals suitable for X-Ray diffraction analysis was isolated yet. 
Similarly, attempts to assemble complementary NB-terPy tectons, T-terPy/A-terPy and C-
terPy/G-terPy, were performed. Unfortunately, again single crystals suitable for X-Ray analysis 
were not obtained yet. Therefore, the future perspective is to combine the complementary tectons 
and crystalize them with and without metal salts, using different methods, aiming to obtain 
molecular networks assembled via Watson-Crick H-bonding, as shown in Figures 21 and 22. In 
addition, the second perspective is to combine NB-Py and NB-terPy tectons with metal salts to 
generate heteroleptic complexes, which can assemble via Watson-Crick H-bonding (Figure 23).  
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Figure 47: The chemical structure of T16-T25. 
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I. Conclusion 
 
Molecular tectonics is a domain of supramolecular chemistry dealing with the formation of one, 
two and three-dimensional molecular networks. The latter is formed through the self-assembly of 
tectons bearing complementary interaction sites, which form a recognition pattern via specific 
interactions. In this project, we focused on two types of interactions, the coordination interactions 
and the hydrogen bonding interactions, more specifically the Watson-Crick H-bonding between 
nucleobases (NBs).  
NBs are found in the main source of life, the DNA, thus making them targeted motifs to be studied 
in biology and chemistry. Nucleobases have the possibility to form non-covalent interactions, such 
as the Watson-Crick H-bonding between complementary NBs, self-dimerization interactions and 
coordination interactions with metal salts. All these properties offer NBs advantages over other 
motifs when it comes to designing molecular networks assembled via non-covalent interactions.  
The first objective of this project is to introduce nucleobases to different coordination sites, thus 
designing molecular tectons with the possibility to self-assemble via both coordination and H-
bonding interactions. Four coordination scaffolds possessing amine sites were used: porphyrins, 
dipyrrins, pyridines and terpyridines. Each one of these motifs provides specific properties 
essential to build molecular networks. Porphyrin has the ability to be functionalized in the 4 meso 
positions along with the 8 β-positions, and to coordinate metal cations via its azacore. Similarly, 
dipyrrins is an anionic bidentate ligand that can be functionalized in the meso, β and α positons. 
In addition, dipyrrins are known to form either homoleptic or heteroleptic metal complexes. Last 
but not least, pyridines and terpyridines are strong coordinating moieties, which have the ability 
to form complexes of different stoichiometry and various geometries.  
To introduce NBs in the meso position of porphyrins, a porphyrin bearing two triple bonds in trans 
meso positions (Po1) was synthesized and coupled with I-U-Ph2 and I-U-C6, under Sonogashira 
conditions, to result in T1, T2 and T3. (Figure 1) Unfortunately, complications of the cross 
coupling reactions prevented the extension of this strategy to other NBs. Therefore, NBs were 
introduced to porphyrins by C-N bonds via their active NH sites, N1 site of pyrimidines and N9 site 
of purines.  Using this strategy, we were able to introduce T, A, C, P and G in the periphery of the 
porphyrin bearing two trans active bromine site, generating 5 porphyrin based tectons T5-T9. 
Moreover, a tetra-functionalized porphyrin substituted with 4 thymines (T10) was successfully 
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synthesized. Similarly, the five NBs were introduced in the meso-position of dipyrrins bearing a 
bromine active site, resulting in five novel tectons T11-T16. Furthermore, the nucleobases were 
introduced to pyridine and terpyridine, by reacting each NB with 4-bromopyridine and 4’-(4-
bromomethylphenyl) terpyridine resulting T17-T25 (Figure 1). 
 
 
Figure 1: The chemical structure of all synthesized tectons. 
 
 
The second objective of this PhD project is to generate molecular networks based on the 
synthesized tectons. To produce molecular networks, the tectons were crystallized by using 
different methods and under different conditions. In addition to being complementary to their 
respective base pair partner, nucleobases are self-complementary, thus the self-assembly of each 
tecton is possible. For that reason, attempts to crystallize each tecton alone with and without metal 
salts were performed, along with combining complementary tectons. For instance, porphyrin 
bearing thymine (T3) and porphyrin bearing adenine (T4) were mixed and crystallized together. 
The same procedure was done for all complementary tectons. Unfortunately, co-crystals suitable 
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for X-ray analysis are not yet obtained. However, monocrystals were obtained for several tectons 
forming networks assembled via the H-bonding between the same NB. 
The self-assembly of T11 in the presence of Zn(II) resulted in a molecular network formed via the 
coordination bond of the dipyrrin site to the metal center and via  T-T interactions. In addition, the 
self-assembly of T16-T18 were studied by X-ray analysis. Pyridine bearing adenine (T17) and 
cytosine (T18) assembled via H-bonding interactions between the adenine and cytosine moieties 
respectively. However, 4-(N1-methylthymine)pyridine (T16) assembled via the H-bond between 
pyridine and thymine. This proves that, under the conditions used, the H-bonding interaction 
between Py and T is thermodynamically more favored than T-T interactions, which is known to 
be weaker than the A-A and C-C hydrogen bonding. Moreover, the generation of coordination 
networks was successful for T17 with Cd(II) and Hg(II) and for T18 with Zn(II) and Cd(II). Those 
molecular networks assembled through the coordination interactions of pyridine to the metal 
center, and through the different interactions of NBs. For example, within the T17-Hg(II) and T18-
Cd(II) networks, the NBs formed coordination interactions with the metal center, and in T17-
Cd(II) and T18-Zn(II), the NBs were involved in H-bonding interactions. Last but not least, 
molecular networks of T21 were obtained in the presence of Cu(II) and Cd(II). These networks 
revealed the coordination interactions of the terpyridine site to the metal center and the H-bonds 
between the thymine moieties.   
 
II.    Perspectives 
 
One of the main objectives of this project, which is the generation of networks assembled via H-
bonds of complementary tectons, was not reached for all the 16 tectons. Therefore, future work 
will focus on designing new networks by launching more crystallization to obtain suitable crystals. 
Multiple combinations are possible: either based on one tecton with different metallic salts or by 
mixing two complementary tectons of the same category such as: two complementary porphyrins 
(for example T4 and T5) or two complementary dipyrrins  ( for example T13 and T15) .  Moreover, 
combining porphyrin based tectons with dipyrrin, pyridine or terpyridine based tectons in order to 
design heteroleptic and/or heterobimetallic networks is the second perspective of this work.  
Conclusion and Perspectives 
 
189 
 
In addition, future work should focus on studies in solution, in order to determine the association 
constants between complementary and self-complementary tectons, in addition to luminescence 
studies of dipyrrins and terpyridine metal complexes.  
 
 
Figure 2: The chemical structure of possible future tectons. 
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1) Dipyrromethane1  
  
Chemical Formula: C9H10N2 
Molecular Weight: 146.19 g/mol 
 
A mixture of pyrrole (96.6 g, 1.44 mol, 100 mL, 40 eq) and paraformaldehyde (1.7 g, 0.036 mol, 
1 eq) was treated with methanol (55 mL) and acetic acid (150 mL). The mixture was stirred at 
room temperature for 20 hours under argon and protected from light. After 20 hours, the mixture 
was diluted with chloroform (300 mL), then washed with water (2 x 400 mL) and 1 M KOH 
aqueous solution (2 x 400 mL). The organic phase was concentrated under reduced pressure. The 
crude product was purified by column chromatography (silica gel, cyclohexane/dichloromethane 
(2:1)) to give 2.3 g of a white solid (44 %).  
 
1H NMR (300 MHz, CDCl3) δ: 3.95 (2H, s, H4), 6.06 (2H, m, H2), 6.17 (2H, dd, H3, 
3J = 5.7 Hz, 
4J = 2.6 Hz), 6.62 (2H, m, H1), 7.71 (2H, s, br, NH). 
 
2)  5,15-dipentylporphyrin2  
 
Chemical Formula: C30H12N4 
Molecular Weight: 428.45 g/mol 
Montmorillonite K 10 (7 g) was activated under vacuum at 100 oC for 2 hours and then cooled to 
room temperature under argon. To the same flask, a solution of hexanal (0.411 mL, 3.4 mmol, 1 
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eq) in degassed dichloromethane (35 mL) and a solution of dipyrromethane (0.5g, 3.4 mmol, 1 eq) 
in degassed dichloromethane (500 mL) were added. The mixture was degassed and stirred at room 
temperature under argon. The disappearance of dipyrromethane was followed by TLC. After 24 
hours, the dipyrromethane disappeared and p-chloranil (1.25 g, 5 mmol, 1.5 eq) was added, then 
stirred under reflux. After 2 hours, the mixture was filtered through a celite pad and washed with 
chloroform. The filtrate was concentrated under reduced pressure and the crude product was 
purified by column chromatography (silica gel, DCM/ petroleum ether (7:3)) to give 0.21 g of a 
dark purple solid (27 %). 
 
1H NMR (300 MHz, CDCl3) δ: -2.92 (2H, s, br, NH), 0.99 (6 H, t, 
3J=7.3 Hz, Ha), 1.54-1.62 (4H, 
m, Hb), 1.75-1.85 (4H, m, Hc), 2.50-2.60 (4H, m, Hd), 4.99 (4H, t, 3J = 7.4 Hz, He), 9.39 (4H, d, 
3J = 4.6 Hz, Hβ), 9.56 (4H, d, 3J = 4.6 Hz, Hβ), 10.15 (2 H, s, Hf). 
 
3) 5,15-dibromo-10,20-dipentylporphyrin  
 
        Chemical Formula: C30H32Br2N4 
                               Molecular Weight: 608.41 g/mol 
 
5,15-dipentylporphyrin (200 mg, 0.44 mmol, 1 eq) and pyridine (0.2 mL) were dissolved in 150 
mL of dichloromethane. The mixture was cooled to 0 oC in an ice bath and NBS (166 mg, 0.933 
mmol, 2.2 eq) was added. The reaction was stirred for 2 hours, and then quenched with 5 mL of 
acetone. The solvent was evaporated and the crude product was washed with methanol several 
times (3 × 5ml) to give 190 mg of a dark purple solid (74 %). 
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1H NMR (300 MHz, CDCl3) δ: -2.76 (2H, s, br, NH), 0.97 (6H, t, 
3J = 7.4 Hz, Ha), 1.50-1.58 (4H, 
m, Hb) 1.75 (4H, tt, 3J = 7.7 Hz, Hc), 2.55 (4H, tt, 3J = 7.7 Hz, 7.4 Hz, Hd), 4.90 (4H, t, 3J = 7.4 
Hz, He), 9.39 (4H, d, 3J = 4.6 Hz, Hβ), 9.65 (4H, d, 3J = 4.6 Hz, Hβ). 
 
4) 5,15-(4,4,5,5-tetramethyldioxaborane)-10,20-dipentylporphyrin3  
                                                Chemical Formula: C42H56B2N4O4 
                                Molecular Weight: 702.45 g/mol 
 
5,10-dipentyl-15,20-dibromoporphyrin (100 mg, 0.1644 mmol, 1 eq) was dissolved in 50 mL of 
degassed dry dichloroethane and 0.6 mL of triethylamine. To this solution, 4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (0.42 g, 3.28 mmol, 0.48 mL, 20 eq) and PdCl2(PPh3)2 (11.5 mg, 0.0164 
mmol, 0.1eq) were added. The reaction was stirred and heated overnight under reflux. The solution 
was concentrated under reduced pressure. The crude product was a mixture of de-brominated 
porphyrin, monoboronated poprphyrin and diboronated porphyrin. The products were separated 
and purified by column chromatography with a gradient eluent of dichloromethane/cyclohexane 
(silica gel, DCM/cyclohexane (1:2) then (1:1) (2:1)) to give 11 mg diboronated porphyrin (10 %), 
55 mg monoboronated porphyrin (58 %) and 21 mg 5,15-dipentylporphyrin (30 %).  
a) 5,15-(4,4,5,5-tetramethyldioxaborane)-10,20-dipentylporphyrin:  
 
1H NMR (300 MHz, CDCl3) δ (ppm) : -3.00 ( s, 2H, NH), 0.97 (6 H, t, 
3J = 7.4 Hz, Ha), 1.54 (4H 
m, Hb) 1.78 (4H, m, Hc), 1.87 ppm (24 H, s, Hf), 2.54 (4H, m, Hd), 4.68 (4H, t, 3J = 7.4 Hz, He), 
9.57 (4H, d, 3J = 4.6 Hz, Hβ), 9.89 (4H, d, 3J = 4.6Hz, Hβ). 
13C NMR (126 MHz, CDCl3) δ: 14.32 (Ca), 22.95 (Cb), 29.86 (Cf), 32.87 (Cd), 34.75 (Cc), 38.48 
(Ce), 66.06, 104.40, 118.98, 128.63, 128.63(Cβ), 132.16 (Cβ), 128.98, 131.07, 144.31, 147.60. 
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HRMS (ESI): m/z(M+): [M+H]+ calculated = 703.4574, [M+H]+ found = 703.4562. 
 
b) 5-(4,4,5,5-tetramethyldioxaborane)-10,20-dipentylporphyrin 
 
Chemical Formula: C36H45BN4O2 
Molecular Weight: 576.59 g/mol                                
  
1H NMR (300 MHz, CDCl3) δ (ppm) : -3.02 (2H, s, NH), 0.98 (6 H, t, 
3J = 7.3 Hz, Ha), 1.58 (4H, 
m, Hb), 1.75 (4H, m, Hc), 1.89 (s, 12 H, Hf), 2.55 (4H, m, Hd), 5.01(4H, t, 3J = 7 .4 Hz, He), 9.36 
(2H d, 3J = 4.6Hz, Hβ), 9.56 (2H d, 3J = 4.6 Hz, Hβ), 9.61 (2H d, 3J = 4.9 Hz, Hβ), 9.89 (2H d, 3J 
= 4.9 Hz, Hβ), 10.12 ( 1H, s, Hh).  
13C NMR (126 MHz, CDCl3) δ: 14.32 (Ca), 22.95 (Cb), 29.86 (Cf), 32.87 (Cd), 34.75 (Cc), 38.48 
(Ce), 66.06, 104.40, 118.98, 128.63(Cβ), 128.63 (Cβ), 128.72 (Cβ), 132.16(Cβ), 133.07, 144.31, 
147.60.  
HRMS (ESI): m/z(M+): [M+H]+ calculated = 577.3715, [M+H]+ found = 577.3700. 
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5) Zn(II) [5-(4,4,5,5-tetramethyldioxaborane)-10,20-dipentylporphyrin] 
                                          
 Chemical Formula: C36H43BN4O2Zn 
                               Molecular Weight: 617.78 g/mol 
 
10-(4,4,5,5-tetramethyldioxaborane)-5,15-dipentylporphyrin (50 mg, 0.087 mmol, 1 eq) was 
dissolved in 50 mL of chloroform. A solution of Zn(OAc)2.2H2O (35 mg, 0.173 mmol, 2 eq) in 
methanol ( 5 mL) was added. The reaction mixture was stirred at room temperature for 4 hours, 
and followed by TLC. When the reaction was completed, the solvent was removed under reduced 
pressure. The crude product was dissolved with 100 ml of dichloromethane, then washed with 
water (2x50 mL). The organic phase was collected and dried over MgSO4, then filtered and dried 
under reduced pressure to give 47 mg of a purple solid (89 %). 
 
1H NMR (300 MHz, CDCl3) δ (ppm): 0.99 (6 H, t, 
3J = 7.3 Hz, Ha), 1.58-1.61 (4H, m, Hb), 1.83 
(4H, m, Hc), 1.90 (s, 12 H, Hf), 2.58 (4H, m, Hd), 5.02 (4H, t, 3J = 7.4 Hz, He), 9.39 (2H d, 3J = 
4.6 Hz, Hβ), 9.62 (2H d, 3J = 4.6 Hz, , Hβ), 9.71 (2H, d, 3J = 4.9 Hz, Hβ), 9.95 (2H, d, 3J = 4.9 Hz, 
, Hβ), 10.09 (1H, s, Ha).  
13C NMR (126 MHz, CDCl3) δ: 14.33 (Ca), 22.86 (Cb), 29.86 (Cf), 32.85 (Cd), 35.70 (Cc), 38.60 
(Ce), 66.34, 119.52, 128.60 (Cβ), 129.88-129.90(Cβ), 132.10 (Cβ), 136.82, 145.28, 147.75. 
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6) N1-benzylhydryl-5-iodouracil and N1-benzylhydryl-5-bromouracil 4 
 
 Chemical Formula: C17H13IN2O2 
                                 Molecular Weight: 404.21 g/mol 
 
5-iodouracil (1g, 4.20 mmol, 1 eq) in 16 ml of acetonitrile was treated bis(trimethylsily)acetamide 
(2.6 mL, 10.51 mmol, 2.5 eq). The suspension was stirred until the bromouracil dissolved and a 
clear solution was obtained. Benzylhydrylbromide (2.02 g, 8.19 mmol, 2 eq) and a catalytic 
amount (10 mg) of iodine I2 were added to the mixture and heated under reflux overnight. The 
reaction was followed by TLC. When the disappearance of 5-iodouracil was observed (ca. 12 
hours), the reaction was evaporated under reduced pressure then diluted with dichloromethane 
(100 mL) and extracted with water (50 mL x 2). The organic phase was dried over MgSO4, filtered 
and dried under reduced pressure. The crude product was washed with ethylacetate several times 
(4 × 7 mL), filtered and dried to give 1 g of a white precipitate (55 %). 
  
1H NMR (126 MHz, CDCl3) δ: 7.03 ppm (1H, s, Ha), 7.16-7.19 ppm (4 H, m, Ho), 7.37 ppm (1 
H, s, Hb), 7.38-7.46 (6 H, m, Hm and Hp), 8.59 ppm (1H, s, brd, NH).  
13C NMR (126 MHz, CDCl3) δ: 63.09 (Ca), 37.92 (Cc), 128.53, 128.89 (Co), 129.43 (Cm), 137.06, 
146.90 (Cb), 150.51 (Cd), 159.72 (Ce).  
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7) Pentyl-dipyrromethane 5  
                                                              
Chemical Formula: C14H20N 
Molecular Weight: 216.33 g/mol                                    
 
A mixture of pyrrole (68 mL, 984 mmol, 40 eq) and hexanal (3 mL, 24.6 mmol, 1eq) was treated 
with TFA (0.18 mL, 2.35 mmol, 0.1 eq) and stirred under argon at room temperature. After 4 
hours, the reaction was quenched by adding 0.1 M NaOH solution until the medium became neutral 
(ca 5 mL). The mixture was extracted with dichloromethane (2x100 mL) and washed with water 
(2x50 mL). The organic phase was dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude product was purified with column chromatography (silica gel, cyclohexane: 
ethylacetate: triethylamine (8:2:0.1) to give 2.5 g of a yellowish viscous oil (47 %). 
 
1H NMR (400 MHz, CDCl3) δ (ppm): 0.89 (3H, t, 
3J = 6.8 Hz, Ha), 1.32 (6H, m, Hb & Hc & Hd), 
1.94 (2H, m, He), 3.94 (1H, t, 3J = 7.6 Hz, Hf), 6.11 (2H, m, H2 ), 6.18 (2H, dd,
 3J = 5.8 Hz, 4J = 
2.7 Hz, H1), 6.58 (2H, dd, 3J = 5.7 Hz, 4J = 2.6 Hz, H3), 7.57 ppm (2H, s, br, NH). 
13C NMR (126 MHz, CDCl3) δ (ppm): 14.20(Ca), 22.66 (Cb), 27.03 (Cc), 27.30 (Cd), 31.79 (Ce), 
34.39 (Cf), 105.65 (C1), 107.83 (C2), 117.23(C3), 133.78 (C4). 
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8) 5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin (Po1) 6  
 
Chemical Formula: C40H28N4Si2 
Molecular Weight: 642.36 g/mol 
 
Pentyl-dipyrromethane (300 mg, 1.39 mmol, 1 eq) was dissolved in degassed dichloromethane 
(200 mL) and cooled to 0 oC in an ice bath. Then trimethylsilylethynylaldehyde (216 µL, 1.46 
mmol, 1.05 eq) was slowly added to the flask. The reaction was stirred at 0 oC and borontrifluoride 
etherate (BF3.Et2O) (34 µL, 0.28 mmol, 0.2 eq) was added drop wise to the mixture. The reaction 
was stirred for 10 to 15 minutes and followed by TLC. When all the pentyl-dipyrromethane 
disappeared, the ice bath was removed and DDQ (334 mg, 1.06 eq) was added. The mixture was 
stirred at room temperature for 30 minutes, and then quenched by adding 0.56 mL of pyridine. The 
solvent was evaporated under reduced pressure. The crude was purified by column 
chromatography (silica gel, DCM: Cyclohexane (3:7)) to give 446 mg of a dark purple powder  
(38 %). 
 
1H NMR (300 MHz, CDCl3) δ (ppm): -2.39 (2H, s, NH), 0.65 (18H , s, Ha’), 0.96 (6H t, 
3J = 7.30 
Hz, Ha), 1.53 (4H, m, Hb), 1.73 (4H, tt,
 3J = 7.6 Hz, 5.79 Hz,  Hc), 2.44 (4H, tt, 
3J = 7.9 Hz, 7.6 
Hz, Hd), 4.79 (4H, t, 3J = 8.0 Hz, He), 9.30 (4H, d, 3J = 4.8 Hz, Hβ), 9.60(4H d, 3J = 4.8 Hz, Hβ). 
13C NMR (126 MHz, CDCl3) δ (ppm): 0.54 (Ca’), 14.28 (Ca), 22.89 (Cb), 27.07 (Cd), 32.75 (Cc), 
35.04 (Ce), 99.60, 101.87, 107.51, 121.60, 128.24 (Cβ), 131.17 (Cβ). 
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9) Zn(II) [5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin] (Zn-Po1) 
                             
 Chemical Formula: C40H26N4Si2Zn 
Molecular Weight: 704.40 g/mol 
 
A solution of Zn(OAc)2.2H2O (58 mg, 0.29 mmol, 2 eq) in 5 mL methanol was added to a solution 
of 5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin  (90 mg, 0.145 mmol, 1 eq) in 150 mL 
chloroform. The mixture was stirred at room temperature for 3 hours. The disappearance of the 
starting material was followed by TLC. When the reaction was completed, the solvent was 
removed under reduced pressure. The crude product was washed with water (2x50 mL) to remove 
the excess of zinc(II). The organic phase was dried over MgSO4, filtered and evaporated under 
reduced pressure. The crude was purified by column chromatography (silica gel, DCM: 
cyclohexane (3:7)) to give 90 mg of a greenish solid (90 %). 
 
1H NMR (300 MHz, CDCl3) δ (ppm): 0.65 (18 H, s, Ha’), 0.97 (6H, t,
 3J = 7.3 Hz, Ha), 1.53 (4H, 
m, Hb), 1.72 (4H, tt, 3J = 7.6 Hz, 6.7 Hz, Hc), 2.24 (4H, tt, 3J = 7.8 Hz, 7.7 Hz, Hd), 4.52 (4H, t, 3J 
= 7.8 Hz, He), 9.00 (4H d, 3J = 4.6 Hz, Hβ), 9.30 (4H d,  
3J = 4.6 Hz, Hβ).  
13C NMR (126 MHz, CDCl3) δ (ppm): 0.68 (Ca’), 14.33 (Ca), 22.89 (Cb), 27.06 (Cd), 32.95 (Cc), 
35.49 (Ce), 99.66, 100.99, 107.94, 122.12, 128.92(Cβ), 130.99 (Cβ), 149.58, 150.62. 
HRMS (ESI): m/z(M+): [M+H]+ calculated = 705.27, [M+H]+ found = 705.2704. 
UV-VIS (CH2Cl2, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 433 (134.91), 591 (12.25), 694 (4.40). 
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10) Zn(II) [5,15 -di(N1-(benzylhydry)uracil)- 10,20-dipentylporphyrin] (T1)7      
                
Chemical Formula: C70H60N8O4Zn 
                                                                                    Molecular Weight: 1112.37g/mol 
 
Zn(II)[5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin] (120 mg, 0.169 mmol, 1eq), 4N-
benzylhydryl-5-iodouracil (150 mg, 0.3718 mmol, 2.2 eq), AsPh3 (61.39 mg, 0.2 mmol, 1.2 eq) 
and Pd(PPh3)2Cl2 (34.8 mg, 0.0495 mmol, 0.25 eq) were treated with 33 mL of a TBAF solution 
(1M in THF). The reaction was stirred under argon for 3 hours under reflux at 75 oC. The 
disappearance of the starting materials was followed by TLC. When Zn-Po1 disappeared, the 
reaction was concentrated under reduced pressure, extracted by DCM (50 mL) and washed with 
water (50 mL). The organic phase was dried over MgSO4, filtered and dried under reduced 
pressure. The crude was purified by column chromatography (silica gel, 2% methanol in DCM) 
followed by a bio beads separation using a mixture of 20 % methanol in DCM as eluent (88 %). 
 
1H NMR (300 MHz, CDCl3 + MeOD) δ (ppm): 0.93 (6H, t, 
3J = 8.3 Hz, Ha,), 1.48 (4 H, m, Hb), 
1.71 (4H, tt, 3J = 8.3 Hz, 7.2 Hz, Hc), 2.43 (4 H, tt, 3J = 8.4 Hz, 7.5 Hz, Hd), 4.81 (4H, t, 3J = 7.5 
Hz, He), 7.20 (2H, s, Hf), 7.34 (8 H, m, Ho), 7.36 (2H, s, Hh), 7.48 (12 H, m, Hp & Hm), 9.34 (4H 
d, 3J = 4.7 Hz, Hβ), 9.61(4H d, 
3J = 4.7 Hz, Hβ).  
13C NMR (126 MHz, CDCl3 + MeOD) δ (ppm): 14.10 (Ca), 22.74 (Cb), 29.68 (Cd), 32.79 (Cc), 
38.64 (Ce), 63.05 (Cf), 98.61, 98.66, 101.07 (Cg), 101.49, 122.59, 128.69 (Co), 128.83, 129.42 
(Cm), 131.02, 137.23-137.25 (Cβ), 143.09, 149.05 (Ch), 150.18 (Ck) 150.71 (Cl).  
 
HRMS (ESI): m/z(M+): [M+H]+ calculated = 1113.3789, [M+H]+ found= 1113.3721. 
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UV-VIS (CH2Cl2, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) :  452 (123.79), 625 (14.87), 699 (5.08). 
IR ѵ(cm-1): 3060.7, 2921.6, 2851.9, 1692.5, 1441.2, 1260.9, 1238.2, 1075.9, 1010.2, 790.8, 709.8, 
565.7, 432.7. 
 
11) 5,15-di(uracil)- 10,20-dipentylporphyrin (T2) 4 
                                                     
Chemical Formula: C42H36N8O4 
 Molecular Weight: 718.30 g/mol 
 
Zn(II) [5,15-di((N1-benzylhydry)uracil)-10,20-dipentylporphyrin], T1, (40 mg, 0.035 mmol, 1 eq) 
was treated with TFA (5 mL) and triflic acid (0.5 mL) at 0 oC. The reaction was stirred at 0 oC for 
2 hours then the reaction was poured slowly on 50 g of ice. The green precipitate formed was 
filtered and collected to give 20 mg of an insoluble dark green solid (80 %). 
  
HRMS (ESI): m/z(M+): [M+H]+ calculated = 719.3089, [M+H]+ found = 719.3063. 
 
UV-VIS (DMSO, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 431 (165.25), 557 (17.20), 658 (2.7). 
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12) N1-hexyl-5-iodouracil 8   
                                                                                          
Chemical Formula: C10H15IN2O2 
Molecular Weight: 322.15 g/mol. 
5-iodouracil (0.5g, 2.1 mol, 3 eq) and Cs2CO3 (0.3 g, 0.91 mmol, 1.3 eq) were dissolved in 60 mL 
of dry DMF. To the suspension, 1-bromohexane (0.1 mL, 0.7 mmol, 1 eq) was added drop wise. 
The reaction was stirred at 40 oC under argon. After 24 hours, the mixture was evaporated under 
reduced pressure and then diluted with DCM (100 mL) and washed with water (50 mL x 2). The 
organic phase was dried over MgSO4, filtered, and dried under reduced pressure. The crude 
product was purified by column chromatography (silica gel, DCM: MeOH (200:1)) to yield 210 
mg of 1- hexyl-5-iodouracil as a white solid. (94 %) 
 
1H NMR (500 MHz, CDCl3) δ (ppm):  0.89 (3H, t, 
3J = 6.7 Hz, Ha), 1.32 (6 H, m, Hb & Hc & 
Hd), 1.68 (2H, tt, 3J = 7.5 Hz, 7.4 Hz, He), 3.73 (2H, t, 3J = 7.5 Hz, Hf), 7.60 (1H, s, Hh), 8.39 (1H, 
s, br, NH). 
13C NMR (126 MHz, CDCl3) δ (ppm): 14.12 (Ca), 22.60 (Cb), 26.15 (Cd), 29.30 (Ce), 31.40 (Cc), 
49.41 (Cf), 67.51 (Cg), 149.03 (Ch), 150.25 (Cj), 160.32 (Ci). 
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13) Zn(II) [5, 15-di(N1-hexyluracil)-10,20-dipentylporphyrin] 7 (T3) 
 
                                                                                                   Chemical Formula: C55H63N8O4Zn 
                                                                                       Molecular Weight: 965.54 g/mol 
 
Zn(II)[5,15-di(trimethylsilylethynyl)-10,20-dipentylporphyrin] (100 mg, 0.141 mmol, 1eq), N1-
hexyl-6-iodouracil (96 mg, 0.311 mmol, 2.2 eq), AsPh3 (51.81 mg, 0.169 mmol, 1.2 eq) and 
Pd(PPh3)2Cl2 (24 mg, 0.035 mmol, 0.25 eq) were treated with 27 mL of a TBAF solution (1M in 
THF) under argon. The reaction was stirred for 3 hours under reflux and followed by TLC. When 
all starting porphyrin material disappeared, the reaction was concentrated under reduced pressure 
then extracted with DCM (50 mL) and washed twice with water (20 mL). The organic phase was 
dried over MgSO4, filtered, and dried under reduced pressure. The crude was purified by column 
chromatography (silica gel, 2% methanol in DCM) followed by bio beads separation for further 
purification to give 136 mg of a green solid (80 %). 
 
1H NMR (300 MHz, CDCl3) δ (ppm): 1.19 (12 H, t, 
3J = 7.2 Hz, Ha & Ha’), 1.41-152 (20 H, m, 
Hb & Hc & Hb’ & Hc’ & Hd’), 1.77 (4H, m, tt, 3J = 7.4 Hz, 4.7 Hz, He’), 2.50 (4 H, t, 3J = 8.3 
Hz, Hd), 4.24 (4H, t, 3J = 7.5 Hz, Hf’), 4.93 (4H, m, t, 3J = 8.4 Hz, He), 8.14 (2H, s ,brd, Hh), 9.01 
(4H, d, 3J = 4.7 Hz, Hβ), 9.49 (4H, d, 3J  = 4.7 Hz, Hβ). 
13C NMR (126 MHz, CDCl3) δ (ppm): 14.1 (Ca & Ca’), 20.9 (Cb & Cb’), 22.7- 26.4- 27.7- 30.8- 
31.9 (Cc, Cc’, Cd, Cd’, Ce, Ce’), 49.6 (Cf’), 88.4, 99.09, 100.9 (Cg), 117.5, 122.05, 130.39 (Cβ), 
131.45 (Cβ), 142.7, 142.8 (Ch), 150.8 (Ck), 161.6 (Cl). 
HRMS (ESI): m/z(M+): [M+H]+ calculated = 965.5432, [M+H]+found = 965.54325. 
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UV-VIS (CH2Cl2, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) :  455 (237.60), 591 (12.71), 663 (7.42). 
 
14) 5-iodocytosine 8 
    
                                                                                                              Chemical Formula: C4H4IN3O 
                                                                                             Molecular Weight: 237 g/mol 
 
Cytosine (1g, 9.0 mmol, 1 eq), Iodine (3.4 g, 13.5 mmol, 1.5 eq) and Iodic Acid (2.2 g, 12.6 mmol, 
1.4 eq) were treated with 33 mL of acetic acid. The mixture was stirred at 40 oC. After 24 hours, 
the mixture was treated with 200 mL of a saturated aqueous solution of Na2S2O3, resulting in a 
color change from black to white and the formation of white precipitate. If necessary, a 1 M 
aqueous NaOH solution was added to the filtrate to reach a final pH of 7. The precipitate was 
filtered and dried under reduced pressure to give 2g of a white solid (94 %).  
1H NMR (300 MHz, DMSO-d6) δ (ppm): 6.96 (2 H, s, br, H4), 7.78 (1H, s, H6), 10.36 (1H, s, br, 
H1). 
13C NMR (126 MHz, MeOD-d4) δ: 54.45 (C5), 139.47 (C6) 149.40 (C2) 178.95 (C4). 
 
15) N1-hexyl-5-iodocytosine 8 
                                                                                        
Chemical Formula: C10H16IN3O 
Molecular Weight: 321.16 g/mol 
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5-iodocytosine (0.5 g, 2.1 mmol, 1 eq) and K2CO3 (0.3455 g, 2.5 mmol, 1.2 eq) were dissolved in 
10 mL of dry DMF. Iodohexane (0.5 mL, 0.53 g, 2.5 mmol, 1.2 eq) was added drop wise to the 
suspension. The reaction was stirred for 12 hours at 40 oC under argon. After the reaction was 
completed, the mixture was evaporated and then diluted with DCM (100 mL) and washed with 
water (2x50 mL). The organic phase was dried over MgSO4, filtered and evaporated under reduced 
pressure. The crude was purified by washing with ethyl acetate and petroleum ether to give 270 
mg of a white solid (40 %).  
 
1H NMR (300 MHz, CDCl3) δ (ppm): 0.88 (3H, t, 
3J = 6.9 Hz, Ha), 1.30 (6H, m, Hb & Hc & Hd), 
1.69 (2H, tt, 3J = 7.60 Hz, 7.5 Hz, He), 3.75 (2H, t, 3J = 7.5 Hz, Hf), 5.44 (1H, s, br, H4), 7.48 (1H, 
s, br H3), 7.56 (1H, s, H6).  
13C NMR (126 MHz, CDCl3) δ (ppm): 14.30 (Ca), 22.51 (Cb), 26.51 (Cd), 29.28 (Ce), 31.38 (Cc), 
50.55 (Cf), 54.87 (C2), 151.01 (C1), 155.42 (C3), 163.70 (C4). 
 
16) 5-((4-methoxyphenyl)ethynyl)-N1-hexylcytosine  
   
Chemical Formula: C19H23N3O2 
  Molecular Weight: 325.419 g/mol 
 
 [(4-methoxyphenyl)ethynyl](trimethyl)silane (0.247 mL, 237 mg, 1.16 mmol, 1 eq) and a 1 M 
TBAF solution in THF (1.16 mL, 1.16 mmol, 1 eq) were reacted for 2 hours at RT under argon. 
The solvent was evaporated under vacuum and the crude was extracted with diethylether several 
times until all the product was extracted. The deprotected (4-methoxyphenyl)ethynyl was dried 
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under vacuum and diluted with 20 mL THF:Et3N 1:1 solution. To this solution, iodo-hexyl 
cytosine (247 mg, 0.77 mmol, 1 eq) was added and the solution was degassed for 10 minutes. PPh3 
(0.044 g, 0.2 eq) and Pd(OAc)2 (0.025 g, 0.15 eq) were added to the solution. The mixture was 
stirred under argon and under reflux at 80 oC for 12 hours. The mixture was extracted by 50 mL 
DCM and washed with 50 mL of water. The organic phase was dried over MgSO4, filtered and 
dried under reduced pressure. The crude was purified by column chromatography (silica gel, 2% 
methanol in DCM) to give 113 mg of a white solid (30 %). 
 
1H NMR (500 MHz, CDCl3) δ: 0.87  (3H, t, 
3J = 6.9 Hz, Ha), 1.31 (6 H, m, Hb & Hc & Hd), 1.81 
(2H, tt, 3J = 7.6 Hz, 7.5 Hz, He), 3.84 (3H, s, Hg), 4.01 (2H, t, 3J = 7.4 Hz, Hf), 6.32 (1H, s, br, 
NH, H4), 6.97 (2H, d, 3J = 8.8 Hz, Ho), 7.73 (2H, d, 3J = 8.7 Hz, Hm), 8.07 (1H, s, br, NH, H3).  
13C NMR (126 MHz, CDCl3) δ: 14.13 (Ca), 22.63 (Cb), 26.43 (Cd), 29.55 (Ce), 31.60 (Cc), 52.46 
(Cf), 55.51 (Cg), 94.49, 110.55, 114.60, 122.94, 127.06, 129.83, 138.79 (C6), 140.56, 155.43 (C2), 
160.58 (C4). 
 
17) N9-hexyladenin 8 
      
Chemical Formula: C11H17N5 
Molecular Weight: 219.29 g/mol 
 
Adenine (100 mg, 0.74 mmol, 1 eq) and K2CO3 (121 mg, 0.88 mmol, 1.2 eq) were dissolved in 20 
mL of degassed DMF. Bromohexane (146 mg, 0.12 mmol, 0.88 mmol, 1 eq) was added drop wise 
to the suspension. The mixture was stirred for 12 hours at 40 oC under argon, and was followed by 
TLC. When all adenine disappeared, the mixture was concentrated then diluted with 50 mL of 
DCM and washed with 20 mL of water and then with 20 mL of brine solution. The organic phase 
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was dried over MgSO4, filtered and dried under reduced pressure. The crude product was purified 
by column chromatography (silica gel, 2% MeOH in DCM) to give 250 mg of a white solid (90 
%).  
 
1H NMR (300 MHz, CDCl3+ MeOD) δ (ppm): 0.87 (3H, t, 
3J = 7.0 Hz Ha), 1.33 (6H, m, Hb &Hc 
& Hd), 2.00 (2H, tt, 3J = 7.5 Hz, 7.3 Hz, He), 4.38 (2H, t, 3J = 7.3 Hz, Hf), 7.99 (1H, s, H8) 8.06 
(1H, s, H2).  
13C NMR (126 MHz, CDCl3) δ (ppm): 14.24 (Ca), 22.74 (Cb), 26.61 (Cd), 30.35(Ce), 31.50(Cc), 
44.25(Cf), 120.03 (C5), 140.62 (C8), 150.35 (C4), 153.20 (C2), 156.06 (C6). 
 
18) 8-iodo-N9-hexyladenin 8 
                                                                                      
Chemical Formula: C11H16N5I 
                                                                                    Molecular Weight: 345.19 g/mol 
 
N9-hexyladenin (220 mg, 1.00 mmol, 1 eq), Iodine (67 mg, 0.38 mmol, 0.38 eq) and periodic acid 
H5IO6 (227 mg, 1.00 mmol, 1 eq) were dissolved in 10 mL of dry DMF and stirred at 70 °C for 12 
hours. The reaction was followed by TLC. When all starting material disappeared, the mixture was 
evaporated and then diluted with 50 mL of DCM, washed with a 20 mL of a saturated aqueous 
solution of Na2S2O5, then with 20 mL of water and 20 mL of brine solution. The organic phase 
was dried over MgSO4, filtered and evaporated under reduced pressure. The crude was purified by 
column chromatography (silica gel, 5 % Methanol in DCM) to give 200 mg of a white solid           
(60 %). 
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1H NMR (500 MHz, CDCl3) δ (ppm): 0.88 (3H, t, 
3J = 6.80 Hz, Ha) 1.33 (6H, m, Hb & Hc & Hd), 
1.83 (2H, tt, 3J = 7.8 Hz, 7.2 Hz, He), 4.14 (2H, t, 3J = 7.3 Hz, Hf), 8.29 (1H, s, H2).  
13C NMR (126 MHz, CDCl3) δ (ppm): 14.10 (Ca), 22.60 (Cb), 26.46 (Cd), 30.19 (Ce), 31.34 (Cc), 
44.12 (Cf), 119.77 (C5), 140.58 (C8), 150.21 (C4), 153.06 (C2), 16.61 (C6). 
 
19) N1-methylphenylthymine 
 
Chemical Formula: C12H12N2O2 
Molecular Weight: 216.24 g/mol 
 
 
Thymine (200 mg, 1.58 mmol, 2 eq), K2CO3 (120 mg, 0.87 mmol, 1. eq) and 4-(bromomethyl) 
benzene (135 mg, 0.79 mmol, 1 eq) were mixed in 15 mL of dry degassed DMF.  The reaction 
was stirred at 40 oC for 24 hours. The crude was dried under vacuum, and then washed with a 
minimum amount of water (5 mL). The product was purified by column chromatography (SiO2, 5 
% MeOH in DCM) to yield 100 mg of the targeted product as a white solid (60 %).   
 
1H NMR (500 MHz, CDCl3) δ (ppm): 1.87 (3H, d, 
4J = 1.2 Hz, Ha), 4.89 (2H, s, Hb), 6.99 (1H, q, 
4J = 1.1 Hz, Hc), 7.33 (5H, m, HPhenyl), 9.87 (1H, s, brd, NH). 
 
20) 4-(bromomethyl)benzaldehyde (Br-Ald)9  
 
Chemical Formula: C8H7BrO 
Molecular Weight: 199.05 g/mol 
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4-bromomethylbenzonitrile (1.0 g, 5.0 mmol, 1 eq) was dissolved in 20 mL of dry toluene. 1 M 
H-DIBAL solution in cyclohexane (1.023 g, 7.2 mmol, 7.2 mL, 1.4 eq) was added via an additional 
funnel over 20 minutes. The reaction was stirred at 0 oC and followed by TLC. After 2.5 hours, all 
starting material disappeared, and 25 mL of chloroform and 33.3 mL of 10 % HCl aqueous solution 
were added to the mixture and stirred for 1 hr at RT. The organic phase was separated and the 
aqueous phase was extracted twice with 100 mL of chloroform. The organic phases were 
combined, dried over MgSO4, and evaporated. The crude was re-crystalized from hexane to give 
0.94 g of white crystals (94 %).  
 
1H NMR (300 MHz, CDCl3) δ (ppm): 4.51(2H, s, Ha), 7.54 (2H, d, 
3J = 8.2 Hz, Hm), 7.85 (2H, d, 
3J = 8.2 Hz, Ho), 10.01 (s, 1H, Hb). 
13C NMR (126 MHz, CDCl3) δ (ppm): 32.13 (Ca), 129.82 (Cm), 130.31 (Co), 136.22 (Cp), 144.38 
(Cp’), 191.69 (Cc).  
 
21) Phenyl-dipyrromethane 10 
                                                                  Chemical Formula: C15H14N2 
                                                      Molecular Weight: 220.10 g/mol 
 
Pyrrole (97 mL, 1.4 mol, 100 eq) was filtered on an Alumina pad and then transferred to a round 
bottom flask and degassed. Benzaldehyde (1.5 mL, 1.53 g, 14 mmol, 1 eq) and InCl3 (0.32 g, 1.4 
mmol, 0.1 eq) were added to pyrrole. The mixture was protected from light and stirred under argon 
at RT for 2 hours. The reaction was quenched by adding NaOH (56 mg, 1.4 mmol, 0.1 eq) and 
stirred for 45 minutes. The mixture was filtered on a Büchner funnel and the filtrate was dried 
under vacuum. To remove the excess of pyrrole, petroleum ether and cyclohexane were added to 
Experimental Part 
 
210 
 
the flask and then evaporated under vacuum to give a yellowish solid. The solid was washed with 
a solution of ethanol: water (2:1) to give 2.2 g of a shiny white solid (72 %). 
 
1H NMR (300 MHz, CDCl3) δ (ppm): 5.48 (1H, m, Ha), 5.93 (2H, m, H1), 6.17 (2H, m, H2), 
6.70 (2H, m, H3), 7.31 (4H, m, Hb & Hc), 7.90 (2H, s, brd, NH). 
 
22) 5,15-bis(4-(bromomethyl)phenyl)-10,20-diphenylporphyrin (Po2) 
                                      
Chemical Formula: C46H32Br2N4 
Molecular Weight: 800.60 g/mol 
 
Phenyl-dipyrromethane (289 mg, 1.316 mmol, 1 eq) and 4-(bromomethyl)benzaldehyde (262 mg, 
1.316 mmol, 1 eq) were dissolved in 150 mL of degassed chloroform. The solution was degassed 
with argon for 15 minutes, then BF3.Et2O (4.65 µL, 53.55 mg, 0.7896 mmol, 0.6 eq) was added 
slowly, and the solution was stirred at RT .under argon for 2 hours. p-chloranil (480 mg, 1.95 
mmol, 1.5 eq) and triethylamine (0.163 mL, 0.12 mmol, 0.09 eq) were added to the mixture and 
stirred for another 2 hours under reflux at 65 oC. The crude was evaporated under vacuum then 
diluted with 50 ml of a solution of DCM: cyclohexane (1:1) and filtered twice over a pad of silica. 
The filtrate was evaporated under vacuum to give a purple solid that consisted of a mixture of 6 
different porphyrins. Scrambling could be proved by MS and NMR. (Total mass: 310 mg, 34 %) 
The different porphyrins could not be clearly differentiated by NMR but they could be identified 
by MS.  
 
MS (ES): m/z(HRM+): [M+H]+ calculated = 801.62, [M+H]+ found= 895.03, 801.11, 709.18, 
615.26. 
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23) 5-(N1-methylphenylthymine )10,15,20-triphenylporphyrin (T4) 
                                    
Chemical Formula: C50H36N6O2 
Molecular Weight: 752.88 g/mol 
 
The crude mixture containing 6 different porphyrins (174 mg, ca 0.217 mmol based on the major 
product : the 5,15-diphenyl-10,20-dibromoporphyrin) 1 eq), thymine (137 mg, 0.1086 mmol, 5 eq) 
and K2CO3 ( 89 mg, 0.651 mmol, 3 eq) were dissolved in 10 mL of degassed DMF and stirred at 
40 oC. After 24 hours, the solvent was evaporated under vacuum. The crude was purified by 
column chromatography using gradient eluent. DCM: Cyclohexane 2:1 was used to elute H2TTP, 
1% MeOH in DCM to elute the 5-(N1-methylphenylthymine)-10,15,20-triphenylpoprhyrin (T4) 
while further factions did not contain pure products. The fraction containing T4 was evaporated 
under reduced pressure to give 30 mg of a purple solid (18 % with respect to the mixture of starting 
material). 
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1H NMR (500 MHz, CDCl3) δ (ppm): - 2.79 ( 2H, s, NH), 2.04 (3 H, s, Ha), 5.24 (2H, s, CH2), 
7.31 (1H, s, Hb), 7.66( 2H, d, 3J = 7.9 Hz, Hm’), 7.75 (9H, m, Hm & Hp1), 8.21-8.24 (8H, m, 
Hβ), 8.29 (1H, s, brd, NHthymine), 8.85 (8H, m, Ho & Ho’), 8.90 (8H, m, Hβ). 
13C NMR (126 MHz, CDCl3) δ (ppm): 12.70 (Ca), 51.33 (Cc), 111.69 (Ca’), 119.05, 120.41 (Cβ), 
120.54, 126.26 (Cm’), 126.85 (Cβ), 127.91 (Cm), 134.70, 135.05 (Cb), 135.31 (Co), 140.20 (Co’), 
142.22, 142.63, 151.18 (Cd), 163.88 (Ce).  
HRMS (ESI): m/z(M+): [M+H]+ calculated = 753.2982, [M+H ]+ found = 753.2984. 
UV-VIS (DMF, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 418 (298.76), 515 (11.72), 549 (5.18), 589 
(3.68), 645 (3.58). 
IR ѵ(cm-1): 2924.43, 2849.8, 1696.1, 1679.5, 1596.9, 1475.4, 1439.1, 1349.9, 1249.5, 1176.2, 
1071.9, 965.6, 727.0, 417.2.  
 
24) Mesityl-dipyrromethane 
        
Chemical Formula: C18H20N2 
     Molecular Weight: 264.37g/mol 
 
Mesitylaldehyde (2.5 g, 16.85 mmol, 1 eq) was dissolved in pyrrole (118 mL, 1.18 mol, 70 eq) 
and degassed with argon for 30 minutes. BF3.Et2O (1.726 mL, 1.985 g, 13.95 mmol, 0.8 eq) was 
added drop wise to the mixture and stirred for 3 hours at RT under argon. NaOH (0.55 g, 13.95 
mmol,0.8 eq) was added to the mixture and stirred for 1 hour. The mixture was filtered on a frit 
and the filtrate evaporated under vacuum. Cyclohexane was used to help remove all the excess of 
pyrrole. The crude was purified by column chromatography (SiO2, 5% ethylacetate in 
cyclohexane). The obtained solid was washed with diethylether to give 1.3 g of a white solid 
(30%). 
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1H NMR (400 MHz, CDCl3) δ (ppm): 2.06 (s, 6H, Ha), 2.28 (s, 3H, Hb), 5.93 (s, 1H, Hc), 6.00 
(m, 2H, H1), 6.20 (m, 2H, H2), 6.68 (2H, m, H3), 6.90 (2H, s, Hd), 7.96 (s, brd, 2H, NH). 
13C NMR (126 MHz, CDCl3) δ (ppm): 20.68 (Ca), 20.71 (Cb), 38.45 (Cc), 106.68 (C1). 108.78 
(C2), 116.26 (C3), 130.47 (Cd), 131.37 (C4), 134.66 (Cb”), 136.69 (Cb’), 137.73 (Ca’). 
 
25) 5,15-bis(4-(bromomethyl)phenyl)-10,20-dimesitylporphyrin (Po3)11  
 
 
 
 
 
 
                                                                                      Chemical Formula: C52H44Br2N4 
                                         Molecular Weight: 884.76 g/mol 
 
Mesityl-dipyrromethane (0.5 g, 1.89 mmol, 1 eq) and 4-(bromomethyl)benzaldehyde (0.376 g, 
1.89 mmol, 1 eq) were dissolved in 189 mL of dichloromethane and degassed for 15 minutes. Then 
TFA (0.259 mL, 3.36 mmol, 0.3839 g, 1.78 eq) was added drop wise over 30 seconds to the 
mixture. The latter was stirred for 45 minutes at RT under argon in the dark. The reaction was 
followed by TLC, and when all DPM was consumed (ca 1 hour) DDQ (0.429 g, 1 eq) was added 
to the reaction and stirred for ca 30 minutes at RT. Then the mixture was poured on a silica pad 
and eluted by DCM. The filtrate was evaporated and purified by column chromatography (Silica 
gel, DCM: cyclohexane 1:1 then DCM to give 250 mg of a purple solid (15 %). 
 
1H NMR (400 MHz, CDCl3) δ (ppm): -2.63 (2H, s, brd, NH), 1.85 (12 H, s, Ha), 2.64 (6 H, s, Hb), 
4.85 (4H, s, Hc), 7.30 (4H, s, Hd), 7.78 (4H, d, 3J = 7.8 Hz, Hm), 8.21 (4H, d, 3J = 7.8 Hz, Ho) 
8.71(4H, d, 3J = 4.5 Hz, Hβ), 8.81 (4H, d, 3J = 4.5 Hz, Hβ).  
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13C NMR (126 MHz, CDCl3) δ (ppm): 21.64 (Cb), 21.71 (Ca), 33.74 (Cc), 118.62, 118.68, 
127.58(Cβ), 127.91 (Cm & Co), 134.99(Cd), 137.33, 137.92, 138.47, 139.50, 142.29.  
HRMS (ESI):  m/z(M+): [M+H]+ calculated = 885.1992, [M+H]+ found = 885.1914.  
UV-VIS (DMF, λmax (nm) (Ԑ x 10
3 (mol-1Lcm-1)): 419 (253.63), 515 (10.75), 549 (4.49), 591 
(3.33), 646 (2.45).  
 
26) 5,15-bis(N1-methylphenylthymine)-10,20-dimesitylporphyrin (T5) 12 
      
                                                                                      Chemical Formula: C62H54N8O4 
                                         Molecular Weight: 974.43 g/mol 
 
5,15-bis(4-(bromomethyl)phenyl)-10,20-dimesitylporphyrin (132 mg, 0.1497 mmol, 1 eq) and 
excess of thymine (94 mg, 0.748 mmol, 5 eq) were dissolved in dry degassed DMF (8 mL). K2CO3 
(62 mg, 0.449 mmol, 3 eq) was added to the suspension and stirred for 24 hours at 40 oC. The 
reaction was followed by TLC and stopped when all starting porphyrin was consumed. The solvent 
was evaporated and the resulting solid was washed with water (10 mL) to remove the excess of 
thymine and salt. The crude product was purified by Column Chromatography (Silica gel, 5% 
methanol in DCM) to give 106 mg of a purple solid (72 %). 
 
1H NMR (400 MHz, DMSO-d6) δ (ppm): -2.77 (2H, s, NH), 1.76 (12 H, s, Ha), 1.87 (6H, s, Hf), 
2.59 (6 H, s, Hb), 5.21 (4H, s, Hc), 7.35 (4H, s, brd, Hd), 7.70 (4H, d, 3J = 7.8 Hz, Hm), 7.94 (2H, 
s, He), 8.24 (4H, d, 3J = 8.0 Hz, Ho), 8.64 (4H, d, 3J = 4.8 Hz, Hβ), 8.77 (4H,d, 3J = 4.9 Hz, Hβ). 
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13C NMR (126 MHZ, CDCl3 + MeOD) δ (ppm): 12.44 (Cf), 21.44 (Cb), 21.59 (Ca), 51.15 (Cc), 
111.5, 118.55, 123.81, 126.15 (Cβ), 127.79 (Cm & Co), 135.01, 135.08 (Cd), 137.88, 138.26, 
139.36, 140.40(Ce), 142.14, 151.64 (Ct1), 164.89 (Ct2). 
HRMS (ESI): m/z: [M+H]+ calculated = 975.4323, [M+H]+ found = 975.4322 
UV-VIS (DMF, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)): 419 (227.97), 515 (9.69), 549 (3.85), 589 (2.99), 
644 (2.38).  
IR ѵ(cm-1): 3028.3, 2928.8, 1715.8, 1666.6, 1477.9, 1445.3, 1423.7, 1380.4, 1243.2, 1201.1, 
1027.6, 981.9, 933.7, 830.2, 810.5, 756.5, 738.4, 558.2, 470.9, 419.3. 
 
27) 5,15-bis(N9-methylphenyladenine)-10,20-dimesitylporphyrin (T6)12 
 
Chemical Formula: C62H52N14 
                                             Molecular Weight: 992.45 g/mol 
 
5,15-bis(4-(bromomethyl)phenyl)-10,20-dimesitylporphyrin (150 mg, 0.170 mmol, 1 eq) and 
excess of adenine (114.5 mg, 0.848 mmol, 5 eq) were dissolved in dry degassed DMF (10 mL). 
K2CO3 (70.1 mg, 0.508 mmol, 3 eq) was added to the suspension and stirred for 24 hours at 40 
oC. 
The reaction was followed by TLC and stopped when all starting porphyrin was consumed. The 
mixture was dried under vacuum, then washed with water (10 mL) to remove the excess of salt 
and adenine. The crude was purified by column chromatography (Silica gel, 5% Methanol in 
DCM) to give 90 mg of purple solid (54 %).  
 
Experimental Part 
 
216 
 
1H NMR (500 MHz, CDCl3 + MeOD) δ (ppm):  -2.74 (2 H, s, brd, NH), 1.76 (12H, s, Ha), 2.58 
(6 H, s, Hb), 5.69 (4H, s, Hc), 7.23 (4H, s, Hd), 7.60 (4H, d, 3J = 7.9 Hz, Hm), 8.07 (2H, s, He), 
8.16 (4H, d, 3J = 7.9 Hz, Ho), 8.40 (2H, s, Hf), 8.63 (8 H, m, Hβ).  
13C NMR (126MHz, CDCl3 + MeOD) δ (ppm): 21.49 (Cb), 21.63 (Ca), 47.39 (Cc), 118.34, 118.85, 
119.11 (Cj), 126.08 (Cβ), 127.82 (Cm & Co), 134.89, 135.11 (Cd), 137.89, 138.27, 139.38, 140.59 
(Ce), 142.30, 150.03 (Ck), 153.29 (Cf), 155.70 (Cl). 
HRMS (ESI): m/z (M+): [M+H]+ calculated = 993.4575, [M+H]+ found = 993.4516. 
UV-VIS (DMF, λmax (nm) (Ԑ x 10
3 (mol-1Lcm-1)): 418 (283.28), 516 (3.19), 551 (2.68), 591 (2.30), 
648 (2.22).  
IR ѵ (cm-1): 3076.5, 2922.1, 2851.8, 1681.2, 1603.7, 1580.9, 1468.4, 1431.3, 1332.1, 1308.8, 
1245.9, 1076.1, 1076.1, 1021.5, 967.5, 825.1, 791.6, 771.8, 745.1, 727.7, 544.1, 407.7.  
 
In addition to the target molecule, a minor fraction was also obtained with a yield of 5 %. This 
fraction is more soluble and less polar than the previous one.  
 
1H NMR (500 MHz, CDCl3 + MeOD) δ (ppm):  -2.67 (2 H, s, NH), 1.81 (12H, s, Ha), 2.61 (6 H, 
s, Hb), 5.73 (2H, s, Hc), 5.84 (4H, s, brd, NH2), 5.93 (2H, s, Hc’), 7.27 (4H, s, Hd), 7.63 (2H, d, 
3J = 7.9 Hz, Hm), 7.74 (2H, d, 3J = 7.9 Hz, Hm’), 8.09 (1H, s, He), 8.10 (1H, s, He’), 8.20 (4H, m, 
Ho+o’) 8.37 (1H, s, Hf) 8.52 (1H, s, Hf’), 8.66-8.74 (8 H, m, Hβ). 
HRMS (MALDI-TOF): m/z (M+): [M+H]+calculated = 993.4575, [M+H]+ found = 993.4586. 
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28) 5,15-bis(N1-methylphenylcytosine)-10,20-dimesitylporphyrin (T7) 12 
  
Chemical Formula: C60H52N10O2 
Molecular Weight: 944.43 g/mol 
 
5,15-bis(4-(bromomethyl)phenyl)-10,20-dimesitylporphyrin (130 mg, 0.156 mmol, 1 eq) and 
excess of cytosine ( 86 mg, 0.779  mmol, 5 eq) were dissolved in dry degassed DMF (12 mL). 
NaH (11.20 mg, 0.467 mmol, 3 eq) was added to the suspension and stirred for 24 hours at 40 oC. 
The reaction was followed by TLC and stopped when all starting porphyrin were consumed. The 
reaction was dried under vacuum then washed with water to remove the excess of salt and cytosine. 
The crude was purified by Column Chromatography (Silica gel, 5% Methanol in DCM) to give 55 
mg of a purple solid (37 %). 
 
 1H NMR (400 MHz, DMSO-d6) δ (ppm):  -2.76 (2 H, s, NH), 1.75 (12H, s, Ha), 2.58 (6 H, s, Hb), 
5.21 (4H, s, Hc), 5.82(2H, d, 3J = 7.3 Hz, He), 7.09 (2H,s, brd, NHcytosine) 7.19 (2H,s, brd, 
NHcytosine), 7.34 (4H, s, Hd), 7.66 (4H, d, 3J = 7.9 Hz, Hm), 7.96 (2H, d, 3J = 7.2 Hz, Hf), 8.19 
(4H, d, 3J = 7.9 Hz, Ho), 8.62 (4 H, d, 3J = 4.6 Hz, Hβ), 8.78 (4 H, d, 3J = 4.7 Hz, Hβ).  
13C NMR (126 MHz, DMSO-d6) δ (ppm): 21.12 (Cb), 21.27 (Ca), 51.48 (Cc), 93.99 (Ce), 113.49, 
117.84, 119.16, 126.01 (Cβ), 127.98 (Cm & Co), 134.45 (Cd), 137.11, 137.75, 137.83, 138.48, 
139.96, 140.50 (Cf), 156.17 (Ck), 166.24 (Cj). 
HRMS (ESI): m/z: [M+H]+ calculated = 945.4347, [M+H]+ found = 945.4354. 
UV-VIS (DMF, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)): 418 (190.49), 514 (9.50), 548 (4.87), 591 (3.21), 
647 (2.85).  
IR ѵ(cm-1): 3320.8, 1644.5, 1489.3, 1384.9, 1264.7, 1077.7, 787.3, 726.3, 606.2, 410.7. 
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29) 5,15-bis(N9-methylphenyl-2-amino-6-chloropurine)-10,20-dimesitylporphyrin 
(T8) 12 
 
Chemical Formula: C62H50Cl2N14 
                                                Molecular Weight: 1062.08 g/mol 
 
5,15-bis(4-(bromomethyl)phenyl)-10,20-dimesitylporphyrin (100 mg, 0.113 mmol, 1 eq) and 
excess of 2-amino-6-chloropurine (95.81 mg, 0.565 mmol, 5 eq) were dissolved in dry degassed 
DMF (15 mL). K2CO3 (46.85 mg, 0.339 mmol, 3 eq) was added to the suspension and stirred for 
24 hours at 50 oC. The reaction was followed by TLC and stopped when all starting porphyrin was 
consumed. The reaction was dried under vacuum then washed with water (5 mL) to remove the 
excess of 4-chloro-1-aminopurine and salt. The crude product was purified by Column 
Chromatography (Silica gel, 5% Methanol in DCM) to give two fractions F1 (96 mg) and F2 (ca. 
10 mg) of purple solids (80 % for F1, 8 % F2). 
For F1:  
1H NMR (500 MHz, CDCl3) δ (ppm):  -2.68 (2 H, s, NH), 1.81 (12H, s, Ha), 2.63 (6 H, s, Hb), 
5.21 (4H, s, NH2), 5.61 (4H, s, Hc), 7.28 (4H, s, Hd), 7.63 (4H, d, 
3J = 7.9 Hz, Hm), 8.05 (2H, s, 
He), 8.20 (4H, d, 3J = 8.0 Hz, Ho), 8.62 (4 H, d, 3J = 4.7 Hz, Hβ), 8.78 (4 H, d, 3J = 4.7 Hz, Hβ).  
13C NMR (126 MHz, CDCl3 + MeOD) δ (ppm): 21.63 (Cb), 21.77 (Ca), 47.31 (Cc), 118.39, 
118.72, 125.51 (Ci), 126.17 (Cβ1 & Cβ2), 127.92 (Cm& Co), 135.21 (Cd), 137.97, 138.37, 139.46, 
142.47 (Ce), 142.53, 151.80 (Cj), 154.23 (Ck), 159.44 (Cl). 
HRMS (ESI): m/z: [M+H]+calculated = 1061.3793, [M+H]+ found = 1061.3782. 
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UV-VIS (DMF, λmax (nm) (Ԑ x 10
3 (mol-1Lcm-1)): 418 (348.60), 514 (16.15), 548 (7.33), 591 
(5.07), 647 (4.43).  
IR ѵ(cm-1): 3458.8, 33313.1, 3073.9, 1699.9, 1628.7, 1559.1, 1518.0, 1469.1, 1407.6, 1391.8, 
1348.0, 1210.9, 1165.8, 1119.3, 991.9, 914.2, 819.2, 782.7, 755.9, 734.1, 638.8, 605.9, 528.4, 
496.2, 437.9. 
For F2: 
 
 
1H NMR (500 MHz, CDCl3) δ (ppm): -2.67 (2 H, s, NH), 1.82 (12H, s, Ha), 2.63 (6 H, s, Hb), 5.21 
(2H, s, NH2), 5.26 (2H, s, NH2
’
 ), 5.60 (2H, s, Hc), 5.88 (2H, s, Hc’), 7.28 (4H, s, Hd), 7.50 (2H, 
d, 3J = 7.9 Hz, Hm’), 7.63 (2H, d, 3J = 7.9 Hz, Hm), 8.05 (1H, s, He), 8.20 (4H, m, Ho+o’), 8.50 
(1H, s, He’), 8.69 ( 8 H, m, Hβ). 
13C NMR (126 MHz, CDCl3 + MeOD) δ (ppm): 21.62 (Cb), 21.76 (Ca), 47.30 (Cc), 50.74 (Cc’), 
116.82, 118.22, 118.42, 118.75, 125.51 (Ci), 125.147 (Cβ1), 126.16 (Cβ), 127.92 (Cm & Co), 
134.79-134.89 (Ci’), 135.20 (Cd), 137.96, 138.34, 139.45, 142.47 (Ce), 144.53, 144.08, 149.01 
(Ce’), 151.78 (Cj), 154.22 (Ck), 159.69 (Cl), 159.69 (Cj’) 164.58 (Ck’). 
MS (ESI): m/z: [M+H]+calculated = 1061.37, [M+H]+ found = 1061.38. 
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30) 5,15-bis(N9-methylphenylguanine)-10,20-dimesitylporphyrin (T9) 12 
  
Chemical Formula: C62H52N14O2 
                                                Molecular Weight: 1024.44 g/mol 
 
5,15-bis(N9-methylphenyl-2-amino-6-chloropurine)-10,20-dimesitylporphyrin (60 mg, 0.0565 
mmol, 1 eq) was dissolved in 20 mL of MeOH. 0.1 M of HCl aqueous solution was added to the 
mixture (4 mL, 0.4 mmol, 7 eq). Upon addition of HCl, the color of the solution changed from 
purple to green. The mixture was stirred overnight under reflux and the reaction was followed by 
TLC. When all starting material was consumed, 0.1 M NaOH solution was added drop wise to 
neutralize the solution (ca. 3 mL). The resulting purple precipitate was filtered, washed with water 
(10 mL) and acetone (10 mL) and dried under reduced pressure to give 56 mg of the final product 
(98 %).  
 
1H NMR (500 MHz, DMSO-d6) δ (ppm): -2.80 (2 H, s, NH porph), 1.74 (12H, s, Ha), 2.58(6 H, s, 
Hb), 5.55 (4H, s, Hc), 6.77 (4H, s, brd, NH2 guanine), 7.34 (4H, s, Hd), 7.62 (4H, d, 
3J = 7.8 Hz, 
Hm), 8.04 (2H, s, He), 8.21 (4H, d, 3J = 8.0 Hz, Ho), 8.63 ( 4H, d, 3J = 4.2 Hz, Hβ), 8.75 (4H, d, 
3J = 4.2 Hz, Hβ), 10.87 (2H, s, brd, NH Guanine). 
13 C NMR (126 MHz, d6-DMSO) δ (ppm): porphyrin is not soluble. 
13C NMR was dilute and could 
not be attributed. Even with 1,1,3,3-Hexafluoro-2-propanol-d2 (HFIP-d2) the 13C NMR was not 
clear.  
HRMS (ESI): m/z: [M+H]+ calculated = 1025.4478, [M+H]+ found = 1025.4489. 
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UV-VIS (DMF, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 418 (76.94), 514 (4.00), 548 (2.09), 591 (1.44), 
647 (1.34).  
IR ѵ(cm-1): 3113.9, 2923.1, 2852.0, 1682.8, 1606.8, 153.5, 1480.3, 1409.3, 1260.0, 1213.1, 
1167.7, 1093.7, 1017.1, 797.8, 757.1, 688.9, 477.9. 
 
31) 5,10,15,20-tetrakis[4-(bromomethyl)phenyl]porphyrin (Po4) 13 
                                               
Chemical Formula: C48H34Br4N4 
                                                                                    Molecular Weight: 986.95 g/mol 
 
Pyrrole (0.168g, 2.5 mmol, 0.17 mL, 1 eq) and 4-(bromomethyl)benzaldehyde (0.5g, 2.5 mmol, 1 
eq) were dissolved in 250 mL of degassed chloroform. A solution of BF3.Et2O (55.95 mg, 0.825 
mmol, 0.05mL, 1 eq) in 0.33 mL chloroform was added to the solution. The solution was stirred 
under argon at RT for 2 hours. Then Et3N (0.142 mL, 1.02 mmol, 0.4 eq) and p-chloranil (0.4616 
g, 1.88 mmol, 0.75 eq) were added to the mixture and heated under reflux at 65 oC for 1 hour. The 
mixture was evaporated under vacuum and then dissolved in DCM and filtered over a pad of Silica. 
The filtrate was dried under vacuum to give 0.6 g of a purple solid (70 %).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): -2.73 (2H, s, NH), 4.86 (8H, s, Ha), 7.78 (8 H, d, 
3J = 7.9 
Hz, Hm), 8.19 (8H, d, 3J = 7.9Hz, Ho), 8.84 (8H, s, Hβ).  
13C NMR (126 MHz, CDCl3) δ: 33.65 (Ca), 118.95(Cβ), 119.67, 127.62 (Cm), 135.06 (Co), 
137.51, 140.71, 142.32, 143.32.  
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HRMS (ESI): m/z(M+): [M+H]+ calculated = 985.9831, [M+H]+ found = 986.9532. 
UV-VIS (DMF, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 418 (263.32), 515(38.7), 550 (24.63), 593 
(6.75), 646 (6.43). 
 
32) 5,10,15,20-tetrakis(N1-methylphenylthymine)porphyrin (T10) 
                                                      
                                                                                                               Chemical Formula: C68H54N12O8 
                                                                                          Molecular Weight: 1167.26 g/mol 
  
5,10,15,20-tetrakis(4-(bromomethyl)phenyl)porphyrin (200 mg, 0.203 mmol, 1 eq), excess of 
thymine (255 mg, 2.03 mmol, 10 eq) and K2CO3 ( 141 mg, 1.02 mmol, 5 eq) were dissolved in 10 
mL of degassed DMF. The mixture was stirred overnight at 40 oC under argon. The reaction was 
followed by TLC. After the disappearance of the starting porphyrin, the reaction was dried under 
vacuum and then triturated with water (10 mL). The purple precipitate was filtered over a frit and 
washed with water (20 mL), then dried under vacuum to give 220 mg of a purple solid. (93 %) 
1H NMR (400 MHz, CDCl3) δ (ppm): -2.80 (2H, s, brd, NH), 1.88 (12H, s, Ha), 5.22 (8H, s, Hc), 
7.73 (8H, d, 3J = 7.7 Hz, Hm), 7.96 (4H, s, Hb), 8.22 (8H, d, 3J = 7.7 Hz, Ho), 8.84(8H, s, Hβ), 
11.50 (4H, s, brd, NHthymine). 
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13C NMR (126 MHz, DMF-d7) δ (ppm): 11.74 (Ca), 50.73 (Cc), 73.38, 108.32 (Ca’), 110.05 (Cβ), 
126.74 (Cm), 135.22 (Co), 137.57(Cb), 138.11, 141.79, 152.02 (Cd), 164.84 (Ce). 
HRMS (ESI): m/z(HRM+): [M+H]+ calculated = 1167.4260, [M+H]+ found = 1167.4257. 
UV-VIS (DMF, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 419 (231.96), 515(11.20), 550 (6.69), 593 
(4.42), 646 (4.08). 
IR ѵ(cm-1): 2925.5, 1661.0, 1382.2, 1349.1, 1212.8, 982.2, 966.1, 798.8, 558.6, 477.6, 411.8.  
 
33) 4-(N1-methylthymine)benzylaldehyde (T-Ald) 
 
Chemical Formula: C13H12N2O3 
Molecular Weight: 244.25 g/mol 
 
Thymine (507 mg, 4.0 mmol, 2 eq) and K2CO3 (414 mg, 3.0 mmol, 1.5 eq) were dissolved in 10 
mL of dry DMF under argon. In a separate flask, 4-(bromomethyl)benzaldehyde (400 mg, 2.0 
mmol, 1 eq) was dissolved in 10 mL of dry and degassed DMF and added dropwise to the mixture, 
after which the clear mixture was brought to 50 °C and left to stir for 12h. Then, the mixture was 
dried under vacuum and washed with a minimum amount of water (5 mL) to remove the excess of 
salt. The crude product was purified by column chromatography (silica gel, 1% Methanol in DCM 
then 3% MeOH in DCM) to give 278 mg of a white solid (57 %). 
1H NMR (500 MHz, DMSO-d6) δ (ppm): 1.76 (3H, s, Ha), 4.94 (2H, s, Hb), 7.48 (2H, d, 
3J = 8.0 
Hz, Hm), 7.66 (1H, s, Hc), 7.90 (2H, d, 3J = 8.0 Hz, Ho), 9.99 (1H, s, Hf), 11.39 (1H, s, 
NHthymine). 
Experimental Part 
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13C NMR (126 MHz, DMSO-d6) δ (ppm): 12.04 (Ca), 50.08 (Cb), 109.28 (Ca’), 127.88 (Cm), 
129.94 (Co), 135.52, 141.39 (Cc), 143.90, 151.07 (Cd), 164.35 (Ce), 192.81 (Cg). 
HRMS (ESI): m/z: [M+H]+ calculated = 245.0921, [M+H]+  found = 245.0926. 
 
34) 1,3,7,9-tetramethyl-5-(N1-methylphenylthymine)-dipyrrin (T-dipyrrin) (T11) 
 
Chemical Formula: C25H26N4O2 
Molecular Weight: 414.21 g/mol 
 
T-Ald (180 mg, 0.737 mmol, 1 eq) was dissolved in 5 mL of degassed DCM. The flask was 
protected from light and 2,4-dimethylpyrrole (0.152 mL, 1.47 mmol, 2 eq) was added. 
Subsequently,  two drops of TFA were added, and the reaction mixture was stirred at RT for 12h 
under argon and protected from light. When the disappearance of the aldehyde was confirmed by 
TLC, the reaction was stopped and the mixture dried under vacuum. The crude product was 
dissolved in 5 mL of dry THF. In a separate flask, DDQ (152 mg, 0.668 mmol, 0.9 eq) was 
dissolved in 5 mL of dry THF and added drop wise to the reaction mixture. The mixture was stirred 
overnight and followed by TLC. When all the dipyrromethane was oxidized, the reaction was 
stopped, the solvent was evaporated and the product purified by column chromatography (silica 
gel, 1% 7N ammonia in MeOH in DCM) to give 160 mg of pure T-dipyrrin (T11) as brown red 
solid (53 %).   
 
1H NMR (500 MHz, CDCl3) δ (ppm): 1.26 (6H, s, H3), 1.88 (3H, d, 
4J = 1.1 Hz, Ha), 2.34 (6H, s, 
H1), 4.97 (2H, s, Hb), 5.89 (2H, s, H2), 6.95 (1H, q, 4J = 1.1 Hz, Hc), 7.33-7.36 (4H, m, Hm & 
Ho). 
Experimental Part 
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13C NMR (126 MHz, CDCl3) δ (ppm): 12.55 (C3),
 14.72 (Ca), 16.19 (C1), 50.76 (Cb), 111.48 
(Ca’), 119.86 (C2), 128.40 (Cm), 130.20 (Co), 135.52, 136.25, 137.73, 138.50, 139.50 (Cc), 
140.12, 151.19 (Cd), 152.01, 164.06 (Ce). 
HRMS (ESI): m/z(M+): [M+H]+ calculated = 415.2129, [M+H]+ found = 415.2102. 
UV-VIS (CHCl3, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)): 272 (13.33), 307 (6.78), 447 (5.91). 
IR ѵ(cm-1): 2925.9, 1681.9, 1575.5, 1536.6, 1435.2, 1348.5, 1281.9, 1100.4, 942.4, 805.8, 712.8, 
556.6, 473.1. 
 
35) Zn(II)[1,3,7,9-tetramethyl-5-(N1-methylphenylthymine)-dipyrrin]  
(Zn-T-dipyrrin) 
 
Chemical Formula: C50H50N8O4Zn 
Molecular Weight: 890.32g/mol 
 
T-dipyrrin (30 mg, 0.077 mmol, 1 eq) was dissolved in a 15 mL of a mixture of CHCl3/MeOH 
(70/30). In a separate flask, Zn(OAc)2.2H2O (22 mg, 0.100 mmol, 1.3 eq) was dissolved in 5 mL 
of MeOH. The zinc solution was added to the reaction mixture that was left to stir for 12h. The 
solvent was evaporated and the crude was washed with water (10 mL) and subsequently dried over 
MgSO4, to afford 60 mg of Zn-T-dipyrrin as a yellow solid (87 %).  
1H NMR (400 MHz, Methanol-d4) δ (ppm): 1.24 (24H ,s, H3), 1.86 (6H d, 
4J = 1.1 Hz, Ha), 2.34 
(6H, s, H1), 4.26 (24H, s, H1), 4.96 (4H s, Hb) 7.33-7.30 (2H d, 4J = 1.1 Hz, Hc), 7.39 (4H d, 3J 
= 8.3 Hz, Hm), 7.58 (4H d, 3J = 8.2 Hz, Ho). 
Experimental Part 
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13C NMR (126 MHz, DMSO-d6) δ (ppm): 13.81 (C3),
 14.73 (Ca), 17.24 (C1), 53.30 (Cb), 110.57 
(Ca’), 115.67 (C2), 127.34 (Cm), 129.60 (Co), 136.87, 136.95, 137.87, 138.50, 139.25 (Cc), 
141.10, 150.80 (Cd), 152.01, 164.36 (Ce). 
UV-VIS (CHCl3, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)):  267 (17.32), 355 (6.75), 491 (3.10). 
 
36) 4-(N9-methylphenyladenine)benzylaldehyde  (A-Ald) 
  
Chemical Formula: C13H11N5O 
Molecular Weight: 253.27 g/mol 
 
Adenine (407 mg, 3.01 mmol, 2 eq) and K2CO3 (312.4 mg, 2.26 mmol, 1.5 eq) were added to 5 
mL of dry degassed DMF. To the suspension, a 4-(bromomethyl)benzaldehyde solution (300 mg, 
1.57 mmol, 1 eq) in 10 mL of dry DMF was added drop wise. The reaction mixture was stirred 
under argon at 50 °C overnight and followed by TLC. When all the aldehyde was consumed, the 
mixture was dried under vacuum and purified by column chromatography (silica gel, 3% MeOH 
in DCM) to give 170 mg of A-Ald as a white solid (45 %). 
 
1H NMR (500 MHz, CDCl3 + MeOD-d4) δ (ppm): 5.52 (s, 2H, Ha), 7.46 (2H, d, 
3J = 8.2 Hz, Hm), 
7.87 (2H, d, 3J = 8.2 Hz, Ho), 8.13 (1H, s, Hb), 8.22 (1H, s, Hc), 9.95 (1H, s, Hh).  
13C NMR (126 MHz, CDCl3 + MeOD-d4) δ (ppm): 46.96 (Ca), 118.9 (Cd), 128.16 (Cm), 130.53 
(Co), 136.25, 140.27 (Cb), 142.03, 149.71 (Ce), 153.12 (Cc), 155.58 (Cf), 191.95 (Cg). 
HRMS (ESI): m/z (H+): [M+H]+ calculated = 254.10 [M+H]+ found = 254.10.  
 
Experimental Part 
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37) 1,3,7,9-tetramethyl-5-(N9-methylphenyladenine)-dipyrrin (A-dipyrrin) (T12) 
 
Chemical Formula: C25H25N7 
Molecular Weight: 423.52 g/mol 
 
A-Ald (160 mg, 0.632 mmol, 1 eq) was dissolved in 5 mL of degassed DCM protected from light, 
then 2,4-dimethylpyrrole (0.130 mL, 1.26 mmol, 2 eq) was added followed by two drops of TFA. 
The reaction mixture was stirred at RT overnight. The disappearance of the aldehyde was 
confirmed by TLC. When all the starting material was consumed, the reaction was stopped and 
the mixture was dried under vacuum protected from light. Then the mixture was dissolved in 5 mL 
of dry THF and a solution of DDQ (0.9 eq., 129 mg, 0.569 mmol) in 5 mL of dry THF was added. 
The mixture was stirred at RT and followed by TLC. After 24 hours, the reaction was stopped and 
purified by column chromatography (silica gel, 1% 7N ammonia and 2 % MeOH  in DCM, then 
1% 7N ammonia and 5 % MeOH in DCM) to give 70 mg A-dipyrrin (T12) as a brown/orange 
solid (26 %). 
1H NMR (500 MHz, CDCl3) δ (ppm): 1.25 (6H, s, H3), 2.33 (6H, s, H1), 5.44 (2H, s, Ha), 5.88 
(2H, s, brd, NH2 adenine), 5.90 (2H, s, H2), 7.41-7.27 (4H, m, Hm & Ho), 7.75 (1H, s, Hb), 8.39 (1H, 
s, Hc). 
13C NMR (126 MHz, CDCl3) δ (ppm): 14.76 (C3), 16.14 (C1), 47.21 (Ca), 119.62 (C2), 119.87 
(Cd), 128.20 (Cm), 129.25, 130.23 (Co), 135.72, 136.22, 138.52, 140.24, 140.34 (Cb), 150.40 
(Ce), 151.99, 153.40 (Cc), 155.60 (Cf). 
Experimental Part 
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HRMS (ESI): m/z(H+) : [M+H]+calculated = 424.2244, [M+H]+ found = 424.2258. 
UV-VIS (4% MeOH in CHCl3, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)) : 269 (91.23), 312 (18.7), 460 
(9.2). 
IR ѵ(cm-1): 3146.5, 2923.9, 2850.8, 1645.6, 1597.6, 1574.5, 1533.7, 1513.2, 1414.7, 1387.6, 
1279.1, 1213.8, 1151.2, 1097.9, 941.2, 798.0, 712.8, 644.6, 588.1, 492.6. 
 
38) 4-(N1-methylcytosine)benzylaldehyde  (C-Ald) 
 
Chemical Formula: C12H11N3O2 
Molecular Weight: 229.24 g/mol 
 
Cytosine (446 mg, 4.02 mmol, 2 eq) was suspended in 15 mL of dry DMF under argon. NaH (72 
mg, 3.01 mmol, 1.5 eq) was added to the suspension, which was stirred for 30 min. A solution of 
4-(bromomethyl)benzaldehyde (400 mg, 2.01 mmol, 1 eq) in 5 mL of dry DMF was added 
dropwise to the reaction mixture, and  it was left to stir for 12h at 40 °C. The disappearance of the 
aldehyde was followed by TLC. When all the aldehyde was consumed, the mixture was dried 
under vacuum and purified by column chromatography (silica gel, 3% MeOH in DCM) to give 
207 mg of C-Ald as a white solid (45 %).   
 
1H NMR (500 MHz, DMSO-d6) δ (ppm): 4.94 (2H, s, Ha), 5.69 (1H, d, 
3J = 7.2 Hz, Hc), 7.12 (1H, 
s, brd, NH cytosine), 7.18 (1H, s, brd, NH cytosine), 7.43 (2H, d, 3J = 8.0 Hz, Hm), 7.73 (1H, d, 
3J = 7.2 Hz, Hb), 7.88 (2H, d, 3J = 8.1 Hz, Ho), 9.98 (1H, s, Hf).  
13C NMR (126 MHz, DMSO-d6) δ (ppm): 51.41 (Ca), 93.93 (Cc), 127.91 (Cm), 129.86 (Co), 
135.31 (Cp), 145.09 (Cp’), 146.23 (Cd), 155.85 (Ce), 166.17 (Cf), 192.90 (Cg).  
Experimental Part 
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HRMS (ESI): m/z (H+): [M+H]+ calculated = 230.0924, [M+H]+ found = 230.0935. 
 
39) 1,3,7,9-tetramethyl-5-(N1-methylphenylcytosine)-dipyrrin (C-dipyrrin) (T13) 
 
Chemical Formula: C24H25N5O 
Molecular Weight: 399.50 g/mol 
 
C-Ald (200 mg, 0.872 mmol, 1 eq) and 2,4-dimethylpyrrole (0.180 mL, 1.74 mmol, 2 eq) were 
dissolved in 5 mL of degassed DCM protected from light, then two drops of TFA were added to 
the suspension. The reaction mixture was stirred at RT overnight and followed by TLC. When all 
starting material was consumed, the reaction was stopped and the mixture dried under vacuum 
protected from light. The crude was dissolved in 5 mL of dry THF and a solution of DDQ (179 
mg, 0.785 mmol, 0.9 eq) in 5 mL of dry THF was added to the reaction mixture. The mixture was 
stirred at RT and followed by TLC. After 24 hours, the reaction was stopped and purified by 
column chromatography (silica gel, 5% 7N ammonia and 5 % MeOH in DCM) to give 70 mg of 
C-dipyrrin (T13) as a brown-red solid (20 %). 
 
1H NMR (300 MHz, DMSO-d6) δ (ppm): 1.23 (6H, s, H3), 2.29 (6H, s, H1), 4.94 (2H, s, Ha), 5.69 
(1H, d, 3J = 7.2 Hz, Hb), 5.97 (2H, s, H2), 7.02 (1H, s, brd, NH cytosine), 7.10 (1H, s, brd, NH 
cytosine), 7.24 (2H, d, 3J = 7.9 Hz, Hm), 7.37 (2H, d, 3J = 7.9 Hz, Ho), 7.69 (1H, d, 3J = 7.2 Hz, 
Hc). 
Experimental Part 
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13C NMR (500 MHz, CDCl3 + MeOD-d4) δ (ppm): 14.20 (C3), 17.00 (C1), 51.45 (Ca), 94.98 (Cb), 
119.87 (C2), 126.95 (Cm), 127.53 (Co), 128.20, 132.64, 135.42, 142.88, 144.87, 145.41 (Cc), 
152.83, 157.12 (Cd), 166.09 (Ce). 
HRMS (ESI): m/z (H+): [M+H]+calculated = 400.2129,  [M+H]+ found = 400.2130. 
UV-VIS (4% MeOH in CHCl3, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)): 280(22.02). 340 (12.66), 505(9.8). 
IR ѵ(cm-1): 3175.8, 1644.0, 1488.6, 1434.7, 1384.6, 1286.5, 1138.3, 962.6, 798.4, 691.9, 610.3. 
 
40) 4-(N9-methyl-2-amino-6-chloropurine)benzylaldehyde  (P-Ald) 
 
Chemical Formula: C13H10N5ClO 
Molecular Weight: 287.71 g/mol 
 
2-amino-6-chloropurine (1 g, 6.03 mmol, 2 eq) and K2CO3 (624 mg, 4.52 mmol, 1.5 eq) were 
dissolved in 15 mL of dry degassed DMF. A solution of 4-(bromomethyl)benzaldehyde (600 mg, 
3.014 mmol, 1 eq) in 5 mL of dry DMF was added dropwise, and the mixture was left to stir for 
12h at 50 °C. The reaction was followed by TLC. When all the aldehyde was consumed, the 
mixture was dried under vacuum and purified by column chromatography (silica gel, 2% MeOH 
in DCM) to yield 380 mg of P-Ald as a white solid (43 %). 
 
1H NMR (400 MHz, MeOD-d4) δ (ppm): 5.43 (2H, s, Ha), 7.50 (2H, d, 
3J = 8.0 Hz, Hm), 7.89 
(2H, d, 3J = 8.0 Hz, Ho), 8.11 (1H, s, Hb), 9.96 (1H, s, Hh). 
Experimental Part 
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13C NMR (126 MHz, DMSO-d6) δ (ppm): 45.60 (Ca), 116.59 (Cc), 127.49 (Cm), 129.65 (Co), 
135.46, 137.52 (Cb), 144.02, 149.71 (Cd), 153.12 (Ce), 156.85 (Cf), 192.73 (Cg). 
HRMS (ESI): m/z (H+):  [M+H]+ calculated = 288.0647, [M+H]+ found = 288.0650. 
 
41) 1,3,7,9-tetramethyl-5-(N9-methylphenyl-2-amino-6-chloropurine)dipyrrin  
(P-dipyrrin) (T14) 
 
Chemical Formula: C25H24N7Cl 
Molecular Weight: 457.97 g/mol 
 
P-Ald (300 mg, 1.04 mmol, 1 eq) and 2,4-dimethylpyrrole (0.213 mL, 2.07 mmol, 2 eq) were 
dissolved in 5 mL of degassed DCM protected from light, then two drops of TFA were added to 
the mixture. The reaction mixture was stirred at RT overnight and followed by TLC. When all 
starting materials were consumed, the reaction was stopped and the mixture dried under vacuum, 
protected from light. The crude was dissolved in 5 mL of dry THF. A solution of DDQ (222 mg, 
0.931 mmol, 0.9 eq) in 5 mL of dry DMF was added to the reaction mixture and stirred at RT. 
After 24 hours, the reaction was stopped and purified by column chromatography (silica gel, 1% 
7N ammonia and 1% MeOH in DCM) to give 105 mg of P-dipyrrin (T14) as a brown/yellow 
solid (33 %). 
 
1H NMR (500 MHz, CDCl3) δ (ppm): 1.25 (6H, s, H3), 2.33 (6H, s, H1), 5.17 (2H, s, brd, NH2), 
5.31 (2H, s, Ha), 5.87 (s, 2H, H2), 7.36-7.29 (m, 4H, Hm & Ho), 7.70 (s, 1H, Hb)  
Experimental Part 
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13C NMR (500 MHz, CDCl3) δ (ppm): 14.72 (C3), 16.16 (C1), 47.19 (Ca), 119.88 (C2), 125.31 
(Cc) , 128.28 (Cm), 130.25 (Co), 135.16, 136.27, 137.59, 138.70, 140.08, 141.85 (Cb), 151.59, 
151.59, 154.01 (Ce), 159.32 (Cf). 
HRMS (ESI): m/z (H+):  [M+H]+ calculated = 458.1854, [M+H]+ found = 458.1853. 
UV-VIS (4% MeOH in CHCl3, λmax(nm) (Ԑ x 10
3 (mol-1Lcm-1)): 280(19.37). 360 (12.55), 504(5.8). 
IR ѵ(cm-1): 3322.2, 2924.5, 1609.2 (C=N stretching), 1561.4, 1514.3, 1462.6, 1406.3, 1368.9, 
1281.6, 1216.3, 1139.2, 1099.1, 998.3, 942.2, 807.8, 911.5, 785.2, 720.7, 696.1, 644.1, 606.1, 
460.0. 
 
42) 1,3,7,9-tetramethyl-5-(N9-methylphenylguanine)dipyrrin (G-dipyrrin) (T15) 
 
Chemical Formula: C25H25N7O 
Molecular Weight: 439.52 g/mol 
 
P-dipyrrin (30 mg, 0.0655 mmol, 1 eq) was dissolved in 15 mL of MeOH, and 10 mL of 0.1 M 
HCl (aq) was added to the solution. The reaction mixture was brought to reflux and left to stir. 
After 12 hours, 0.1 M NaOH (aq) solution was added drop wise to the reaction mixture until 
precipitate started to form. The pH was then checked and the NaOH (aq) addition process was 
continued until a neutral pH was reached (ca. 10 mL of 0.1M  NaOH (aq)). The mixture was 
filtered and the precipitate was collected, washed with 5 mL of water and then dried under vacuum 
to give 23 mg of G-dipyrrin (T15) as a low soluble bright red solid (80 %). 
HRMS (ESI): m/z (H+):  [M+H]+ calculated = 440.2193, [M+H]+ found = 440.2203. 
Experimental Part 
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IR ѵ(cm-1): 2924.7, 1682,7 (C=O stretching), 1586.6, 1507.5, 1439.3, 1349.7, 1269.9, 1137.8, 
1034.8, 957.1, 807.7, 740.4, 680.6, 484.3. 
 
43) 4-(N1-methylthymine)pyridine (T-Py) (T16)14 
                                                        
  Chemical Formula: C11H11N3O2 
                                                   Molecular Weight: 217 g/mol 
 
Thymine (0.75 g, 5.94 mmol, 3 eq), K2CO3 (0.68 g, 4.95 mmol, 2.5 eq) and KI (10 mg, catalytic 
amount) were mixed in 17 mL of dry degassed DMF. The suspension was degassed for 15 minutes. 
A solution of 4-(bromomethyl)pyridine (0.5 g, 1.98 mmol, 1 eq) in 4 mL of dry degassed DMF 
was added slowly to the suspension. The reaction was stirred at 40 oC overnight and followed by 
TLC. The crude was dried under vacuum and then washed with a minimum amount of water (7 
mL). The product was purified by column chromatography (SiO2, MeOH: Et3N: DCM 1:0.2:20) 
to yield 190 mg of T-Py as a white solid (45 %).   
 
1H NMR (500 MHz, CDCl3) δ (ppm):  1.92 (3H, d, 
4J = 1.1 Hz, Ha), 4.90 (2H, s, Hb), 6.96 (1H, 
q, 4J = 1.1 Hz, Hc), 7.19 (2H, d, 3J = 6.0 Hz, H3), 8.62 (2H, d, 3J = 6.0 Hz, H2). 
13C NMR (126 MHz, CDCl3) δ:  12.74 (Ca), 50.41 (Cb), 112.26 (Ca’), 122.47 (C3), 144.66 (Cc), 
150.86 (C4), 151.16 (C2), 151.16 (Cd), 163.97 (Ce). 
HRMS (ESI): m/z(H+):  [M+H]+ calculated =  218.0924, [M+H]+ found = 218.0926.  
IR ѵ(cm-1): 2996.5, 2927.8, 2748.2, 2680.7, 1600.6, 1444.9, 14717.5, 1382.3, 1345.8, 1314.9, 
1226.6, 1214.9, 1065.2, 1006.6, 912.7, 799.5, 764.9, 540.1, 483.4, 465.9, 408.4. 
 
 
Experimental Part 
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44) 4-(1N9-methyladenine)pyridine (A-Py) (T17)14  
                                                             
  Chemical Formula: C11H10N6 
                                                  Molecular Weight: 226.24 g/mol 
 
Adenine (0.39 g, 2.92 mmol, 2 eq), K2CO3 (0.51 g, 3.7 mmol, 2.5 eq) and KI (10 mg, catalytic 
amount) were mixed in 10 mL of dry degassed DMF. The suspension was degassed for 15 minutes. 
A solution of 4-(bromomethyl)pyridine (0.37 g, 1.46 mmol, 1 eq) in 2 mL of dry degassed DMF 
was added slowly to the suspension. The reaction mixture was stirred at 40 oC overnight and 
followed by TLC. The crude was dried under vacuum, and then washed with a minimum amount 
of water (7 mL). The product was purified by column chromatography (SiO2, MeOH: Et3N: DCM 
1:0.2:20) to give 177 mg of A-Py as a white solid (53 %). 
  
1H NMR (500 MHz, DMSO-d6) δ (ppm):  5.43 (2H, s, Ha), 7.18 (2H, d,
 3J = 6.0 Hz, H3), 7.30 
(2H, s, brd, NH2 adenine), 8.12 (1H, s, Hb), 8.28 (1H, s, Hc), 8.51 (2H, d, 
3J = 6.0 Hz, H2). 
13C NMR (126 MHz, DMSO-d6) δ: 45.14 (Ca), 118.67 (Cd), 122.05 (C3), 140.98 (Cb), 145.92 
(Ce), 149.53 (C4), 149.96 (C2), 152.79 (Cc), 156.08 (Cf). 
HRMS (ESI): m/z (H+): [M+H]+ calculated = 227.1040, [M+H]+ found = 227.1025. 
IR ѵ(cm-1): 3309.0, 3086.8, 1647.0, 1571.6, 1596.0, 1484.8, 1415.5, 1389.0, 1356.1, 1326.5, 
1246.5,  1155.32,1069.9, 1006.3, 970.5, 877.8, 796.0, 772.7, 726.0, 649.7, 852.7, 542.4, 464.8. 
 
 
 
Experimental Part 
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45) 4-(N1-methylcytosine)pyridine (C-Py) (T18)15 
                                                             
   Chemical Formula: C10H10N6O 
                                                   Molecular Weight: 202.22 g/mol 
 
Cytosine (0.65 g, 5.93 mmol, 3 eq) and KI (10 mg, catalytic amount) were mixed in 10 mL of dry 
DMF and degassed for 15 minutes. To the suspension, NaH (0.118 g, 4.9 mmol, 2.5 eq) was added 
and stirred for 30 minutes. A solution of 4-(bromomethyl)pyridine (0.5g, 1.97 mmol, 1 eq) in 2 
mL of dry degassed DMF was added slowly to the mixture. The reaction mixture was stirred at 40 
oC overnight and followed by TLC. The crude was dried under vacuum, and then washed with a 
minimum amount of water (10 mL). The product was purified by column chromatography (silica 
gel, MeOH: Et3N: DCM 1:0.2:20) to yield 120 mg of C-Py as a white solid (30 %).   
 
1H NMR (500 MHZ, DMSO-d6) δ (ppm): 4.87 (2H, s, Ha), 5.73 (1H, d, 
3J = 7.2 Hz, Hb), 7.08 
(1H, s, brd, NH cytosine) 7.17 ( 2H, d, 3J = 6.0 Hz, H3), 7.21 (1H, s, brd, NH cytosine), 7.69 (1H, 
d, 3J = 7.2 Hz, Hc), 8.50 (2H, d, 3J = 6.0 Hz, H2).  
13C NMR (126 MHZ, DMSO-d6) δ (ppm): 50.61 (Ca), 93.90 (Cb), 122.01 (C3), 146.12 (Cc), 
146.97 (C4), 149.67 (C2), 155.73 (Cd), 166.15 (Ce). 
HRMS (ESI): m/z (H+): [M+H]+ calculated = 203.0927, [M+H]+ found = 203.0934. 
IR ѵ(cm-1): 3337.2, 3115.4, 1652.0, 1597.7, 1486.1, 1423.2, 1384.4, 1369.7, 1278.9, 1208.1, 
1130.3, 965.3, 815.9, 781.6, 704.4, 682.8, 567.6, 521.4, 474.6, 405.4.  
 
 
 
Experimental Part 
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46) 4-(N9-methyl-2-amino-6-chloropurine)pyridine (P-Py) (T19)15  
 
Chemical Formula: C11H9N6Cl 
                                                Molecular Weight: 260.69 g/mol 
 
2-amino-6-chloropurine (0.8 g, 4.74 mmol, 2 eq), K2CO3 (0.81 g, 5.90 mmol, 2.5 eq) and KI (10 
mg, catalytic amount) were mixed in 10 mL of dry degassed DMF. The suspension was degassed 
for 15 minutes.  A solution of 4-(bromomethyl)pyridine (0.6 g, 2.37 mmol, 1 eq)  in 2 mL of dry 
degassed DMF was added slowly to the suspension. The reaction mixture was stirred at 40 oC 
overnight and followed by TLC. The crude was dried under vacuum and then washed with a 
minimum amount of water (10 mL). The product was purified by column chromatography (silica 
gel, MeOH: Et3N: DCM 1:0.2:20) to give 185 mg of P-Py a white pure solid (30 %).  
 
1H NMR (400 MHz, DMSO-d6) δ (ppm):  5.36 (2H, s, Ha), 6.92 (2H, s, brd, NH2 purine), 7.18 
(2H, d, 3J = 5.9 Hz, H3), 8.24 (1H, s, Hb), 8.51 (2H, d, 3J = 6.0 Hz, H2). 
13C NMR (126 MHz, CDCl3) δ: 45.97 (Ca), 121.93 (C3), 125.13 (Cd), 141.94 (Ce), 144.17(C4), 
150.64 (C2), 151.88 (Cc), 153.93 (Ce), 159.46 (Cf). 
MS (ESI): m/z (M+): [M+H]+ calculated = 261.06, [M+H]
+
 found = 261.07. 
IR ѵ(cm-1): 3314.9, 3196.5, 2920.7, 1613.8, 1563.8, 1524.5, 1408.7, 1282.4, 1176.0, 1024.2, 
999.6, 913.6, 761.9, 720.1. 
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47) 4-(N9-methylguanine)pyridine (G-Py) (T20) 15  
 
Chemical Formula: C11H10N6O 
                                                Molecular Weight: 242.24 g/mol 
 
P-Py (100 mg, 0.384 mmol, 1 eq) was dissolved in 20 mL of 0.1 M HCl aqueous solution. The 
reaction was stirred under reflux and followed by TLC. The reaction was left to stir for 5 hours 
until all 2-amino-6-chloropurine was oxidized into guanine. Then, 0.1 M NaOH solution was 
added dropwise to neutralize the solution (ca. 5 mL). The white precipitate was then filtered, 
washed with water (10 mL) and acetone (10 mL) and dried under reduced pressure to give 89 mg 
of G-Py as a white solid (96 %). 
 
1H NMR (500 MHz, DMSO-d6) δ (ppm):  5.24 (2H, s, Ha), 6.74 (2H, s, brd, NH2 guanine), 7.11 
(2H, d, 3J = 5.6 Hz, H2), 7.79 (1H, s, Hb), 8.51 (2H, d, 3J = 5.6 Hz, H3), 10.94 (1H, s, brd, NH 
guanine). 
13C NMR (126 MHz, DMSO-d6) δ: 44.79 (Ca), 116.59 (Cc), 121.66 (C3), 137.48 (Cb), 146.24 
(C4), 149.93 (C3), 151.33 (Cd), 154.23 (Ce), 157.05 (Cf). 
HRMS: m/z(M+): [M+H]+ calculated = 243.0989, [M+H]+ found = 243.0991. 
IR ѵ(cm-1): 3314.4, 1672.9, 1552.1, 1478.5, 1416.5, 1389.6, 1260.5, 1214.5, 1100.8, 775.9, 536.1.  
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48) 4’-(4-bromomethylphenyl)-2,2’:6’,2”-terpyridine (Br-terPy)16  
   
     Chemical Formula: C22H16BrN3 
        Molecular Weight: 402.30 g/mol 
 
4’-p-tolyl-2,2’:6’,2”-terpyridine (0.5g, 1.55 mmol, 1 eq) and NBS (0.33g, 1.86  mmol, 1.2 eq) were 
dissolved in 24 mL of benzene. The reaction mixture was stirred for 3 hours under reflux and argon 
while illuminated by a 120 Watts lamp. The crude was evaporated under vacuum, diluted with 50 
mL of DCM and then extracted twice with 50 mL of water. The organic phase was dried with 
MgSO4, filtered and then evaporated under vacuum. The product was further washed with acetone 
to give 0.37 g of a white solid (60 %).   
 
1H NMR (400 MHz, CDCl3) δ (ppm): 4.27 (2H, s, Ha), 7.36 (2H, ddd, 
3J = 7.4 Hz, 7.4 Hz, 4J = 
1.1 Hz, H5), 7.53 (2H, d, 3J = 7.2 Hz, Hm), 7.88 (4H, m, Ho & H4), 8.66 (2H, d, 3J = 7.4 Hz, H6), 
8.74 (4H, m, H3 & H3’). 
 
 
 
 
 
 
Experimental Part 
 
239 
 
49) 4’-( N1-methylphenylthymine)-2,2’:6’,2”-terpyridine (T-terPy) (T21)14 
 
Chemical Formula: C27H21N5O2 
Molecular Weight: 447.50 g/mol 
 
Br-terPy (136 mg, 0.34 mmol, 1 eq), thymine (127 mg, 1.014 mmol, 3 eq) and K2CO3 (70.5 mg, 
0.5 mmol, 1.5 eq) were mixed in 5 mL of dry DMF. The suspension was degassed for 15 minutes 
and stirred at 40 oC overnight. The crude was dried under vacuum and then diluted with 50 mL of 
DCM and extracted twice by 25 mL of water. The organic phase was dried over MgSO4 then 
filtered and dried under vacuum. The product was purified by column chromatography (Al2O3, 2% 
MeOH in DCM) to yield  60 mg of T-terPy as a white solid (40 %). 
 
1H NMR (500 MHz, CDCl3) δ (ppm): 1.91 (3H, d, 
4J = 1.1 Hz, Ha), 4.97 (2H, s, Hb), 7.01 (1H, q, 
4J = 1.1 Hz, Hc), 7.36 (2H, ddd, 3J = 7.4 Hz, 7.4 Hz, 4J = 1.1 Hz, H5), 7.44 (2H, d, 3J = 8.2 Hz, 
Hm), 7.88 (2H, m, H4), 7.91 (2H, d, 3J = 8.2 Hz, Ho), 8.28 (1H, s, brd, NH thymine), 8.67 (2H, d, 
3J = 7.4 Hz, H6), 8.72(4H, m, H3 & H3’).  
 
 13C NMR (126 MHZ, CDCl3) δ(ppm): 12.57 (Ca), 50.81 (Cb), 111.55 (Ca’), 118.98 (C3’), 121.52 
(C3), 124.08 (C5), 128.28 (Cm), 128.73 (Co), 137.07 (C4), 139.06, 139.72 (Cc), 149.30 (C6), 
149.60, 151.01 (Cd), 156.20,  156.22, 163.76 (Ce). 
HRMS: m/z(M+): [M+H]+ calculated = 448.1752, [M+H]+ found = 448.1759. 
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IR ѵ(cm-1): 2924.3, 2850.7, 1703.3, 1666.7, 1583.8, 1565.3, 1455.9, 1343.9, 1323.6, 1130.7, 
1036.6, 1004.9, 936.0, 907.6, 732.5, 706.6, 602.0, 553.5, 404.3. 
50) 4’-(N9-methylphenyladenine)-2,2’:6’,2”-terpyridine (A-terPy) (T22)14 
 
Chemical Formula: C27H20N8 
Molecular Weight: 456.51 g/mol 
 
Br-terPy (140 mg, 0.348 mmol, 1 eq), adenine (94.5 mg, 0.70 mmol, 2 eq) and K2CO3 (72 mg, 
0.522 mmol, 1.5 eq) were mixed in 5 mL of dry DMF. The suspension was degassed for 15 minutes 
and stirred at 40 oC overnight. The crude was dried under vacuum and then diluted with 50 mL of 
DCM and extracted twice with 25 mL of water. The organic phase was dried over MgSO4 then 
filtered and dried under vacuum. The product was purified by column chromatography (Al2O3, 2% 
MeOH in DCM) to yield 86 mg of A-terPy as a white solid (54 %).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): 5.46 (2H, s, Ha), 5.60 (2H, s, brd, NH2), 7.36 (2H, ddd, 
3J 
= 7.8 Hz, 7.5 Hz, 4J = 1.1 Hz, H5), 7.44 (2H, d, 3J = 8.2 Hz , Hm), 7.83 (1H, s, Hb), 7.89 (4H, m, 
Ho & H4), 8.43 (1H, s, Hc), 8.67 (2H, d, 3J = 7.9 Hz, H6), 8.72 (4H, m, H3 & H3’). 
13C NMR (126 MHz, CDCl3) δ(ppm): 47.12 (Ca), 118.95 (C3’), 119.73 (Cd), 121.50 (C3), 124.06 
(C5), 128.21 (Cm), 128.51 (Co), 136.40, 137.05 (C4), 137.05, 140.52 (Cb), 149.29 (C6), 149.57 
(Ce), 150.44, 153.49 (Cc), 155.55 (Cf), 156.18, 156.23. 
HRMS: m/z (M+): [M+H]+ calculated  = 457.1884, [M+H] + found = 457.1900. 
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IR ѵ(cm-1): 3092.3, 1649.3, 1600.4, 1584.8, 1567.7, 1479.3, 1467.6, 1438.4, 1410.1, 1390.2, 
1353.0, 1323.6, 1302.4, 1245.6, 1114.9, 1077.9, 1039.4, 787.4, 770.0, 732.4, 688.7, 614.81, 551.6, 
499.7. 
 
51) 4’-(N1-methylphenylcytosine)-2,2’:6’,2”-terpyridine (C-terPy) (T23)15  
                                        
 
Chemical Formula: C26H20N6O 
Molecular Weight: 432.49 g/mol 
 
Cytosine (329 mg, 2.97 mmol, 3 eq) and NaH (35 mg, 1.48   mmol, 1.5 eq) were dissolved in 10 
mL of dry DMF, then degassed for 15 minutes. To the suspension, a solution of Br-terPy (400 
mg, 0.99 mmol, 1 eq) in 2 ml of dry DMF was added drop wise. The reaction was stirred at 40 oC 
overnight and followed by TLC. After the disappearance of Br-terPy, the mixture was dried under 
vacuum and then diluted with 50 mL DCM and extracted twice with 25 mL of water. The organic 
phase was dried over MgSO4 then filtered and dried under vacuum. The product was purified by 
column chromatography (Al2O3, 2% MeOH in DCM) resulting in 330 mg of C-terPy as a white 
solid (79 %). 
1H NMR (400 MHz, DMSO-d6) δ (ppm): 4.96 (2 H, s, Ha), 5.71 (1 H, d, 
3J = 7.2 Hz, Hb), 7.03 
(1H, s, brd, NH cytosine), 7.10 (1H, s, brd, NH cytosine), 7.48 (2 H, d, 
3J = 8.1 Hz, Hm), 7.53 (2 
H, ddd, 3J = 7.2 Hz, 7.3 Hz, 4J = 1.2 Hz, H5), 7.75 (1 H, d, 3J = 7.2 Hz, Hc), 7.92 (2 H, d, 3J = 8.1 
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Hz, Ho), 8.04 (2 H, ddd, 3J = 7.9 Hz, 7.8 Hz, 4J = 1.2 Hz,  H4), 8.66 ( 2H, d, 3J = 8.0 Hz, H6), 8.72 
(4H, m, H3 & H3’).   
13C NMR (126 MHZ, CDCl3 + MeOD) δ(ppm): 52.01 (Ca), 95.07(Cb), 118.83 (C3’), 121.81 (C3), 
124.12 (C5), 127.72 (Cm), 128.67 (Co), 137.25, 137.36 (C4), 138.07, 145.07 (Cc),  149.71, 
155.87, 157.23 (C2), 157.23 (Cd), 165.86 (Ce). 
HRMS: m/z (M+): [M+H]+ calculated = 433.1771, [M+H]+  found = 433.1733. 
IR ѵ(cm-1): 3133.2, 1610.3, 1583.9, 1567.1, 1516.9, 1488.9, 1466.1, 1358.5, 1265.8, 11863.8, 
1038.5, 787.4, 729.2, 884.3, 689.6, 602.1, 538.9, 404.8. 
 
52) 4’-(N1-methylphenyl-2-amino-6-chloropurine)-2,2’:6’,2”-terpyridine  
(P-terPy)15 (T24) 
                   
Chemical Formula: C27H19N8Cl 
 Molecular Weight: 490.96 g/mol 
 
2-amino-6-chloropurine (337.2 mg, 1.988 mmol, 2 eq) and K2CO3 (206 mg, 1.49 mmol, 1.5 eq) 
were dissolved in 15 mL of dry DMF and degassed for 15 minutes. To the suspension, a solution 
of Br-terPy (400 mg, 0.994 mmol, 1 eq) in 2 ml of dry DMF was added drop wise. The reaction 
was stirred at 50 oC overnight and followed by TLC. After the disappearance of Br-terPy, the 
crude was dried under vacuum and then washed with 10 mL of water. The product was then 
purified by column chromatography (Al2O3, 2% MeOH in DCM) to give 0.2 g of G-terPy as white 
solid (43 %).  
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1H NMR (500 MHz, DMSO-d6) δ (ppm): 5.41 (2H, s, Ha), 6.99 (2H, s, brd, NH2 purine), 7.45 
(2H, d, 3J = 8.0 Hz, Hm), 7.46 (2H, ddd, 3J = 7.1 Hz, 7.1 Hz, 4J = 1.7 Hz, H5), 7.92 (2H, d, 3J = 
8.1 Hz, Ho), 8.04 (2H, ddd, 3J = 7.2 Hz, 7.3 Hz, 4J = 1.1 Hz, H4), 8.31 (1H, s, Hb), 8.66 (4H, d, 3J 
= 8.05 Hz, H6), 8.67 (4H, m, H3 & H3’). 
13C NMR (126 MHz, DMSO-d6) δ(ppm): 45.87 (Ca), 117.95 (C3’), 21.02 (C3), 123.30 (Cc), 
124.64 (C5), 127.42 (Cm), 128.15 (Co), 136.96, 137.56 (C4), 138.03, 143.35 (Cb), 149.05 (Cd), 
149.41 (C6), 149.58, 154.19, 154.92 (C2), 155.74 (Ce), 160.01 (Cf). 
HRMS (ESI): m/z (M+): [M+H]+ calculated = 491.1494, [M+H]+ found = 491.1495. 
IR ѵ(cm-1): 3478.0, 3306.3, 3178.3, 3086.0, 1629.0(C=N stretching), 160.6, 1584.6, 1562.1, 
1515.0, 1460.4, 1406.1, 1389.5, 1345.5, 1277.2, 1218.2, 1137.9, 1115.7, 1036.4, 997.9, 939.1, 
914.8, 879.5, 792.8, 784.1, 658.6, 594.6, 562.6, 529.2, 500.8, 409.2. 
 
53) 4’-(N1-methylphenylguanine)-2,2’:6’,2”-terpyridine (G-terPy)15 (T25) 
                                                 
Chemical Formula: C27H20N8O 
Molecular Weight: 472.51 g/mol 
P-terPy (0.1 g, 0.2 mmol, 1 eq) was dissolved in 20 mL of 0.1 M aqueous HCl solution and stirred 
at 100 oC under reflux overnight. The reaction was followed by TLC and then stopped when all 
the P-terPy was oxidized into G-terPy. To the reaction mixture, 0.1 M NaOH solution (3 mL) was 
added drop wise to neutralize the mixture. A white precipitate was formed, which was filtered and 
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washed with acetone (10 mL). The precipitate was dried under reduced pressure to give 90 mg of 
G-terPy as a white solid (96 %). 
 
1H NMR (500 MHz, DMSO-d6) δ (ppm): 5.30 (2H, s, Ha ), 6.56 (2H, s, brd, NH2 guanine), 7.41 
(2H, d, 3J = 8.2 Hz, Hm,), 7.53 (2H, ddd, 3J = 7.3 Hz, 7.3 Hz, 4J = 1.0 Hz, H 5), 7.85 (1H, s, Hb), 
7.91 (2H, d, 3J = 8.2 Hz, Ho), 8.04 (2H, ddd, 3J = 7.8 Hz, 7.7 Hz, 4J = 1.7 Hz, H4), 8.66 (4H, d, 3J 
= 7.95 Hz, H6), 8.72 (4H, m, H3 & H3’), 10.68 (1H, s, brd, NH guanine). 
13C NMR (126 MHz, CDCl3) δ(ppm): 45.57 (Ca), 116.62 ( Cc), 117.99 (C3’) 121.07 (C3), 124.69 
(C5), 127.39 (Cm), 128.08 (Co), 136.82, 137.62 (C4), 137.4 (Cb), 138.75, 149.16 (Cd), 149.45 
(C6), 151.34, 153.86 (Ce), 154.96, 155.78 (C2), 156.91 (Cf). 
HRMS (ESI): m/z (M+): [M+H]+ calculated =  473.1833, [M+H]+ found = 473.1830. 
IR ѵ(cm-1):  3177.7, 272.5, 1716.2 (C=O stretching), 1604.7, 1586.8, 1567.8, 1544.2, 1468.7, 
1442.1, 1391.7, 1265.8, 1190.8, 1155.5, 1080.0, 1039.2, 864.2, 786.7, 764.7, 685.5, 680.4, 548.6, 
503.0, 403.8. 
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Zn(II) [5,15 -di(N1-(benzylhydry)uracil)- 10,20-dipentylporphyrin] (T1) 
 
 
1H NMR (300 MHz, CDCl3 + MeOD)  
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13C NMR (126 MHz, CDCl3 + MeOD) 
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5,15-di(uracil)- 10,20-dipentylporphyrin (T2) 
 
 
HRMS 
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Zn(II) [5, 15-di(N1-hexyluracil)-10,20-dipentylporphyrin] (T3) 
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1H NMR (300 MHz, CDCl3)  
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5-(N1-methylphenylthymine )10,15,20-triphenylporphyrin (T4) 
 
 
1H NMR (500 MHz, CDCl3) 
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13C NMR (126 MHz, CDCl3) 
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5,15-bis(N1-methylphenylthymine)-10,20-dimesitylporphyrin (T5) 
 
 
1H NMR (400 MHz, DMSO-d6) 
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13C NMR (126MHz, CDCl3 + MeOD) 
 
 
 
HRMS: 
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5,15-bis(N9-methylphenyladenine)-10,20-dimesitylporphyrin (T6) 
 
 
1H NMR (500 MHz, CDCl3 + MeOD) 
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13C NMR (126MHz, CDCl3 + MeOD) 
 
 
 
HRMS  
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5,15-bis(N1-methylphenylcytosine)-10,20-dimesitylporphyrin (T7) 
 
 
1H NMR (400 MHz, DMSO-d6) 
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13C NMR (126MHz, DMSO-d6) 
 
 
 
HRMS  
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5,15-bis(N9-methylphenyl-2-amino-6-chloropurine)-10,20-dimesitylporphyrin (T8) 
 
 
1H NMR (500 MHz, CDCl3) 
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13C NMR (126 MHz, CDCl3 + MeOD) 
 
 
 
HRMS  
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5,15-bis(N9-methylphenylguanine)-10,20-dimesitylporphyrin (T9) 
N
NH N
HN
HN
N
N
N
O
H2N
NH
N
N
N
O
NH2
 
 
1H NMR (500 MHz, DMSO-d6) 
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5,10,15,20-tetrakis(N1-methylphenylthymine)porphyrin (T10) 
 
 
1H NMR (400 MHz, CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
HRMS  
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1,3,7,9-tetramethyl-5-(N1-methylphenylthymine)-dipyrrin (T-dipyrrin) (T11) 
 
 
1H NMR (500 MHz,CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
 
HRMS 
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1,3,7,9-tetramethyl-5-(N9-methylphenyladenine)-dipyrrin (A-dipyrrin) (T12) 
 
 
1H NMR (500 MHz,CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
HRMS 
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1,3,7,9-tetramethyl-5-(N1-methylphenylcytosine)-dipyrrin (C-dipyrrin) (T13) 
 
 
1H NMR (300 MHz,DMSO-d6) 
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13C NMR (500 MHz, DMSO-d6) 
 
 
 
HRMS 
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1,3,7,9-tetramethyl-5-(N9-methylphenyl-2-amino-6-chloropurine)dipyrrin 
(P-dipyrrin) (T14) 
N
N
N
N
Cl
NH2
NNH
 
 
1H NMR (500 MHz,CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
 
HRMS 
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1,3,7,9-tetramethyl-5-(N9-methylphenylguanine)dipyrrin (G-dipyrrin) (T15) 
NH
N
N
N
O
NH2
NNH
 
 
HRMS 
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4-(N1-methylthymine)pyridine (T-Py) (T16) 
 
 
1H NMR (500 MHz, CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
 
HRMS 
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4-(N9-methyladenine)pyridine (A-Py) (T17) 
 
 
1H NMR (500 MHz, DMSO-d6) 
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13C NMR (126 MHz, DMSO-d6) 
 
 
 
HRMS 
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4-(N1-methylcytosine)pyridine (C-Py) (T18) 
 
 
1H NMR (500 MHz, DMSO-d6) 
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13C NMR (126 MHz, DMSO-d6) 
 
 
 
HRMS  
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4-(N9-methyl-2-amino-6-chloropurine)pyridine (P-Py) (T19) 
 
 
1H NMR (500 MHz, DMSO-d6) 
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13C NMR (126 MHz, DMSO-d6) 
 
 
 
MS 
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4-(N9-methylguanine)pyridine (G-Py) (T20) 
 
 
1H NMR (500 MHz, DMSO-d6) 
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13C NMR (126 MHz, DMSO-d6) 
 
 
 
HRMS  
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4’-(N1-methylphenylthymine)-2,2’:6’,2”-terpyridine (T-terPy) (T21) 
H
N
N
O O
N
NN
 
 
1H NMR (500 MHz, CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
 
HRMS  
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4’-(N9-methylphenyladenine)-2,2’:6’,2”-terpyridine (A-terPy) (T22) 
 
 
1H NMR (500 MHz, CDCl3) 
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13C NMR (126 MHz, CDCl3) 
 
 
 
HRMS 
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4’-(N1-methylphenylcytosine)-2,2’:6’,2”-terpyridine (C-terPy) (T23) 
 
 
1H NMR (400 MHz, DMSO-d6) 
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13C NMR (126 MHz, CDCl3 + MeOD) 
 
 
 
HRMS 
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4’-(N1-methylphenyl-2-amino-6-chloropurine)-2,2’:6’,2”-terpyridine 
(P-terPy) (T24) 
 
 
1H NMR (500 MHz, DMSO-d6) 
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13C NMR (126 MHz, DMSO-d6) 
 
 
 
HRMS 
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4’-(N1-methylphenylguanine)-2,2’:6’,2”-terpyridine (G-terPy)
 (T25) 
 
 
1H NMR (500 MHz, DMSO-d6) 
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13C NMR (126 MHz, DMSO-d6) 
 
 
 
HRMS 
 
3
9
.5
2
4
5
.5
7
1
1
6
.6
2
1
1
7
.9
9
1
2
1
.0
7
1
2
4
.6
9
1
2
7
.3
9
1
2
8
.0
8
1
3
7
.6
2
1
3
7
.6
7
1
3
8
.7
5
1
4
9
.1
6
1
4
9
.4
5
1
5
1
.3
4
1
5
3
.8
6
1
5
4
.9
6
1
5
5
.7
8
1
5
6
.9
1
List of Tectons 
 
326 
 
N
N N
N
NH
N
O
OO
O
N
HN
Zn
N
NH N
HN
NH
NH
O
OO
O
HN
HN
T1 T2
N
N N
N
NH
N
O
OZn
HN
N
O
O
T3
N
HNN
NH
HN
N
O
O
T4  
 
List of Tectons 
 
327 
 
 
 
 
 
List of Tectons 
 
328 
 
 
 
 
 
 
 
 
 
 
 
